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Abstract 
 
Diarrhoeal diseases remain a global health threat and are responsible for high levels 
of morbidity and mortality worldwide, with an estimated 1.7 billion cases every 
annum. Additionally, according to the World Health Organisation, diarrhoeal 
diseases are the second leading cause of death in children under 5 years old. 
Salmonella are one of the most common diarrhoeal pathogens [1] (WHO Accessed 
20 February  2015) with serovars Enteritidis, Typhimurium and Typhi playing a 
major role in outbreaks worldwide. However, Salmonella enterica serovar 
Weltevreden (S. Weltevreden) has recently attracted a great deal of interest due to 
increasing reports of its isolation by reference laboratories around the world, with a 
particular high incidence in South East Asia. However, relatively little is known 
about the genotypic or phenotypic properties of this understudied serovar. 
 
In this study, phylogenetics and comparative genomics based on whole genome 
sequences were used to define the genetic diversity within a sizeable collection of S. 
Weltevreden isolates collected from across the globe, with a focus in South East 
Asia. This phylogenetic analysis confirmed that the S. Weltevreden isolates belong to 
a monophyletic clade formed of several sub-clades presenting distinct geographical 
clustering and characteristics. Phenotypic characterisation was performed on selected 
isolates, with an aim to dissect aspects of host-pathogen interaction during infection, 
providing a foundation to compare S. Weltevreden with other serovars such as S. 
Typhimurium. Interestingly, an overall attenuated pathology was observed both in-
vitro (hep 2 cell line) and in-vivo (murine and zebrafish embryos) for S. Weltevreden 
compared to the S. Typhimurium reference strain. 
 
This is the first report of the phylogenetic analyses of S. Weltevreden and of a 
systematic in-vitro and in-vivo characterisation of the sub-species. 
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1 Introduction 
 
Infectious diseases are still one of the most common causes of morbidity and 
mortality in both humans and domestic animals. In regions of the world with poor 
economic development, many of the classical infections such as cholera and typhoid 
still persist and new diseases such as ebola are emerging [2-4]. In the more 
economically developed parts of the world, infections associated with zoonosis or 
health-care systems are an ever-present threat and given the increasing age 
demographic these threats are unlikely to recede [5, 6]. Further, the global 
emergence of multiple drug resistant microbes is challenging our ability to treat 
infections in a reliable manner and new antimicrobials are urgently required [7]. 
Thus, the ability to identify and understand pathogens and determine how they are 
spread will be central to our future success in combatting our old adversaries. 
The challenges presented by infections are considerable. It is clear that microbes 
have the ability to evolve rapidly to fill new ecological niches and to resist our 
attempts to kill them. Fortunately, these challenges coincide with an era where we 
are learning more about the epidemiology of disease and the molecular basis of 
infection. Modern molecular and immunological techniques, linked to the genomic 
sciences, are providing a rich source of tools for studying pathogen genetics, 
immunity and evolution [8-10]. Over the past decades a reductionist approach has 
yielded vital information on how microbial genes contribute to virulence and how 
their translated products contribute to pathogenesis [11, 12]. More recently, 
mammalian genetics is revealing the contribution of host genes to infection 
susceptibility [13-15]. The introduction of new generation sequencing technologies 
has revolutionised our ability to sequence the genomes of microbial populations, 
facilitating the analysis of whole genomes as a source of information on phylogeny, 
pathogen evolution and disease transmission [16-18]. As more human genomic data 
becomes available, similar progress can be anticipated in terms of identifying 
infection-susceptible individuals. It is hoped that many of these basic scientific 
advancements will begin to have impact in the form of improved treatments in the 
near future.  
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1.1 Diarrhoeal diseases  
Infections of the intestine associated with diarrhoea are still an important component 
of the global infectious disease burden with an estimated 1.7 billion cases of 
diarrhoeal disease every year [19]. In the developing world these impact 
disproportionately on new-borns and infants, particularly those that are poorly 
nourished or lack access to an effective public health infrastructure. According to the 
World Health Organisation (WHO), diarrhoeal diseases are the second leading cause 
of death in children under 5 years old and are accountable for ~760,000 deaths 
annually out of 2.2 million deaths overall [20]. 
A recent global study, known as the Global Enterics Multi-Center Study (GEMS), 
reported extensively on links between the incidence of severe diarrhoea and death 
[21]. GEMS was funded by the Bill and Melinda Gates Foundation (Gates) and 
managed from the University of Maryland, covering sites in sub-Saharan Africa 
(Kenya, Mali, Mozambique, and The Gambia), and South Asia (Bangladesh, India, 
and Pakistan). GEMS ran over a 3-year period involving children aged from 0 – 59 
months residing in high endemic areas. The GEMS study found that the risk of child 
mortality was 8.5 fold higher in infants with moderate to severe diarrhoea than in 
children without diarrhoea. GEMS also highlighted that rotaviruses, 
Cryptosporidium, Enterotoxigenic Escherichia coli producing heat- stable toxin (ST-
ETEC; with or without co-expression of heat-labile enterotoxin (LT)), and Shigella 
were important cases of severe to moderate diarrhoea in many of these sites. Other 
pathogens were frequently isolated from diarrhoea cases either at specific sites, 
within regions or were consistently present, but at lower incidence levels 
(Aeromonas, Vibrio cholerae O1, Campylobacter, Salmonella). Figure 1.1 shows the 
incidence of pathogen-specific diarrhoea per 100 children per year, in different age 
stratum from the GEMS data.   
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Figure 1.1: Incidence of pathogen-specific moderate-to-severe diarrhoea per 100 child-years  
Incidence of pathogen-specific moderate-to-severe diarrhoea per 100 child-years by age stratum in 
endemic areas (all sites combined). The bars show the incidence rates and the error bars show the 95% 
CIs [21]. Data taken from the GEMS study. 
GEMS and other related studies suggest that interventions specifically targeting the 
pathogens causing diarrhoea, potentially by identifying transmission pathways or 
reservoirs, could be a route towards significantly reducing the burden of diarrhoeal 
diseases. Understanding the microbial complexity of the diarrhoeal diseases could 
also facilitate the implementation of new prevention and treatment strategies that are 
urgently needed if we are to reduce infections and improve disease outcomes [21]. 
Salmonella were consistently isolated at the different GEMS sites, although they 
were clearly not the dominant cause of severe diarrhoea at any particular site. 
However, in addition to any role in causing diarrhoea in children, Salmonella can 
play a key role in bloodstream infection in Africa and Asia, adding to their overall 
disease burden. Bloodstream infection in Africa is a major healthcare threat 
associated with high mortality. A review on community-acquired bloodstream 
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infections in Africa, analysing 22 case-studies of infection, revealed that overall 
13.5% of adults and 8.2% of children had experienced some form of bloodstream 
infection [22]. Where recorded, patients with systemic infections had an overall case 
fatality of 18·1%. Although malaria accounted for a significant proportion of 
systemic infections, Salmonella was responsible of ~30% of non-malaria invasive 
diseases (~60% of these being nontyphoidal Salmonella (NTS)). Streptococcus 
pneumoniae was also a significant cause of invasive bacterial disease in the same 
regions and was the most commonly isolated bacterial species in children. HIV co-
infection was associated with an increased risk of invasive bacteraemia in general; 
particularly with Salmonella enterica and Mycobacterium tuberculosis [22]. A 
number of different serovars of Salmonella were associated with invasive disease 
(see below). 
The burden of infectious diarrhoea in developed countries is generally distinct from 
that in the developing world. In economically developed regions, many diarrhoeal 
diseases are acquired through contamination of the food chain, involving zoonotic 
sources such as meat, dairy products or indirectly contaminated produce such as 
lettuces exposed to sewage [23, 24]. At a global level, Salmonella has been reported 
as one of the most common foodborne pathogens by the WHO along with 
Campylobacter, E. coli, Shigella and Trichinella [1]. Diseases associated with 
Salmonella are frequently caused by clades/strains that are spreading internationally 
(see below). E. coli infections, particularly those involving Enteropathogenic or 
Enterohemorrhagic E. coli (EPEC/EHEC) are also relatively common, as are 
Shigella infections in children associated with Shigella sonnei [25, 26]. The spread of 
Shigella is likely to involve human to human transmission rather than a zoonotic 
source as Shigella is largely a human restricted pathogen. Other common causes of 
diarrhoeal disease in developed regions are viruses such as norovirus and rotaviruses 
that also usually spread directly between humans. Perhaps the most common cause 
of bacterial diarrhoea in many developed countries are specific Campylobacter 
species, especially C. jejuni [27]. These are frequently found associated with the 
handling and improper cooking of poultry. In addition, travellers to endemic regions 
of the world can bring back cases of disease (known as traveller’s diarrhoea). 
Another emerging form of diarrhoeal diseases is the so-called antibiotic-associated 
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diarrhoeas that can follow treatment with antibiotics. Such infections are particularly 
common in the elderly and the immunocompromised in health-care associated 
settings such as hospitals [28]. A common cause of antibiotic-associated diarrhoea is 
due to Clostridium difficile which has emerged to prominence over the past few 
decades [29]. C. difficile is a broad species from which highly infectious sub-clades 
emerge periodically to cause epidemics [30-32]. Many of these clades are now 
endemic within the hospital systems of countries. C. difficile can overgrow in the 
intestine following antibiotic treatment, releasing potent enterotoxins that cause 
significant local and systemic pathology [33]. Individuals treated with antibiotics 
frequently relapse with C. difficile infection and thus the clinical management of the 
disease is challenging. 
1.2 Salmonella enterica  
Salmonella are a common cause of infections in many parts of the world in both 
humans and animal species. Salmonella infection is associated with different disease 
syndromes ranging from acute gastroenteritis/diarrhoea to generally more chronic 
systemic diseases such as typhoid. Salmonella are rod shaped non-spore forming and 
Gram-negative bacteria. They are predominantly motile due to the expression of 
flagellae and individual cells can vary somewhat in size. They are also chemo-
organotrophs and facultative anaerobes. 
The genus Salmonella was named after Daniel Elmer Salmon, an American 
veterinary pathologist who discovered the pathogen while searching for the cause of 
common hog cholera. Salmonella are Gammaproteobacteria and belong in the 
family Enterobacteriaceae. It is generally acknowledged that there are two species of 
Salmonella; Salmonella bongori and S. enterica. S. bongori is commonly found in 
cold-blooded animals, including reptiles and snakes and likely evolved within such 
animals. S. bongori can occasionally cause diarrhoeal disease in humans, although 
this is relatively rare [34, 35]. S. enterica is an old, broad and complex species that is 
likely millions of years old [36]. It harbours a number of distinct sub-species but the 
most common causes of disease in humans and veterinary animals fall into S. 
enterica sub-species I (Figure 1). The six main sub-species are enterica (I), salamae 
(II), arizonae (IIIa), diarizonae (IIIb), houtenae (IV) and indica (VI). 
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Figure 1.2: Phylogeny of selected members of the enterobacteriaceae based on sequence 
comparison of core genes within the respective genomes 
Connecting lines coloured according to species/subspecies: six subspecies of S. enterica in red, S. bongori 
in blue, E. coli in green, S. flexneri in purple, and Klebsiella pneumoniae in pink. Branch lengths are 
indicative of the estimated substitution rate per variable site. Taken from. [37] 
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Salmonella nomenclature is complex and has changed over time. Initially, isolates 
were designated or named according to clinical considerations or after the host 
species they were frequently isolated from, for example, S. Typhimurium (mouse 
typhoid fever), Salmonella Cholerasuis (hog cholera) etc. Later on, it was recognised 
that host specificity was not a property of all Salmonella; therefore new strains or 
serovar (short for serological variants) were named according to the location where 
they were isolated from; for instance Salmonella Newport, Salmonella Montevideo.  
The above nomenclature was developed without any specific consideration of the 
phylogeny of the isolates. Many thought that individual Salmonella serovars were 
actually separate species but DNA comparison studies proved that this was not the 
case. Since S. enterica can refer to either a species or subspecies a rethink on the 
nomenclature was required. Committees of the WHO and other esteemed bodies, 
alongside the recognition that S. enterica was a single species, developed a new 
nomenclature system for S. enterica based on DNA comparison studies linked to 
serological analysis. The complete description of a Salmonella now uses the 
following typical designation: S. enterica subspecies enterica serotype Typhimurium 
(or Dublin, Gallinarum etc. depending on the serovar) and this can be shorten to 
Salmonella typhimurium or now more commonly Salmonella Typhimurium [38]. 
The bacteria of the genus Salmonella are commonly classified using a serological 
scheme developed by Kauffmann and White (known accordingly as the Kauffmann-
White Scheme) [39]. Indeed, this is the approach used by most current reference 
microbiology laboratories. The scheme works by raising typing sera in rabbits 
against key antigens present on the surfaces of the Salmonella. These typing sera 
work as references. The typing antigens are diverse and facilitate discrimination and 
groupings simultaneously. O antigen, a component of bacterial lipopolysaccharide, is 
one of the key typing antigens. There is significant diversification in the somatic O 
typing antigen (repeat units of saccharide, which give the smooth appearance to 
colonies growing on agar). Another key typing antigen is the flagellin protein or H 
antigen (a heat labile antigen located in bacteria flagellae). H typing can be based on 
Salmonella phase 1 and phase 2 flagella antigens [39]. A third class of antigen is the 
surface component known as "Vi" (a capsular polysaccharide that contributes to the 
virulence of the bacterium in the host). Vi is a linear, acidic homopolymer of α-1,4-
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linked N-acetylgalactosaminuronate (D-GalNAcA), variably O-acetylated at C-3 [40, 
41] and is commonly found on isolates of S. Typhi, S. Paratyphi C and occasionally 
on isolates of S. Dublin.  
The Kauffmann-White scheme is significantly discriminating and has proved to be a 
robust, if not completely accurate approach to typing Salmonella. There are currently 
over 2400 reported Salmonella serovars and others are likely to emerge in the future. 
The frequency of isolation of Salmonella of a particular serovar varies over time and 
location with evidence of frequent epidemics and outbreaks. S. Typhimurium, S. 
Enteritidis and S. Dublin are commonly isolated serovars associated with human 
gastroenteritis. 
S. enterica can cause a range of different disease syndromes. Certain serovars are 
regarded as more likely to cause gastroenteritis in a particular host (for example, S. 
Enteritidis in humans), whereas others are more likely to cause systemic typhoid (for 
example, S. Typhi in humans). This is a useful, but not an absolute classification, and 
disease outcome can be influenced by a range of factors such as the host/isolate 
pairing, immune status and infectious dose. Nevertheless, Salmonella are often 
classified based on the most common clinical outcome and in this context are 
described as either typhoidal (typhoid fever and paratyphoid fever) or non-typhoidal 
Salmonella. 
1.2.1 Typhoidal Salmonella 
Originally isolated in 1880 by Karl J. Eberth, the causative organism of typhoid fever 
S. Typhi is a pathogen that can colonise the lymphatic tissues of the small intestine, 
liver, spleen, and bloodstream of infected humans. It does not cause disease in 
animals, other than higher primates under experimental conditions [42]. Most S. 
Typhi isolates from typhoid fever cases express the polysaccharide capsule Vi, which 
is associated with increased infectiousness and virulence [43]. Humans are the only 
natural host and reservoir for S. Typhi although the pathogen can survive for days in 
water and for months in contaminated food. Reported risk factors include a history of 
contact with other patients before illness, access to dirty water and past evidence of 
infection with Helicobacter pylori [44]. Work on typhoid fever patients in Vietnam 
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has suggested an important role of HLA-linked genes in governing susceptibility or 
resistance to this infection. HLADRB1* 0301/6/8, HLA-DQB1*0201-3, and the 
tumour necrosis factor A loci (TNFA*2-308) were associated with susceptibility to 
typhoid fever, while HLA-DRQB1*04, HLA-DQB1*0401/2 and TNFA*1(-308) 
were associated with lower risk [45, 46]. HLA-DRB1*12 is associated with 
protection against complicated typhoid fever [47]. 
The clinical presentation of typhoid fever is variable, ranging from fever with little 
morbidity to marked toxaemia and associated complications involving many 
systems. The commonest complications are gastrointestinal bleeding, intestinal 
perforation and typhoid encephalopathy [48, 49]. In endemic regions, diagnosis can 
be missed because of non-specific features like diarrhoea and vomiting, or 
predominant respiratory symptoms. In children younger than 5 years, typhoid fever 
can be milder and can mimic a viral syndrome. The rate of severe complications is 
lower than at later ages. Factors affecting severity could include duration of illness 
before therapy, choice of antimicrobial therapy, strain virulence, inoculum size, 
previous exposure or vaccination, and other host factors such as HLA type (see 
above), immune suppression or antacid consumption.  
Clinical features of paratyphoid fever are generally reported to be similar to those of 
typhoid fever but are usually thought to be milder with a shorter incubation period. S. 
Paratyphi A or Paratyphi B can manifest with jaundice, thrombosis, and systemic 
infections. S. Paratyphi B might occasionally have an onset similar to non-specific 
gastroenteritis [50]. Gastrointestinal symptoms are usually not present with S. 
Paratyphi C but there have been cases with systemic complications such as 
septicemia and arthritis [51]. 
Unlike many Salmonella infections, typhoid can be associated with a chronic, 
potentially asymptomatic carrier state involving systemic tissues such as the 
gallbladder. Chronic typhoid carriers are likely important for survival of the 
pathogen, and may be responsible of the contamination of water and food. Carriers 
can be notoriously difficult to identify because they are usually quite healthy, 
although elevated levels of anti-Vi antibodies can be present in the serum of carriers 
[52]. 
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1.2.2 Nontyphoidal Salmonella (NTS) 
The NTS are more frequently associated with localised acute gastroenteritis and 
diarrhoeal disease rather than typhoid. Acute gastroenteritis is the most common 
presentation of NTS infection. Typical symptoms include diarrhoea, nausea, 
headache, and sometimes vomiting. Fever and abdominal cramps are almost always 
present. Bloody diarrhoea and invasive disease may occur, particularly with certain 
serotypes. NTS can cause invasive disease, particularly in compromised hosts. 
Invasive infection may present as urinary tract infection, septicaemia, abscess, 
arthritis, cholecystitis and rarely as endocarditis, pericarditis, meningitis, or 
pneumonia. Asymptomatic carriage can occur in as many as 5% of healthy hosts 
[53].   
NTS bacteria are widely distributed in the animal kingdom, including humans, 
livestock, pets, wild mammals, poultry (and other birds), reptiles and amphibians as 
well as in seafood. Most NTS serovars are regarded as being more promiscuous in 
terms of their abilities to infect different hosts, compared to the typhoidal serovars 
that are often host-adapted or even host-restricted. As NTS are generally 
promiscuous they often have zoonotic potential, surviving in veterinary herds or 
companion animals, from which they can spread to humans via food consumption or 
environmental contamination. Although NTS may cause disease in one animal they 
may just colonise other species or older members of the same species. Thus, the 
status quo of the host/pathogen relationship can vary. Indeed, NTS that frequently 
cause gastroenteritis in humans, such as S. Typhimurium and S. Enteritidis, can cause 
invasive disease in the compromised [54-56]. Approximately 2 to 8 percent of NTS 
infections are associated with bacteraemia, and are not always preceded by 
gastroenteritis. Risk factors for NTS bacteraemia include being 
immunocompromised (including HIV, malignancy, chemotherapy, steroid therapy) 
and extremes of age (less than 3 month and greater than 50 years old). However, 
such risk factors are not apparent in up to one third of cases of NTS bacteraemia. 
Extra-intestinal focal infections such as arthritis, meningitis or pneumonia occur in 5-
10% of those with bacteraemia. Additionally, NTS can be more associated with 
invasive disease in particular settings, for example in sub-Saharan Africa where the 
epidemiology may be different and the genotype of the isolates may be specialised 
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[16]. Further, there may be significant differences on pathogenic potential even 
within a serovar. For example, DT2 isolates of S. Typhimurium are largely host 
restricted to pigeons and do not efficiently infect humans [57]. Common 
transmission routes for NTS include ingestion of contaminated water or food, direct 
exposure to infected animal or their waste as well as faecal-oral transmission. 
Infection can also occur in medical care settings where immunocompromised 
patients are at increased risk.  
1.3 Molecular approaches to identify and 
discriminate between S. enterica  
The ability to identify and discriminate between microbes associated with disease is 
important for epidemiological surveillance and facilitating public health policy 
decision-making. Many different methods have been developed to identify pathogens 
with relatively varying degrees of success. Microbial culture is the classical 
approach, although not all microbes can be readily cultured. Once, cultured, 
microbes can be subjected to different phenotypic and molecular tests. If the microbe 
cannot be cultured, then sensitive molecular or immunological assays may be more 
appropriate. The most common traditional phenotypic assays applied to cultured 
microbes include the use of serological and metabolic tests, although such assays 
may be challenging in terms of their specificity and discriminatory power. Multi-
Locus Enzyme Electrophoresis (MLEE) is a metabolic assay that measures different 
enzyme activities and this approach proved useful in the early days of defining S. 
enterica phylogeny [58]. The Kauffmann-White scheme has proved to be a robust 
methodology for serotyping S. enterica isolates, with over 2000 different serovars 
being defined to date. These serovars can be allocated to generalised typhoidal and 
non-typhoidal classes and into host adapted or host restricted types (Figure 1.3). 
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                                                     Figure 1.3: General overview of the current classification of S. enterica. Taken from [59] 
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Serotyping in S. enterica relies on specific reference sera that are generated by 
immunising rabbits or other animals. These reference sera are difficult to quality 
control and are usually generated in reference laboratories or by companies. Thus, 
serotyping can be challenging and expensive and is utilised predominantly in 
reference laboratories. Nevertheless, the Kauffmann-White scheme has proved to be 
of tremendous value in terms of defining S. enterica serovars over decades, 
facilitating diagnosis and outbreak analysis. However, serotyping does not readily 
discriminate below the serovar level and provides little or no phylogenetic 
information. 
Serotyping relies on detecting antigenic variation in a limited number of surface 
associated bacterial antigens. Another target for the identification and typing of 
microbes is the genome. Analysis targeting DNA can indirectly measure differences 
in genome organisation (chromosome, plasmids etc.) or can be directly DNA 
sequence based. Techniques that analyse genome organisation include plasmid 
profiling [60] and Pulsed Field Gel Electrophoresis (PFGE) [61]. Plasmid profiling 
has limited utility as plasmids represent only a small component of the genome and 
can transfer between isolates, compromising identification. PFGE works by targeting 
rare restriction sites on the chromosome and analysing large DNA fragments 
generated by restriction using pulse field electrophoresis. This approach has found 
broad utility in the area of S. enterica molecular epidemiology and has proved 
extremely useful for analysing global spread and local outbreaks [62, 63]. Specific 
software has been developed to image and compare the patterns of DNA fragments 
generated by PFGE and networks such as PulseNet have appeared to facilitate data 
exchange. Nevertheless, PFGE provides only limited genomic and phylogenetic 
information and lacks discriminatory power and methods based on whole genome 
analysis are likely to supersede them. Other sub-genomic methodologies have also 
been developed based on Polymerase Chain Reaction (PCR) methods, including 
Restriction Fragment Length Polymorphism (RFLP) [64]. These have proved useful 
for discrimination, but are also likely to be superseded by whole genome sequencing. 
DNA sequence based methodologies have the advantage of simplifying comparative 
analysis. Such typing methods exploit the unambiguous nature and electronic 
portability of nucleotide sequence data to classify microorganisms. Multi-Locus 
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Sequence Typing (MLST) was one of the first methodologies developed that was 
based on sequence reads and the approach has found broad utility for different 
pathogens, including S. enterica [59, 65]. Classical MLST is based on sequences 
derived from 7 housekeeping gene fragments (alleles) that represent the core genome 
of a microbe. The 7 sequences generated by different isolates can be compared at the 
nucleotide level and differences quantified. Isolates that possess identical alleles for 
all gene fragments are assigned to a common Sequence Type (ST), and STs that 
share all but 1 or 2 alleles can be grouped into ST-based clonal complexes on the 
basis of software such as eBurst [66, 67]. This scheme has also been used to survey 
the genetic properties of various S. enterica serovars, including antibiotic resistant 
clades. The results suggested that most of the time, the MLST type correlates with 
serovar, with some exceptions [59]. eBurst analysis provides some phylogenetic 
information and allows sub-serovar discrimination within many serovars. A recent 
study using MLST of the population structure of subspecies in S. enterica showed 
that many Salmonella STs cluster together in discrete groups called eBGs 
(eBurstGroups) [59]. Here, an eBG was defined by groups of 2 or more STs that 
were connected by pair-wise identity at 6 of the 7 gene fragments, thus sharing 6 of 
the 7 alleles that defined the ST. However, some serovars, such as S. Typhi, are 
significantly monophyletic and here the utility of MLST is somewhat limited. 
Nevertheless, it has been proposed that MLST analysis, or similar approaches, could 
replace serotyping. Variants of MLST have also been developed that target specific 
genetic loci (for example, O antigen loci) or genes (for example, fliC for flagellin) 
[68]. 
In general, bacterial taxonomy can exploit a top-down approach based on 
phylogenetics in order to elucidate a genealogical tree or a bottom up analysis 
exploiting population genetics in order to identify populations and networks. Trees 
are appropriate for clonal organisms. Population genetic analysis is arguably more 
appropriate for organisms with frequent homologous recombination such as S. 
pneumoniae [69].  S. enterica does exhibit recombination but not at the level of the 
more recombinogenic species. In reality, bacterial taxonomy benefits generally from 
a combined approach. Indeed, new approaches are in development, which explicitly 
include lateral gene transfer events in the genealogy. Considering that frequent 
recombination has the potential to alter classical phylogenetic data, definition of 
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eBurst groups based on allelic identity rather than sequence identity provide discrete 
clusters of related organisms even in presence of significant levels of homologous 
recombination [59]. 
1.4 Evolution of the genus Salmonella 
The genus Salmonella is thought to have evolved from a common ancestor within the 
Enterobacteriaceae over many millions years, with estimates of at least 100 million 
years of such evolution [70]. The two recognised Salmonella species S. bongori and 
S. enterica are thought to have diverged 40 - 65 million years ago although such 
lengths of time are very difficult to estimate. The evolutionary signatures that mark 
differentiation and those that track different branch points have been investigated by 
analysing factors including sequence variation, gene flux across the 
species/subspecies, the distribution of the different virulence-associated systems and 
metabolic traits.  
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Figure 1.4: Maximum likelihood phylogenetic tree of Salmonella based on concatenated MLST loci. 
Taken from [71] 
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A combination of MLST and whole genome analysis (see Section 1.3) can be used to 
provide an overview of the general organisation of the Salmonella. For example, 
Figure 1.4 displays a candidate phylogeny based on concatenated MLST analysis. 
Such analysis places S. bongori on a separate evolutionary branch from S. enterica, 
suggesting a common ancestor but no direct succession [71]. S. bongori is likely the 
older species that evolved largely, and remains predominantly, within cold blooded 
animals, including reptiles. The various S. enterica sub-species can be seen 
distributed along the phylogeny leading to sub-species I, which has undergone 
significant relatively recent expansion, likely within predominantly warm blooded 
animals, including humans. 
Gene flux and exchange can provide insight into the evolution of the Salmonella. For 
example, the analysis of the presence or absence of major virulence-associated 
systems is a useful approach to trace the evolution of S. bongori and S enterica.  
There are currently 22-reported Salmonella Pathogenicity Island (SPIs) and among 
those, only SPI-1, SPI-4 and SPI-9 are present in the reference genome S. bongori 
12419. These shared islands have a similar gene composition in each species, 
although there is significant sequence drift. However, the other S. enterica SPIs are 
either incomplete or absent. This indicates that there are significant differences in the 
pathogenic potential of the two species in different hosts. An important 
distinguishing feature of S. bongori is the absence of SPI- 2. The site occupied by 
SPI-2 at tRNA–valV in S. enterica is occupied by a 20 kb genomic island in S. 
bongori encoding a novel type VI secretion system called SPI-22, although the 
tetrathionate respiration (ttr) gene cluster present in SPI-2 is retained by S. bongori. 
Although S. bongori lacks the 4 distinct T6SSs described for Salmonella, encoded on 
SPI-6, SPI-19, SPI-20 and SPI-21 [71], the T6SS genes carried on SPI-22 share 
extensive similarity with the T6SS of other Enterobacteriaceae.  These include the 
recently identified CTS2 T6SS locus of Citrobacter rodentium ICC168 [72] and the 
HSI-III locus of Pseudomonas aeruginosa PA01 [73]. Thus, in this regard S. bongori 
broadly resembles the wider Enterobacteriaceae or ancestral state. In addition to the 
lack of SPI-2, S. bongori lacks part of SPI-6 (encoding a type VI secretion system), 
SPI-13 (necessary for survival in chicken macrophages), SPI-14 (involved in 
electron transport system) and SPI-16 (a bacteriophage remnant, carrying genes 
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associated with LPS modification). These and other potential virulence-associated 
factors absent from S. bongori may go some way to explaining the limited ability to 
cause disease in warm-blooded animals demonstrated by the introduction of SPI-2 
into S. bongori [74]
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         Figure 1.5: Diagram summarising selected aspects of the evolutionary history of S. bongori and S. Typhi, a comparative member of S. enterica. Taken from [71] 
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Metabolic functions have also been shown to exhibit significant evolutionary 
divergence between S. bongori and S. enterica. For example, S. bongori possess only 
fragments of the first and last gene of the cob-pdu gene cluster and therefore lacks 
the faculty to anaerobically synthesise vitamin B12 and to catabolise propanediol 
[74]. The cob-pdu gene cluster is also absent/lost from most Enterobacteriaceae and 
may have been independently acquired by S. enterica [75, 76] potentially as an 
adaptation to the tissues and cells (macrophages) of warm blooded animals [76], a 
niche where S. bongori is arguably poorly adapted [74]. Interestingly, some host 
restricted S. enterica, including S. Typhi, harbours inactivating mutations 
(pseudogenes) in the cob-pdu system and this may, in some way, facilitate host 
adaptation. 
Another example of metabolic differences includes the ability to ferment L-tartrate 
and citrate, which are postulated by others to differentiate high and low 
pathogenicity Salmonella strains [77]. Additionally, in K. pneumoniae, the ability to 
ferment citrate partially divides clinical isolates into two groups and may represent 
an adaptation to different nutrient conditions found within the host [78]. Interestingly 
S. bongori is able to utilise lactose and like E. coli is lactose-positive. In E. coli, the 
lactose system may facilitate the metabolism of milk sugar and adaptation to the 
mammalian gut but it is not clear what the advantage, if any, is for S. bongori. In 
contrast S. enterica are lactose-negative and it has been proposed that lacI expression 
can interfere with the function of SPI-2 and attenuates virulence in macrophage [79]. 
1.5 Major virulence-associated genes  
Salmonella are well adapted to their lifestyle of colonising their hosts through the 
intestinal and transmitting between hosts via the environment. They also are highly 
invasive in terms of their ability to enter both the local tissues associated with the 
intestine and the cells that make up these tissues. The ability to invade both tissues 
and cells is central to the pathogenesis of Salmonella infections and is fundamental 
for their ability to survive within their hosts and spread between them, Clearly 
Salmonella differ significantly in aspects of their pathogenicity, including their 
ability to invade their host tissues. Some of this has already been discussed in 
relation to typhoid and nontyphoidal isolates.  
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S. enterica harbour multiple genes that contribute to virulence and survival. Screens 
involving high throughput mutagenesis and gene tagging technologies such as 
Sequence Tagged Mutagenesis (STM) and Transposon Directed Insertion site 
Sequencing (TraDIS) have identified scores of virulence-associated genes in 
different Salmonella isolates [80]. Salmonella bacteria are believed to target a variety 
of phagocytic and non-phagocytic cells in vivo. Following ingestion, Salmonella can 
be either passively (opsonisation, phagocytosis) or actively (promoted by the 
bacteria) internalised within the host cells through different processes. One of the 
most common internalisation mechanisms is phagocytic uptake, particularly by 
monocytes or macrophages. The phagocytosis of Salmonella, and indeed other 
bacteria, is a complex series of steps involving multiple receptors and potentially 
antibodies and complement factors. Once phagocytosed, pattern-recognition 
receptors on or within the phagocytic cell can recognise pathogen-associated 
molecular patterns such as LPS or flagellin, which bind to their respective ligand, 
either on the cell surface or inside the Salmonella-associated phagosome [81]. 
Alternatively, Salmonella can also actively target both phagocytic and non-
phagocytic cells using a type III secretion system (T3SS), designated T3SS1 or 
Salmonella Pathogenicity Island 1 (SPI-1). T3SS1-mediated invasion by Salmonella 
is a very specific process depending on a highly regulated expression of a number of 
factors that mediate invasion [82, 83]. The T3SS1 apparatus can be visualised as a so 
called needle like complex that facilitates contact with this host cell and secretion of 
effector proteins that prepare the targeted host cell for invasion. The genes encoding 
the expression of the T3SS1 apparatus are largely encoded within the SPI-1 locus 
[84]. A number of effector proteins (for example, SipA, SipC, SopB/SigD, SopD, 
SopE2 and SptP) are actively secreted through the T3SS1 needle into the host cell. 
There they act in a coordinated manner to induce dramatic rearrangement of the actin 
cytoskeleton resulting in membrane ruffling and rapid internalisation of the bacteria 
in a highly engineered process [85-87]. The exact complement of T3SS1 effectors 
can vary between different Salmonella serovars. However, the T3SS1 system is 
present in S. bongori and S. enterica and is a fundamental virulence-associated factor 
of the Salmonella. 
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Of the effector proteins translocated by T3SS1 into the host cell, SopE/SopE2, SopB 
and SipA, are known to play a role in inducing the actin rearrangements required for 
invasion and ruffling [86, 87]. Most of the other effector proteins are implicated in 
multiple post-invasion processes such as modifying host cell survival, forming the 
Salmonella Containing Vacuole (SCV) and modulation of the inflammatory 
response. For instance, some evidence suggest that the inositol phosphatase SopB 
plays a role in Akt activation, fluid secretion and SCV formation during the invasion 
process [88-90]. SopB is localised within the SCV and its activity may be influenced 
by ubiquitination. Another T3SS1 effector AvrA, an ubiquitin-like 
acetyltransferases/cysteine protease, removes ubiquitin from IkBa and beta-catenin, 2 
inhibitors of the NF-kB pathway, thereby inhibiting the inflammatory response [91], 
activating beta-catenin signalling [92, 93] and preventing apoptosis in intestinal 
epithelial cells [91]. SopA, another invasion modulator, harbours a HECT-like E3 
ubiquitin-ligase activity [94]. The tyrosine phosphatase SptP another T3SS1 effector 
involved in SCV formation is required for switching off ruffle formation following 
invasion.  SipA has been shown to influence SCV morphology.  
Fimbriae, non-fimbrial adhesins and flagella on the surface of Salmonella may also 
mediate bacterial attachment and consequently contribute to internalisation via 
processes independent of phagocytosis or T3SS1-mediated invasion [95]. Again, the 
repertoire of fimbria and other adhesins show significant variation within S. enterica, 
as do the type of flagella so the mechanisms of attachment may vary significantly. S. 
Typhimurium and other serovars harbour multiple fimbrial loci, many of which are 
only induced in vivo. Fimbriae can have a role in biofilm formation, attachment to 
host cells and colonisation of the intestine [96].  
Motility has been associated with the invasiveness of Salmonella [97]. Indeed, 
different flagella types may significantly influence the attachment, invasion and 
activation of cells targeted by Salmonella, for example, in S. Typhi. Within 
macrophages, flagellin can be translocated into the cytosol by the T3SS1, resulting in 
activation of the inflammasome and caspase-1-mediated cell death (pyroptosis) [98, 
99]. In the intestinal epithelium flagellin induces inflammation while inhibiting 
apoptosis via TLR5 in basolateral epithelial cells. Flagella are generally down-
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regulated inside the host except in macrophages potentially limiting recognition by 
TLR5. 
Once internalised into the host, bacteria that successfully reach the sub-mucosa need 
to survive and replicate within different host cells in order to establish a sustainable 
infection. Dendritic cells may play a role in the initial penetration of bacteria across 
the mucosal surface involving a mechanism by which dendrites reach through the 
epithelial barrier and engulf Salmonella [100]. Activated dendritic cells may thus be 
a portal of entry into host tissues for the invading Salmonella. However, once within 
the tissues Salmonella are believed to rapidly enter macrophages by largely unknown 
mechanisms. Indeed, multiple data has highlighted a central role for macrophages in 
the survival and persistence of Salmonella in-vivo [101]. 
Non-fimbrial proteins have been associated with enhanced Salmonella adhesion and 
subsequent invasion into cells. These include BapA and SiiE; 2 surface-associated 
proteins secreted via the type I secretion systems BapBCD and SiiCDF respectively. 
SiiE is encoded on SPI-4, which is co-regulated with SPI-1 [102]. Other proteins 
including RatB, SivH and ShdA encoded on the CS54 pathogenicity island have 
been shown to contribute to the persistence and shedding of Salmonella in the 
intestine by targeted connective tissue proteins such as fibronectin [103]. 
T3SS2 or Salmonella Pathogenicity Island 2 (SPI-2) contributes to systemic 
virulence and survival/persistence within macrophages. Although the different roles 
of individual T3SS2 effectors are not fully characterised, some of them have been 
associated with SCV formation and positioning within the cell. For instance, SseF 
and SseG are required for maintenance of the SCV and facilitating intracellular 
replication [104-106]. SifA plays a role in SIF (Salmonella Induced Filaments, 
visible by microscopy) formation, a process linked to maintaining SCV membrane 
integrity [107]. Others T3SS2 effectors, such as PipB2 and SseJ, cooperate with 
SifA, further influencing SCV membrane integrity; PipB2 interacts with kinesin light 
chain, a subunit of the kinesin-1 motor complex by recruiting it to the surface of the 
SCV [108] while SseJ, promotes host membrane tubulation [109]. In epithelial cells 
infected with mutants lacking SseJ cholesterol accumulation is increased compared 
with cells infected with wild-type bacteria, and this is associated with a decrease in 
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intracellular replication. Here, it is worth noting that SseJ is a pseudogene in S. 
Typhi.  SseL, can also modulate NF-kB activation downstream of IkBa kinases 
although its specific role remain unclear. Again different S. enterica can harbour 
different combinations of SPI-2 associated effectors.  
1.5.1 Virulence-associated plasmid 
Isolates from a number of different serovars of S. enterica harbour a plasmid 
associated with systemic virulence in the mouse, known as the Salmonella Virulence 
Plasmid. This plasmid is absent in S. Typhi and S. Paratyphi A. The spvRABCD 
genes are located on these plasmids and are key plasmid-mediated virulence-
associated factors in some serovars. The virulence plasmid is present in many 
isolates of S. Typhimurium and other gastroenteritis-associated serovars such as S. 
Enteritidis [110, 111]. SpvB and C may be translocated into the host cells via T3SS2 
or plasmid encoded genes.  SpvB ADP-ribosylates actin destabilises the cytoskeleton 
and is associated with host cell cytotoxicity [112].  
1.5.2 Examples of other virulence-associated genes 
Many other genes have been associated with Salmonella virulence in different 
models and hosts and some of these will be considered here. For a more detailed 
analysis of Salmonella virulence-associated determinants please consider these 
reviews and screens [113-115]. Many host phagocytic cells produce reactive oxygen 
species through the phagosomal NADPH oxidase (NOX2) complex as a defence 
mechanism for killing intracellular pathogens. To counteract this activity, Salmonella 
can express superoxide dismutases such as SodCI for protection against extracellular 
reactive oxygen species. SodCI is tethered within the periplasm of the phagosome 
and is significantly protease resistant [116]. The level of iron in host tissues and cells 
is tightly regulated to control direct access for pathogens. In the host, free iron binds 
to iron-binding proteins such as transferrin where it is largely unavailable to bacteria 
without specialised acquisition systems. The host has other mechanisms to deny iron 
to pathogens such as Salmonella. For example, Nramp1 is a divalent metal-proton 
transporter found in key protective cells such as macrophages, neutrophils and 
dendritic cells [117] that creates a restricted availability of free iron for the bacteria 
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by limiting iron in the phagosome. This effectively limits the ability of bacteria and 
other pathogens to establish an infection. In response to iron deprivation, Salmonella 
produce siderophores, including enterobactin and salmochelin [118]. Salmochelin is 
a glucosylated derivative of enterobactin and this modification may be important for 
resistance to lipocalin-2, an antimicrobial protein that prevents bacterial iron 
acquisition in the inflamed intestinal epithelium [119]. A recent study using different 
S. Typhimurium mutants lacking iron transporters has shown that iron transporters 
encoded by feoB and sitABCD are required for optimal survival in Nramp1 -/- mice 
and replication in macrophages. Additionally, the Nramp1 homologue MntH, which 
prefers Mn(II) over Fe(II), is also required for optimal virulence [120].  
Salmonella has acquired various proteins for the uptake of Magnesium including 
CorA, MgtA and MgtB, which are essential for virulence in different models [121].  
Mg2+ transporters are required for intra-macrophage survival and growth in 
magnesium-depleted medium. K+ and Zn2+ are also implicated in intracellular 
survival; ZnuABC S. Typhimurium mutant derivatives are defective for virulence in 
both susceptible and resistant mouse strains [122]; ZnuABC is a high-affinity Zn2+ 
transporter in low- zinc conditions. The Trk system functions as a low-affinity K+ 
transporter and may be involved in resistance to antimicrobial peptides [123]. 
1.6 Signatures of adaptation in S. enterica 
Most S. enterica serovars are classically associated with a broad host range. 
However, a few serovars are significantly host-restricted. For example, S. Typhi and 
S. Paratyphi A are highly human adapted, whereas S. Gallinarum isolates are poultry 
(bird) adapted. Even within serovars such as S. Typhimurium there is evidence of 
isolates or clades being adapted or restricted to particular hosts. For example, within 
S. Typhimurium DT2 phage type isolates display avian (for example, pigeon) 
adaptation and ST313 isolate may be adapted to humans [124].  
In recent years, comparative genomic studies of broad-host-range serovars, which are 
believed to be the ancestor-state of host-restricted serotypes, have provided insights 
into the genomic signature of bacterial host adaptation and evolution. These studies 
have identified a number of genome signatures that may represent evidence of host 
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adaptation leading to restriction. These adaptive/restrictive signatures include both 
gene acquisition and inactivation. 
Horizontal gene transfer has been broadly implicated in the evolution of virulence 
and indeed resistance to antimicrobials through plasmids and transposons. In 
bacteria, horizontal gene transfer is recognised as a general mechanism driving 
evolution. The key role of mobile genetic elements in the acquisition of virulence 
traits in bacteria has been extensively studied and several reports have associated 
mobile virulence-associated determinants with host adaptation or the occupation of a 
new niche within the host [125]. Within the E. coli, horizontal transfer events have 
facilitated the transition from a commensal to a pathogenic lifestyle. Examples 
include the acquisition of the heat-labile and stable toxin genes on plasmids and the 
LEE (Locus for Enteric Effacement) and intimin genes of EPEC lineages [126].  
In Salmonella, the evolution of virulence has been driven by the incorporation of 
distinct genetic elements into the genome including pathogenicity islands, T3SSs and 
the Salmonella virulence plasmid. The virulence genes acquired by horizontal 
transfer have to be incorporated into existing gene expression regulatory circuits to 
ensure coordinate expression of virulence-associated genes in a manner that does not 
compromise fitness and competitiveness. Horizontal gene transfer in Salmonella can 
involve phages which are frequently exchanged even within clades or serovars [127]. 
Indeed, S.  Typhimurium phages Gifsy-1, Gifsy-2 and Gifsy-3 have successfully 
lysogenised a range of serovars and different lineages of S. Typhimurium [128].  
Within S. Typhimurium a potentially mobilisable element known as SPI-7 is 
associated with the acquisition of the locus encoding Vi capsule that is directly 
linked to virulence in humans and hence host adaptation [129]. Vi makes S. Typhi 
more resistant to antibody directed killing and complement mediated phagocytosis. 
Vi is also immunomodulatory and may facilitate the ability of S. Typhi to invade 
tissue without inducing inflammation, potentially by enhancing interleukin 10 
production [130]. SPI-7 also encodes a SopE phage and a Type IV pilin that have 
also been associated with virulence. Hence, the acquisition of SPI-7 is a clear 
example of horizontal gene transfer influencing host adaptation. S. Typhi and S. 
Paratyphi A have also recently been shown to encode a novel toxin named typhoid 
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toxin that may also influence human infectivity [131]. The distribution of the genes 
encoding this toxin is limited only a few S. enterica serovars. 
Within Salmonella lateral gene transfer through conjugation can also transfer 
antibiotic resistance determinants [132]. Acquisition of plasmids encoding resistance 
and virulence properties has been known to influence bacterial evolution. Thus, 
plasmids can be acquired by horizon gene transfer from other serovars, or even other 
species or genuses.  For example, S. Typhi CT18 possesses a 218,150-bp multiple-
drug-resistance incH1 plasmid (pHCM1) and a 106,516-bp cryptic plasmid 
(pHCM2), which shows recent common ancestry with a virulence plasmid of 
Yersinia pestis [133]. In S. enterica, many high molecular weight plasmids encode 
virulence-associated genes or are responsible for antibiotic resistance. As discussed, 
the classical Salmonella virulence plasmid encodes the spvRABCD genes involved in 
intra-macrophage survival of Salmonella but this plasmid has also been shown to be 
able to acquire antibiotic resistance genes that have the potential to spread in 
bacterial populations [16]. Many low molecular weight plasmids have been found in 
S. enterica but in general little is known about their function, although some studies 
have suggested a role in increasing resistance to phage infection due to the presence 
of restriction modification systems [134]. Despite limited knowledge on their 
function, their presence or absence is frequently used for strain differentiation in 
epidemiological studies.  
There is now extensive evidence, gathered from genetic and genomic analysis, that 
bacteriophages are drivers of evolution in the enteric bacteria, including within S. 
enterica. Many intestinal commensals and enteric pathogens harbour prophages or 
phage remnants integrated within their genomes, often at multiple sites [128]. 
Additionally, prophages can encode so called ‘cargo’ genes that are not required for 
phage growth but can encode virulence-associated factors that can influence 
pathogenicity [135]. The diversity of prophage within a bacterial population is 
influenced by transduction and recombination involving superinfecting phages, 
resident prophages, or occasional acquisition of other mobile DNA elements. 
Prophages also play a part in the diversification of the genome architecture and 
represent strategic points for genome insertions and inversions [135].  
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1.6.1 Genome degradation/decay 
Genome decay or reductive evolution is a process by which bacteria lose some 
functions by gene deletion or degradation (for example, the acquisition of frame 
shifts or stop codons). Such potentially inactivated genes are often referred to as so 
called pseudogenes. This process has been reported in obligate intracellular parasites, 
such as Rickettsia prowazekii, Mycobacterium leprae and Chlamydia spp. [136-138] 
as well as in Yersinia pestis [139]. As genes become inactivated they may restrict 
bacteria to specialist hosts or novel niches within their hosts. Thus genome 
degradation is a signature of host restriction and niche change. In Y. pestis and S. 
Typhi the host is humans and the niche change is from the intestine into the systemic 
system. Extensive genome degradation has been observed in R. prowazekii, the 
typhus agent, with only 76% of the potential coding genes being likely fully 
functional [140]. Another example of genome reduction was documented in M. 
leprae, which may originally have had a genome similar in size to 
other Mycobacteria (around 4.4 Mb) but this has been downsized during evolution 
through rearrangement. M. leprae may have lost more than 2,000 genes [136] and 
this might explain its extremely slow replication rate, lack of acute disease and 
targeting of neurones.  
Genome degradation has also been documented in S. Paratyphi A and S. Typhi where 
both share components of their genomes and have similar phenotypes (human-
restricted and systemic disease). Around 170 pseudogenes are present in S. Paratyphi 
A, whereas S. Typhi can harbour over 200 [141]. Several of these pseudogenes 
correspond to genes known to contribute to virulence in S. Typhimurium and other 
more promiscuous Salmonella serovars.  About 30 genes are degraded in both S. 
Typhi and S. Paratyphi, although the inactivation of different genes in common 
pathways is more common (for example, in chemotaxis, vitamin B12 acquisition and 
in the production of fimbriae) [142]. Amongst these 30 genes, several genes, such as 
sopA and shdA are known to be important in gastroenteritis and diarrhoea, which is 
uncommon in infections associated with these serovars. 
43 
 
1.7 Methods for phenotyping  
A central aim of biomedical research is to fully understand the mechanisms of 
human disease and develop new and improved therapies or diagnostics. In order to 
achieve this, different disease models have been developed, although many of these 
fail to faithfully recapitulate the human condition. For this reason, researchers exploit 
different models in a complementary way to build a more informed picture of the 
human condition. 
1.7.1 In-vitro models 
While whole animal models have been tremendously useful for the current 
understanding of many human infectious diseases, it can be difficult to identify 
critical cellular and molecular contributors to disease using in vivo models. In order 
to address the role of specific host genes involved in the early host-pathogens 
interactions, many cell lines, have been successfully used as powerful tools to 
understand the mechanistic of infection. Non-polarised cell lines, such as HeLa and 
Hep-2 cells, although quite different from polarised cells of the intestinal epithelium, 
have been used extensively to study the cellular basis of the host-pathogen 
interaction. These cell lines have been used to unravel the molecular mechanisms of 
actin re-organisation [143, 144] and the elucidation of the bacterial and host proteins 
that contribute to this [145]. In addition, non-polarised cells had been used to 
elucidate the process of T3SS-dependent protein translocation into host cells as well 
as functional analyses of the injected effectors [146]. Taking advantage of their ease 
to grow and manipulate, tissue culture cells have successfully been used to analyse 
the biochemical activity of effectors such as Tir, in E. coli [147].  
Non-polarised cells are not appropriate to study intestinal barrier function or 
maintenance of the brush border. Therefore, specific cells lines that mimic intestinal 
cells polarisation have been generated, such as MDCK, Caco-2, T84, and HT29 
cells. These cell lines provide in-vitro models for investigating how bacteria disrupt 
epithelial barrier function during infection [148, 149] and for identifying effectors 
specifically required in the process. As with the non-polarised cell lines, these cell 
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lines offer the advantages of convenience, rapid growth, uniformity and availability 
of genetic tools for insertion of mutations. In addition to interactions with 
enterocytes, enteric pathogens also interact with phagocytic cells and dendritic cells. 
The use of macrophage-like cell lines such as J774 and U937 to model these specific 
immune cells has been essential for the identification of different effector functions 
and for targeting independent aspects of the phagocytic function of mammalian 
macrophages [150]. 
More complex models such as the IVOC (in-vitro organ culture) have been 
developed. IVOC exploits freshly obtained human (or other species such as cattle) 
intestinal biopsies, which are kept in tissue culture media under oxygen to delay cell 
death. The advantage of IVOC is that the infected tissue is close to native live tissue. 
However, compared with other in-vitro models, the use of IVOC for experimental 
infection is technically challenging and requires coordination with a clinic to obtain 
fresh tissue. In addition to the technical challenges, the variability in sampling 
methodologies between donors can result in differences in experimental outcome. 
The IVOC system has been used successfully to study host specificity and tissue 
tropism, including Tir/intimin-dependent colonisation and lesion formation by EHEC 
[151]. Human IVOC has also been used to study S. Typhimurium [152]. 
1.7.2 In-vivo model: The mouse 
It is arguable that biomedical research has benefited significantly from the use of 
animal models to understand the pathogenesis of disease at a whole organism level. 
Additional, insight can be gained into biology at the cellular and molecular level. In- 
vivo models also provide systems for developing and testing new therapies in a 
preclinical setting. Mammalian models, such as the mouse, have been pre-eminent in 
modelling human diseases, mainly because of the significant homology between 
mammalian genomes and the many other similarities in physiology and immune 
components. Moreover, mice are susceptible to an overlapping range of microbes 
infectious to humans. However, it is important to keep in sight the important 
differences between humans and other animals and no in-vivo model can fully 
replace investigations in humans or on human materials. 
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The genetic tools are available for manipulating the mouse [153] (for example, gene 
knock out technologies and homologous recombination), and the strategies available 
to control the expression of microbial genes in-vivo, make the mouse an excellent 
experimental model to study the genetic basis of infections. Some of the above-
mentioned advantages apply to other mammals, but mice are small and relatively 
easy to maintain in the laboratory; their short breeding cycle (about 2 months) and 
their high reproductive capability (5 to 10 offspring per litter and approximately one 
litter every month) make them suitable for genetic analysis. Mutants mouse lines are 
becoming available from open sources and new mutations can be introduced using 
different approaches: irradiation, feeding with chemical mutagens or inserting DNA 
fragments into the genome using, for example, novel CRISPR/Cas9 type 
technologies [154]. Further, murine heterologous gene transfer technology is highly 
advanced in such a way that sophisticated transgenic mice, carrying 
foreign/heterologous genes of interest (transgenes), have allowed the creation of 
experimental animal models that further recapitulate aspects of the pathology of 
human diseases. It is arguably faster to map a mouse disease gene and use its 
sequence and location to find the position of the ortholog in the human genome, than 
it is to map the human gene directly.  
As a result of recent advances in breeding strategies it is now possible to make 
congenic mice, which are genetically identical with the exception of being 
polymorphic in one particular nucleotide, gene or regulatory sequence. In addition, in 
the mouse, selected genes can be deliberately mutated by swapping the functional 
copy of the gene for a mutated version in mouse embryonic stem cells (ES cells). 
This means it is possible to create exact or highly related replicas of the genetic 
defects that cause diseases in humans [155]. 
The mouse has proved to be an invaluable model for study many infections, 
including those caused by Salmonella. Many Salmonella and host genes that 
influence the outcome of infection have been identified, including immune genes and 
some of these have also been shown to influence infection in humans [13]. Some 
Salmonella are highly virulent in the mouse, for example isolates of S. Typhimurium 
and S. Enteritidis and murine salmonellosis models have been a cornerstone of 
studies on pathogenicity and immunity [156]. S. Typhimurium can cause an invasive, 
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systemic disease in mice that resembles aspects of typhoid in humans. S. Typhi is 
relatively avirulent in mice and consequently the S. Typhimurium murine infection 
model has been used as a surrogate for human typhoid. Inbred mice can vary 
significantly in terms of their susceptibility to Salmonella and single gene loci can 
greatly influence this susceptibility. For example, mice harbouring a protective 
Nramp1 allele, (for example, 129 lines), are several logs more resistant to Salmonella 
compared to those harbouring equivalent susceptible alleles (for example, C57 Black 
6 lines) [157, 158]. Many immune genes also play a key role in protection against 
Salmonella infections; for example, genes encoding TNF-α and Interferon-γ (see 
[159] for a comprehensive review of this area). 
1.7.2.1 The streptomycin-pretreated mouse model for colitis 
The most common disease associated with non-typhoidal Salmonella in humans is 
enterocolitis. However in mice, certain serovars including S. Typhimurium do not 
cause gastroenteritis but rather targets the gut-associated lymphatic tissues and cause 
a systemic typhoid-like infection. To increase the knowledge of the pathogenic 
mechanisms of intestinal salmonellosis, a streptomycin-pretreated mouse model was 
established to provide a mouse model for serovar Typhimurium-mediated colitis 
[160]. Pre-treatment of mice with streptomycin disrupts the natural microbiota, 
which can limit colonisation by an incoming pathogen [160]. However, mice pre-
treated with streptomycin can develop colitis soon after oral infection with S. 
Typhimurium and they present with characteristic symptoms of a human enteric 
salmonellosis including epithelial ulceration, oedema and infiltration of CD18-
positive cells [160]. This pathology is significantly dependent on protein 
translocation via the S Typhimurium SPI-1 secretion system. In addition to colitis, 
the S. Typhimurium can still become systemic in susceptible mice, colonising the 
liver and spleen.  
1.7.3 In-vivo model: The zebrafish 
Although the mouse is a key model for studying Salmonella disease, several aspects 
of murine biology limit its utility therefore comparative in-vivo models are 
potentially interesting. The zebrafish, Danio rerio, has attracted a great deal of 
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interest as a model of general physiology and infection. Despite the obvious 
differences in the physiology of fish and humans that could affect the outcome of 
diseases in the model, the zebrafish offers several features that make it an important 
complement to mouse models of disease. Among these, the zebrafish provides 
excellent possibilities for real time in-vivo imaging of host-pathogen interactions, 
given the optical clarity of embryos and larvae. Imaging can be exploited in 
association with the sophisticated tools for genomic and large-scale mutant analysis 
available in this species. The small size of the fish, their high reproductive rate 
(hundreds of offspring per week from a pair), the external development of the 
embryos along with the low maintenance costs and the establishment of methods to 
rear embryos under gnotobiotic conditions have contributed to the uniqueness of 
zebrafish as a model of human diseases. In addition, zebrafish embryos and larvae 
are highly suitable for screening chemical libraries given their small size and 
CRISPR/Cas9 technologies have now been applied to this species [161] 
A number of reports have already established infection models in the zebrafish using 
bacterial and viral pathogens including those exploiting Mycobacteria marinum [162, 
163] and S. enterica [164] involving the systemic infection of early embryos. 
Therefore, the zebrafish model has already been validated to some degree. Zebrafish 
are also susceptible to parasitic infections and recently, fungal infection models have 
also been established [164] 
The zebrafish, mouse and human share components of both innate and acquired 
immune systems. Indeed, equivalents of many mammalian immune cells have been 
identified in zebrafish. Zebrafish embryos possess functional macrophages at day 
one of development and are capable of sensing and responding to microbial 
infections. However, innate immune functions can be studied with some degree of 
separation from adaptive functions in zebrafish embryos, since acquired immune 
cells develop only later during larval stages and are not fully matured until 
approximately 4 weeks post fertilisation as depicted in Figure 1.6. However, all 
major organs are present by 5 days post fertilisation facilitating infection tracking at 
the tissue level. 
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Figure 1.6: Overview of the development of the zebrafish immune system. Taken from [165].  
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The availability of a zebrafish full genome sequence, efficient tools for forward and 
reverse genetics and sophisticated mutagenesis and screening strategies on a large 
scale, and low cost that is not possible in other vertebrate systems also contribute to 
the usefulness of the model. For forward genetic screens, germ-line mutations were 
commonly introduced by ethylnitrosourea (ENU) treatment of male zebrafish [166], 
which yields relatively random point mutations that can be identified by positional 
cloning and DNA sequencing. Retroviral or transposon-mediated insertion 
mutagenesis strategies can also be used [167]. Until recently, reverse genetics in 
zebrafish predominantly relied to an approach known as TILLING (Targeting 
Induced Local Lesions in Genomes) [168, 169], which compensated for the then lack 
of conventional knockout technology available for zebrafish. The use of new Zinc-
Finger Nuclease (ZFNs) [170] and Transcription Activator-Like Effector Nucleases 
(TALENs) [170, 171] technologies was introduced as a useful addition to TILLING 
approaches. Exposure to morpholinos, synthetic oligonucleotides that can be 
designed to block translation or pre-mRNA splicing, can induce a transient 
knockdown of gene expression in zebrafish [172]. 
A more recent approach exploits an old bacterial defence mechanism in which 
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR); together with 
CRISPR- associated (Cas) [173] proteins provide acquired resistance to invading 
viruses and plasmids. The type II CRISPR/Cas system involves the uptake of foreign 
DNA fragments into CRISPR loci and subsequent transcription and processing into 
short CRISPR RNAs (crRNAs), which in turn become a trans-activating crRNA 
(tracrRNA) and direct sequence-specific silencing of foreign nucleic acid by Cas 
proteins. Based on previous in vitro studies that had shown that a single synthetic 
guide RNA (gRNA), consisting of a fusion of crRNA and tracrRNA, can direct 
Cas9-mediated cleavage of target DNA, a platform exploiting customised RNA-
guided Cas9 nucleases has been developed to efficiently induce site-specific 
modifications in vivo in the zebrafish [155] and this approach represent to date the 
easiest and most efficient way to generate genetic modification of zebrafish. Indeed, 
the CRISPR/Cas9 and equivalent systems are finding broad utility in mammalian cell 
genetic manipulation experiments [174]. In terms of genome-based phenotyping, 
transcriptional responses of zebrafish to infection can be studied by exploiting 
reverse transcriptase PCR, microarrays and next generation sequencing studies. 
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However, as this is a relatively new model for infection studies, there is a general 
lack of immunological reagents for detecting proteins and immune signatures. 
However, commercial ventures in antibody production for zebrafish such as 
ANASPEC are increasing. In addition, sometimes, antibodies to the mammalian 
orthologs of some zebrafish proteins show cross-reactivity. The readily available 
zebrafish mutant library at the WTSI, which now covers more than a third of the total 
protein coding genes of the genome, is potentially available to explore pathogen-host 
interaction in specific infection models. Potential infection challenges include M. 
marinum and S. Typhimurium, which can efficiently infect zebrafish and can be a 
resource to characterise novel infection susceptibility loci. 
1.7.4 The mouse genetic screening 
The WTSI is conducting a large phenotypic screen on novel mice harbouring defined 
and conditional ready mutations in different genes. The mice are of the C57/B6 
lineage. To generate these mice, heterozygous ES cells harbouring specific mutations 
are selected for microinjection from a library of over 15,000 mutant stem cells [175]. 
At the time of writing this thesis, over 1,250 mice lines have been screened for a 
range of phenotypes, including plasma chemistry and infection susceptibility. 
Particular mutant lines are selected on the basis of a number of criteria including 
novelty, whether they are a hit in previous GWAS studies or exome sequencing, or 
through recommendation. Currently for infection susceptibility, mice are challenged 
independently with S. Typhimurium M525, influenza virus X31, the worm 
Trichurius muris and DSS (Dextran Sodium Sulphate). The responses of pathogen 
challenged mutant mice are compared to similarly infected wild type mice to assess 
the influence of the murine mutation on phenotype. The combined data can be 
presented as a heat map, which summarises phenotypic differences found in any 
mutant mouse line (http://www.mousephenotype.com).  
1.7.5 The zebrafish genetic screening 
The Zebrafish Mutation Project (ZMP) at the WTSI has an ultimate goal to create a 
mutant allele in every protein-coding gene in the zebrafish genome, using a 
combination of whole exome enrichment and Illumina next generation sequencing. 
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To date, over 26000 alleles have been generated. To exploit the mutant library 
generated, a high-throughput, systematic phenotypic analysis has been developed to 
assess the phenotype associated with any given mutation with a particular attention 
to nonsense and essential splice mutations.  
Secondly, correlations between the predicted disruptive mutations and phenotype are 
established by crossing heterozygous adult fish then examining the embryos for 
morphological and behavioural phenotypes at 5 days post fertilisation (dpf). 
Phenotypes can be linked to genotyped my successive rounds of sequencing and 
genetic crossing. After a particular mutation has been described further phenotyping 
or genome re-engineering can be attempted. Transcript counting or RNA-seq can 
also be performed as part of the primary or secondary phenotyping 
(http://sanger.ac.uk/resources/zebrafish/zmp/).  
1.8 The use of whole genome sequencing for studying 
bacterial genomes and phylogeny 
During the last century combined studies began to highlight the huge genetic 
diversity within the bacterial world and leading scientists started to develop 
phylogenetic schemes in an attempt to explain how life on Earth may have 
developed. An application of phylogenetic analysis is to predict ancestral structures 
that can help to understand the evolutionary path of organisms. The first 
phylogenetic trees of prokaryotes were largely based on morphological, 
physiological and biochemical analysis. The prokaryote-eukaryote dichotomy was 
already well established but did very little to clarify phylogenetic relationships. In 
1970, Carl Woese used a molecular approach to phylogenetics, arguably 
transforming our understanding of evolution in the microbial world by introducing 
the Archaeal domain [176, 177].  
With the advancements in DNA sequencing technologies and the associated increase 
in nucleic acid sequence information, the application of phylogenetic analysis has 
rapidly expanded. It has now been applied broadly to multiple bacterial species as 
well as serovars or clades within the same species [178-181].  Comparative genomics 
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and phylogenomics have been exploited to trace the emergence of new drug-resistant 
bacterial clades [181], tracked the global spread of infectious pathogens [181, 182] as 
well as identify the pandemic source of some infectious threats [183-185]. The use of 
phylogeny also enables a clearer understanding of how bacterial genomes evolve and 
adapt to novel selective pressures. For example, studies have shown that patterns of 
antibiotic usage influences bacteria genome evolution and the patterns of 
recombinant signatures maintained within the genome [186].  
Modern phylogenetic analysis relies on the availability of high quality genome 
sequence information. In order to meet such needs, several new nucleic acid 
sequencing technologies have been developed over the past few years. The Sanger 
sequencing method was the first widely used sequencing technology to be exploited 
for bacterial genome sequencing [187, 188]. The first complete bacterial genome to 
be fully sequenced by this approach was that of Haemophilus influenze but many 
more followed in the following decade [189]. The Sanger sequencing system exploits 
the addition of terminating dideoxyribonucleotides (ddNTPs) by DNA polymerase, 
preventing the incorporation of further nucleotides. 
Although the Sanger method found wide utility, it was not particularly high 
throughput and was a relatively expensive approach. Next generation sequencing 
platforms were invented that exploit the immobilisation of DNA samples onto solid 
supports, incorporate automated cyclic sequencing reactions mediated by fluidics 
devices and exploit sensitive detection of molecular events by imaging. These 
revolutionary technologies are capable of producing an enormous amount of 
sequence data in a relatively short period of time while keeping cost relatively low 
[190]. They can also now generate relatively long DNA sequences facilitating 
genome assemblies [191].  
Two new generation sequencing platforms based on the Illumina/ Solexa and Pacific 
Biosciences technology, were utilised in the studies described in this thesis.  The 
Illumina sequencing platform exploits sequencing by synthesis method in which 
modified dNTPs containing a fluorescently labeled reversible terminator blocks 
further polymerisation so that only a single base can be added by a polymerase 
enzyme to the DNA copy strand. The terminator is imaged then cleaved off to allow 
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incorporation of the next base. The sequencing reaction is conducted simultaneously 
on a large number of different templates spread onto a solid surface, forming 
clusters. The natural competition between all 4 modified dNTPs present during each 
sequencing cycle minimises incorporation bias. Illumina sequencing platforms 
provide multiple applications from whole genome sequencing, SNP (single 
nucleotide polymorphism) detection to transcriptomics and metagenomics analysis. 
The HiSeq, Nextseq and GAIIx platforms are suited for studying larger genomes 
(animal or plant) while the MiSeq platform is ideal for small genomes or targeted 
regions within a genome. The HiSeq X Ten platform (2014 release) is limited to 
sequencing only whole genome human samples.  Illumina platform limitations 
include inadequacies in analysing low diversity samples and they have relatively 
short reads compare to other platforms, although this is improving with longer reads 
now achievable (https://www.illumina.com/). 
The Pacific Bioscience sequencing system, also known as PacBio RS/RS II (latest 
release, 2014) exploits a Single Molecule Real Time (SMRT) method in which an 
optical waveguide (the zero-mode wave guide) is attached to the DNA polymerase, 
generating an illuminated observation volume, small enough to observe the addition 
of only one single nucleotide. Each nucleotide is attached to a different fluorescent 
dye and when incorporated through the DNA polymerase, the fluorescent tag of the 
nucleotide is cleaved off and is no longer observable within the optical waveguide 
area. The fluorescent signal of the nucleotide is detected and the corresponding base 
call is made according to the fluorescence of the specific dye. The major benefits of 
using PacBio sequencing technologies have been attributed to the production of 
reads significantly longer than other sequencing platforms making it ideal for 
sequencing small genomes (such as bacteria or viruses) and assembling larger 
genomes. Also, the system can facilitate the sequencing of regions of high G/C 
content and can identify some modified bases (methylation, hydroxymethylation) 
without necessitating the need for chemical conversion during library preparation 
(http://www.pacificbiosciences.com/).  
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1.9 The focus of this thesis, S. Weltevreden 
Salmonella enterica serovar Weltevreden has recently attracted a great deal of 
interest due to increasing reports of its isolation by reference laboratories and other 
microbiological centres world-wide, particularly in Asia. S. Weltevreden has been 
associated with potential marine sources and it plays a significant role in food 
poisoning. Indeed, a global Salmonella survey conducted by WHO revealed that this 
organism is the most common cause of non-typhoidal salmonellosis in the South East 
Asian Region (SEAR) and Western Pacific region [192]. It is frequently isolated 
from seafood, meat, poultry products and water. Prevalence of S. Weltevreden was 
detected in domestic animals like pigs, chicken and ducks in Vietnam and it is also 
the most common serovar isolated from humans in Thailand and Malaysia. 
According to the Salmonella food poisoning database during 1989-99, S. 
Weltevreden was the second common pathogen encountered, next to S. Enteritidis 
[193]. 
Despite the emergence of S. Weltervreden as a significant health problem relatively 
little has been reported about the genotypic or phenotypic properties of this 
understudied serovar. Reports have been emerging providing the first genome 
sequence data of individual isolates (see chapter 3) but to date these have not been 
placed in a phylogenetic or evolutionary context.  
1.10 Aims and objectives of thesis 
In this study, whole genome sequencing technologies linked to phylogenetics and 
comparative genomics were used to define the genetic diversity within a large 
collection of S. Weltevreden isolates collected worldwide from diverse sources, with 
a focus in Vietnam where such infections are common. This focus on isolates from 
South East Asia and Western Pacific region provide an opportunity to explore the 
relationships between S. Weltevreden predominance in this region. Phenotypic 
characterisation was performed on selected isolates, with an aim to dissect aspects of 
host-pathogen interaction during infection, providing a foundation to compare S. 
Weltevreden with more commons enterics. Thus, the aims of this thesis were to:- 
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• Define the phylogenetic structure of the S. Weltevreden serovar, define the 
core and accessory genomes and provide a high quality reference genome.  
• To assess the pathogenic and metabolic potential of S. Weltevreden using 
simple laboratory assays, including both in-vitro (cellular) and in-vivo 
(mouse, zebrafish models) virulence assays. 
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2 Materials and methods 
 
2.1 Phylogenetic analysis of S. Weltevreden  
2.1.1 Illumina sequencing 
All DNA samples were processed and sequenced by the core sequencing facilities at 
the WTSI. Multiplex libraries were generated using DNA insert of ~200 to 300bp 
with each isolate uniquely tagged. Samples were sequenced using the Illumina Hiseq 
platform (Illumina, Inc., San Diego, California USA) to produce ~100bp reads. The 
first stage of the library preparation involved DNA fragmentation by focused 
ultrasonication using a Covaris E-series ultrasonicator (Covaris, Inc., Woburn 
Massachussett, USA). This was followed by DNA purification using the magnetic 
bead-based technology solid Phase Reversible Immobilisation (SPRI) from 
Agencourt Bioscience (Agencourt Bioscience Corporation, Beverly, Massachussett, 
USA). After this stage, small fragments were removed and the remaining DNA 
consisting of a mixture of blunt end fragments, were repaired. A single “A” 
nucleotide moiety was added to the 3’ ends of the fragments followed by successive 
adaptor ligation. This step, called A-Tailing, deters concatemerisation of templates 
and increased the efficiency of adaptor ligation. Specific adaptors were ligated to the 
3’ and 5’ ends of the DNA templates. 
The DNA molecules that were correctly attached to the adaptors were amplified 
using the DNA polymerase Kapa HiFi enzyme (Kapa Biosystems, Woburn 
Massachusetts, USA) and primers that targeted the unique library index tag. 
Amplification completed the construction of the adaptor ends to produce a fully 
double stranded template. This PCR-amplified library was then denatured using 
sodium hydroxide in hybridisation buffer at a concentration of 3.5pM in order to 
create single stranded DNA, which was loaded onto a single lane of the flowcell on 
the Illumina Hiseq platform. Protocols for cluster formation, primers hybridisation 
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and paired-end sequencing reaction were performed according to the manufacturer’s 
recommendations. 
2.1.2 Sequence assembly from Illumina reads  
The Illumina-generated sequences were assembled using a pipeline 
(https://github.com/sanger-pathogens/vr-codebase) developed at the WTSI. For each 
genome, the de novo short-read assembler Velvet [194] (version 1.2.09) was used to 
generate multiple assemblies by varying the k-mer size between 66% and 90% of the 
read length using Velvet Optimiser (https://github.com/tseemann/VelvetOptimiser). 
From these assemblies, the assembly with the highest N50 was chosen. Contigs were 
excluded from the assembly if they were shorter than the target fragment size (400 
bases).   
An assembly improvement step (https://github.com/sanger-pathogens/assembly_improvement) 
was then run. The raw reads were mapped to the assembly and reads which mapped 
in perfect pairs to the same contig, were excluded (since these have already been 
successfully used). The remaining unmapped and mapped reads were used in an 
improvement step to try and reduce the fragmentation of the assembly. A scaffold 
assembly of the contigs was built by iteratively running SSPACE [195] (version 2.0) 
beginning with the contigs which were predicted to map next to each other. The 
reads were then mapped again to the scaffold assembly and perfect pairs were 
excluded. Next, gaps identified as one or more N’s, were targeted for closure by 
running 120 iterations of GapFiller [196] (version 1.11), using a decreasing read 
evidence threshold. Finally, the reads were aligned back to the improved assembly 
using SMALT (https://www.sanger.ac.uk/resources/software/smalt/) and a set of 
statistics was produced for assessing the quality of the assembly. All the assemblies 
produced were created in a standardised manner and required no input from the user 
so all the results are reproducible. The median number of contigs for the sample set 
was 68. 
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2.1.3 Pacific Biosciences (PacBio) assembly 
 The PacBio raw read data for each sample was manually assembled by Dr. Martin 
Hunt (WTSI Pathogen Informatics team) using the PacBio SMRT analysis pipeline 
(https://github.com/PacificBiosciences/SMRT-Analysis) (version 2.2) utilising the 
HGAP assembler [197]. The raw unfinished assemblies all produced a single 
uncircularised chromosome plus some other small contigs, some of which were 
plasmids or unresolved assembly variants. If the ends of a contig overlapped, they 
were identified as candidates for circularisation using a protocol recommended by 
PacBio (https://github.com/PacificBiosciences/Bioinformatics-Training/wiki/Circularizing-and-
trimming). Figures 2.1.a and 2.1.b illustrate this process. A virtual break was manually 
introduced into the chromosome sequence at the thrA gene, to match the starting 
point of other published S. enterica references. Plasmids were also artificially broken 
at the replication gene. The sequences were then circularised using the genome 
assembler, Minimus [198] (version 2 part of AMOS version 3.1), which removed the 
overlapping sequence. Quiver was then used by the circularised sequence and the 
raw reads to correct errors in the circularised region. As high quality short read data 
from Illumina were available, ICORN2 (Otto et al. 2010) (version 0.97) was used to 
correct minor errors in the assembly, providing a very high quality reference 
sequence, as assessed by REAPR [199] assembly was subsequently annotated with 
Prokka [200]. 
59 
 
   
 
 
     
     
                      
                                                                a. 
 
 
                    
                                                                                                                                                             b. 
 
Figure 2.1: a. graphic representation of S. Weltevreden genome assembly before manual fixing. b. Graphic representation of S. Weltevreden assembly before and after 
manual fixing. 
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2.1.4 Annotation  
Each de novo assembly was annotated using Prokka in an automated pipeline 
(https://github.com/sanger-pathogens/Bio-AutomatedAnnotation). Coding regions 
were first predicted using Prodigal [201] and tRNA/tmRNA genes using ARAGORN 
[202]. These were then annotated using a number of databases involving a 
combination of protein blast [203] and HMMER. To provide community specific 
gene names and annotation, a Salmonella database of amino acids was generated 
from all of the annotated Salmonella genomes in RefSeq 
(http://www.ncbi.nlm.nih.gov/refseq/). Prokka is bundled with prebuilt databases from 
UniprotKB (SwissProt), clusters, CDD, TIGRFAMs, PFAM (A) and RFAM which 
provide more general high quality annotation at the family level.  
As S. Weltevreden 10259 was sequenced on both PacBio and Illumina we could 
perform further analysis using a short read assembly versus a longer read finished 
assembly. The Illumina assembly contained 5034 coding regions and the PacBio 
assembly contained 5110, giving an under prediction of 1.4%. For the whole dataset 
the median number of genes predicted from the short reads assemblies was 4902. 
2.1.5 MLST from de novo assemblies 
The MLST results were verified from the de novo assemblies using MLST check 
(https://github.com/sanger-pathogens/mlst_check/) (version 2.0.1510612). All of the 
assemblies were blasted against the S. enterica MLST database (Achtman et al. 
2012) and were verified as being ST 365. These data were also checked for the 
presence of novel alleles (there should only be 1 copy), a process which can also 
highlight contamination from a closely related serovar, but no obvious contamination 
was detected. 
2.1.6 Checking for S. Weltevrden in sequencing reads 
A Kraken [204] database (version 0.10.6) was created containing the reference 
genomes for Homo sapiens (GRCh38), Mus Musculus (GRCm10), and all 
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archea/viruses/plasmids/bacteria in RefSeq (http://www.ncbi.nlm.nih.gov/refseq/). 
For every sample, each read was categorised to a taxonomic identifier, with the 
results collated into a single report for manual inspection. Any contaminated samples 
were excluded from further analysis. This check highlighted one isolate, which was 
contaminated with E. coli DNA and another which was a mixture of Salmonella 
serovars. No host contamination was identified. 
2.1.7 Detecting regions likely to be erroneous with short 
read sequencing 
The median fragment size was 400 bases for the isolates sequenced on Illumina.  
Repeats larger than this size cannot be reliably resolved, thus any variants which fall 
into these regions cannot be trusted. This is a fundamental limitation of short read 
sequencing technologies and cannot be resolved used bioninformatics. Consequently, 
the reference genome was blasted against itself [203] (version 2.2.31) and the 
coordinates of matches (query and reference), which were over 400 bases in length 
and had greater than 99% identity were noted. All bases falling within these regions 
were then replaced with ‘N’ in the multi-FASTA alignment file. 
2.1.8 Recombination mapping 
The filtered multi-FASTA alignment was then checked for recombination using 
Gubbins [205] (version 1.3.4). Five iterations of Gubbins were run and in each 
iteration a phylogenetic tree was constructed with RAxML [206] (version 7.8.6) with 
the GAMMA GTR model, internal ancestral sequences were inferred using FastML 
[207] (version 3.1). Recombinant sequences were detected and a multi-FASTA 
alignment with the recombinant regions was masked out. This data was then used as 
the input to the next iteration. RAxML with 100 bootstraps was then run over the 
final multi-FASTA alignment to provide a high quality phylogenetic tree in newick 
format. 
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2.1.9 General mapping 
All of the Illumina sequencing short read data was aligned to the complete reference 
genome generated from S. Weltevreden 10259. The reads, in FASTQ format, were 
first split into chunks of one million reads. Each chunk of reads was individually 
aligned using SMALT (https://www.sanger.ac.uk/resources/software/smalt/) (version 
0.7.4), a hashing based read aligner. The aligned reads are then merged together 
using samtools [208] (version 0.1.19), coordinate sorted, and outputted as a BAM 
file. Optical duplicates were identified using Picard 
(http://broadinstitute.github.io/picard/) (version 1.9.2).  Statistics about each mapping 
were generated using BamCheck [208] (version 0.1.19, but since renamed as 
‘samtools stats’) including read coverage of the reference genome, reads aligned, 
perfect pairs, unmapped reads, actual insert size, etc. and these results were evaluated 
manually to identify poor quality sequencing data. 
2.1.10   SNP calling 
 SNPs were called on each set of aligned reads using mpileup with the parameters 
‘samtools mpileup -d 1000 -DSugBf ref bam’. The raw SNPs were then passed into 
BCFtools and were filtered into a higher quality set. A virtual pseudo-genome was 
then constructed by substituting the base call at each site (variant and non-variant) 
into the reference genome. For a SNP to be called the depth had to be greater than 4 
reads, and be present on both strands, with at least 75% of reads containing the SNP 
at that position. The mapping quality had to be greater than 30 (less than 1 in 1000 
probability that the mapping was incorrect). If a SNP failed to meet these criteria it is 
substituted with an ‘N’. Insertions with respect to the reference genome were 
ignored. Deletions with respect to the reference genome were filled up with ‘N’ 
characters in the pseudo-genome in order to keep it aligned and at the same length 
relative to the reference genome. Heterozygous sites were turned into homozygous 
alleles by selecting the first allele in the BCF file. However, if the first allele was an 
insertion or deletion (indel), the second allele in the BCF file was taken. If the 
second allele was also an indel, a single ‘N’ character was used. All of the pseudo-
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genomes were then merged into a single multi-FASTA alignment file, including the 
reference sequence. 
2.1.11  Clusters and defining SNPs 
The population structure of the phylogenetic tree was validated using a Bayesian 
statistical approach. Hierarchical BAPS [209] (version 6.0 of BAPS) was used to 
perform a hierarchical clustering of the multi-FASTA alignment (after 
recombination’s had been removed) to reveal a nested genetic population structure. 
Two distinct S. Weltevreden clusters were identified by BAPS. SNPs, which 
uniquely (in 100% of isolates in a cluster), defined each of the clusters were 
extracted using BioPericles (https://github.com/sanger-pathogens/BioPericles) 
(version 0.1.0). Exploiting the multi-FASTA alignment with recombination removed, 
a consensus sequence was generated for each cluster and any bases which varied or 
contained missing data were replaced by ‘N’. The consensus sequences were merged 
into a single multi-FASTA alignment file and SNP locations were identified using 
SNP sites (https://github.com/sanger-pathogens/snp_sites) (version 2.0.1). Each SNP 
was then annotated using the reference annotation (10259) GFF3 file. An annotated 
VCF file was produced with VEP syntax [210] listing the type of change (intergenic/ 
synonymous/ nonsynonymous), the amino acid (before and after) and the amino acid 
position in the gene, along with the coordinates of each SNP relative to the reference 
genome, the reference base, the allele base and the presence and absence of the 
variant in each cluster. These cluster defining SNPs were then further annotated with 
the functional annotation of the gene they occurred in. 
2.1.12   Predicting antibiotic resistance 
Antibiotic resistance was predicted from each sample’s raw sequencing reads using 
ARIBA [211] (version 0.4.1), which performs antibiotic resistance identification by 
assembly and alignment. A manually curated input database of known resistance 
genes in FASTA format was used as input along with the paired end sequencing 
reads in FASTQ format. The resistance sequences were first clustered using CD-hit 
[212] (version 4.6). The raw reads were then aligned to a representative sequence for 
each resistance cluster. Reads which mapped and their complimentary strand 
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equivalents (even if unmapped) were extracted. A local assembly was performed on 
the reads for each cluster using [213] (version 3.5), where the resistance genes for the 
cluster were used as ‘untrusted contigs’. This generates a candidate gene along with 
sequence on either side if the gene is present in the reads. Algorithms which only use 
alignment suffer from a coverage drop off at either end of the gene, making 
identification less reliable, such as was found with SRST2 [214]. MUMmer [215] 
(version 3.23) was then used to identify differences between the assembled contig 
and the known resistance gene and the results were reported along with any variation 
found and quality flags. These were manually inspected and samples with 100% 
matches to resistance genes and with a complete open reading frame were flagged as 
being potentially candidates for visual inspection. 
2.1.13  Pan genome analysis 
 A pan genome was constructed using Roary [216] (version 3.2.5) from the annotated 
assemblies of the sample set with a percentage protein identity of 95%. This first step 
identified both the candidate core genes, conserved across all isolates and the 
accessory genes, which vary across isolates. The protein sequences were first 
extracted and iteratively pre-clustered with cd-hit (version 4.6) down to 98% 
identity. An all against all blast (version 2.2.31) was performed on the remaining 
unclustered sequences and a single representative sequence from each cd-hit cluster 
was selected. The data were used by MCL [217] (version 11-294) to cluster the 
sequences. The preclusters and the MCL clusters were merged and paralogs were 
split by inspecting the conserved gene neighbourhood [218] around each sequence (5 
genes on either side). Each sequence for each cluster was independently aligned 
using PRANK (Löytynoja 2014) (version 0.140603) and combined to form a multi-
FASTA alignment of the core genes.  
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2.2 Phenotypic characterisation of S. Weltevreden 
2.2.1 Bacterial strains culture conditions 
All bacteria were routinely grown on Luria-Bertani agar (LB agar) plates and broth 
(LB medium) at 37°C. For in vitro assays, genetically transformed isolates 
harbouring the plasmid pSsaG (pSsaG directs the expression of green fluorescent 
protein (GFP) from the ssaG promoter) [219, 220] were used. LB agar and broth 
were supplemented with ampicillin at a concentration of 100 µg/ml. For zebrafish 
infection challenges, bacteria harbouring the plasmid pRTZ3, which drives the 
constitutive expression of the red fluorescent protein dsRed, were used. For these 
experiments, LB agar and broth were supplemented with tetracycline at a 
concentration of 30 µg/ml. 
S. Weltevreden isolates C2346, 10259, 98 11262 and 99 3134 were used throughout 
for phenotyping. S. Typhimurium, used as a control, SL1344 was provided by Dr. 
Derek Pickard from the Wellcome Trust Sanger Institute. S. Weltevreden C2346 and 
10259 were obtained from OUCRU Ho Chi Minh City Vietnam. S.Weltevreden 98 
11262 and 99 3134 were supplied by the Centre National de Référence E. 
coli/Shigella/Salmonella, Unité de Recherche et d'Expertise des Bactéries, Pasteur 
Institute, France.  
2.2.2 Serological identification 
The identification and confirmation of the serotype of each S. Weltevreden isolate 
was performed by a standard agglutination test using O, H or Vi antisera. S. 
Weltevreden is classified as O3, O10 or O15 positive; R and Z6 positive and Vi 
negative based on the Kauffman-White scheme [221]. Anti-Salmonella O3 mouse 
antibody, anti-Salmonella O4 mouse antibody (negative control), anti-Salmonella 
O10mouse antibody, anti-Salmonella O15mouse antibody, anti-Salmonella Hr 
mouse antibody, anti-Salmonella Hz6 mouse antibody and anti-Salmonella Vi mouse 
antibody were obtained from Sifin and rabbit anti-Salmonella O1,3,19 from Statens 
Serum Institute (Copenhagen, Denmark) were used for agglutination tests. A single 
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colony was mixed independently with each of the 7 antibodies and visible clumping 
(agglutination) was observed within 2 minutes for a positive reaction.– was used to 
designate no agglutination through to ++++ for a strong agglutination. 
2.2.3 Bacterial growth assessment 
An isolated colony of S. Typhimurium SL1344 or S. Weltevreden C2346, 10259, 
98_11262 and 99_3134 was grown overnight in 10 ml of LB broth at 37°C. The 
following day, 50 ml of a secondary culture was started from the overnight at an 
OD600 of 0.05. Experiments were performed at 37°C and 28°C and the OD600 was 
measured each hour for the first 2 hours then each 30 minutes for the rest of the 
assay. At each time point 1 ml of culture was used in serial dilution for subsequent 
plating on LB plates to assess bacterial growth.  
2.2.4 Microarray assay (Biolog) 
Phenotype microarrays (PM) to assess the metabolism of individual carbon sources 
(PM 1 to 2), nitrogen sources (PM 3), phosphorus and sulphur sources (PM 4), 
biosynthetic pathway substrates (PM 5), osmotic/ionic response (PM 9) and pH 
response (PM 10) were performed according to the manufacturer’s instructions. 
(Biolog Inc. Hayward, California, USA). The bacteria were grown up to OD600 0.667 
and the cell suspensions were made up to a transmittance of 42%. For S. 
Typhimurium SL1344 the cell suspension was supplemented with histidine and the 
carbon source used was succinate. For S. Weltevreden C2346 the cell suspension was 
supplemented with adenosine and the carbon source used was succinate while for the 
isolates 10259, 98_11262 and 99_3134 the carbon source used was pyruvate with no 
added supplement. PM micro titter plates were incubated at 37°C for 48 hours in the 
Omnilog (Biolog Inc.) and each well was monitored for redox indictor change 
representing kinetic respiration. Tests were performed in duplicate and the kinetic 
data analysed using Omnilog PM software (Biolog Inc.). Data was exported from the 
Biolog File Manager, and further analysis was conducted in R.  
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2.2.5 Gentamicin killing assays using Hep2 cells 
To facilitate the analysis of invasion assays, S. Typhimurium SL1344 and S. 
Weltevreden C2346, 10259, 98_11262 and 99_3134 were transformed with the 
plasmid pSsaG that directs the expression of GFP from the ssaG promoter [219, 
220]. Hep 2 cells were cultured in Glasgow’s minimal essential medium (GMEM, 
Sigma) supplemented with 2 mM L-Glutamate and 10% (volume/volume) heat- 
inactivated fetal bovine serum (FBS). Cells were seeded into 24-well plates (105 
cells per well) and cultured overnight. Salmonella were initially cultured at 37°C 
with shaking (250 rpm) in 5 ml LB broth for 4.5 h. An aliquot was then diluted 1:50 
in L broth and grown at 37°C overnight as a static culture to optimise Salmonella 
pathogenicity island 1 (SPI1) gene expression. For infection, the bacterial cultures 
were re-suspended in fresh GMEM supplemented with 2 mM L-Glutamate and 10% 
(volume/volume) heat-inactivated FBS, in order to obtain a multiplicity of infection 
(MOI) of 50. The MOI was confirmed by plating 10 µl spots of 10-fold serial 
dilutions of the bacterial solution onto agar plates. After 30 min of incubation (to 
allow Salmonella invasion), cells were washed with phosphate-buffered saline before 
adding GMEM supplemented with gentamicin (50 µg/ml). Cells were incubated for 
the appropriate length of time and then washed and lysed with 0.1% Triton X-100. 
Dilutions of the cell lysates were plated onto agar plates to determine the number of 
intracellular bacteria. Alternatively, cells were washed and fixed onto 13mm 
coverslips with 4% formaldehyde then stored in PBS for confocal or electron 
microscopy. This protocol was adapted from [222] 
2.2.6 Confocal microscopy 
 Salmonella infected cells were washed twice with the wash buffer from the 
Cytotoxicity 3 kit after fixation and permeabilised with the permeability buffer from 
the same kit for 10 minutes. The cells were then blocked with the block buffer for 20 
min at room temperature and stained with goat anti-Salmonella CSA-1 antibody 
followed by tagged secondary antibody. Glass coverslips were mounted onto a 
microscopic slide along with ProLong Gold antifade reagent DAPI (Invitrogen). The 
preparations were observed with an LSM510 META confocal microscope (Zeiss). 
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2.2.7 Scanning Electron Microscopy 
After infection with S. Typhimurium SL1344 or S. Weltevreden C2346, 10259, 
98_11262 or 99_3134 for 30 minutes (MOI=100), cells were fixed directly on glass 
coverslips with 2.5% glutaraldehyde and 4% paraformaldehyde in 0.01 M PBS at 
4°C for 1 hour, rinsed thoroughly in 0.1 M sodium cacodylate buffer 3 times, and 
fixed again in 1% buffered osmium tetroxide for 2 hours at room temperature. To 
improve conductivity, using the OTOTO protocol devised by Malick and Wilson 
[223], the samples were then impregnated with 1% aqueous thiocarbohydrazide and 
osmium tetroxide layers, with the steps separated by sodium cacodylate washes. The 
coverslip preparations were dehydrated 3 times using an ethanol series (30, 50, 70, 
90, and 100% ethanol, 20 minutes each) before they were critical point dried in a 
Leica CPD300 and mounted on aluminium stubs with conducting silver. Before a 
specimen had completely set, the coverslip was broken by applying pressure with a 
sharp point to the centre, which caused radial fragmentation of the glass, in order to 
obtain better conductivity between the stub and the cells. The coverslip was then 
sputter coated with a 2-nm gold layer in a Leica ACE600 and examined with a 
Hitachi SU-8030 SEM.  
2.2.8 Transmission Electron Microscopy 
Cells were infected as described for the scanning electron microscopy and fixed on 
ice in their culture wells with a mixture of 2.5% glutaraldehyde and 4% 
formaldehyde in PBS for 1 hour. The cells were rinsed 3 times with 0.1 M sodium 
cacodylate buffer (pH 7.42), carefully removed from the plate with a Teflon scraper, 
and centrifuged at 10,000 rpm for 5 minutes. The pellet was post fixed in buffered 
1% osmium tetroxide at room temperature for 1 hour, followed by 1% buffered 
tannic acid for 30 minutes and then a 1% aqueous sodium sulphate rinse for 10 
minutes. The sample was then dehydrated using an ethanol-propylene oxide series 
(with 2% uranyl acetate added at the 30% step) and embedded in Epon- araldite for 
24 hour at 60°C. Ultrathin sections (60 nm) were cut with a Leica EMUC6 
ultramicrotome, contrasted with uranyl acetate and lead citrate, and viewed with an 
FEI 120-kV Spirit Biotwin TEM. Images were obtained with a Tietz F415 digital 
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TemCam. 
2.2.9 Murine intravenous challenge 
Three groups of five C57BL/6 mice were challenged intravenously with 2 x 103 
colony forming units of respectively S. Typhimurium SL1344, S. Weltevreden 
C2346, and 10259 as described in [224] . The mice were followed for 4 days 
checking for survival. They were all subsequently culled at day 4, or earlier if they 
were critically moribund.   
2.2.10  Colitis infection challenges 
Six groups of five C57BL/6 mice each were pre-treated with 10 mg of streptomycin 
(200 µl of a stock solution of 50 mg/ml of streptomycin) 24 hours before challenge. 
The first group (naïve) was injected with PBS; the second, the third and the fourth 
groups were infected with approximately 5,5x 105 CFUs of respectively S. 
Typhimurium SL1344, S. Weltevreden C2346, S. Weltevreden 10259, S. 
Weltevreden 98_11262 or S. Weltevreden 99_3134. The mice were sacrificed 4 days 
post challenge and caecum and liver were removed from all mice for further analysis. 
This protocol was adapted from [160]. The liver was plated on LB plate for CFU 
counts in order to check for systemic disease. Part of the caecum was used for 
histology to look for inflammation and the remaining part was plated on LB agar in 
order to check for bacterial colonisation of the colon. 
2.2.11  Histology 
Mice caecum segments were fixed in 4% paraformaldehyde; 5 µm-thick paraffin 
sections were stained in haematoxylin and eosin according to standard protocols. 
Stained section were analysed under microscopy to look for sign of intestinal 
inflammation. 
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2.2.12  The zebrafish challenge model 
Groups of 30 to 50 embryos of AB wildtype zebrafish were challenged intravenously 
(blood island) with 250 to 300 colony-forming units of S. Typhimurium SL1344, S. 
Weltevreden C2346 or mock injected with PBS and phenol red solution. The 
embryos were followed for 70 hours post infection removing any dead bacteria at 
each time points. The results were subsequently reported in a survival graph. The 
same set up was used in a secondary experiment were 10 embryos per time point 
were first homogenised using a stomacher then plated on LB-tetracycline plate for 
CFU counts to check for bacterial replication within the host. For experiments 
involving zebrafish harbouring mutations in Irf8_st95 [225], groups of 30 to 50 
embryos from a cross of heterozygous Irf8_st95  and wild type zebrafish parents were 
challenged intravenously (blood island) with 250 to 300 colony forming units of S. 
Typhimurium SL1344, S. Weltevreden C2346 or mock injected with PBS and phenol 
red solution. 70 hours post infection, the surviving embryos were genotyped and the 
results were reported and compared to the expected ratio of a quarter wild type, a 
quarter homozygous and a half heterozygous.   
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3 Phylogenetic diversity within S. 
Weltevreden 
 
3.1 Introduction  
The recent advancements in genome sequencing technologies have enabled a better 
understanding of the basis of bacterial evolution and adaptation to selective 
pressures. Such sophisticated technologies have facilitated outbreak tracking and the 
identification of transmission events in clinical settings as well as in the community. 
These techniques have been successfully used to address the evolution of various 
Salmonella serovars such as S. Typhimurium [226], S. Enteritidis [227] and S. Typhi 
[133].  Despite a global effort to study and tackle these pathogens, salmonellosis still 
represent an important health concern globally as new strains emerge over time. For 
example, S. Weltevreden has emerged as a significant foodborne pathogen 
particularly in South-East Asian countries and the Pacific region. S. Weltevreden has 
increasingly been reported to be associated with different sources including 
vegetables, poultry, meat, animal feed and seafood. Indeed, in a study conducted on 
over 12,000 Salmonella isolates, S. Weltevreden was the most frequently isolated 
serovar from seafood in Vietnam and was amongst the highest Salmonella 
contaminant in fish and seafood samples in the world [228, 229]. Various reports of 
food poisoning due to S. Weltevreden have come from India [230], Reunion Island 
[231], Thailand, Vietnam [232], Fiji [233] and more recently from Norway, 
Denmark and Finland  [234]. 
In recent years, multiple cases and outbreaks of S. Weltevreden have been reported 
to be associated with different disease outcomes. The clinical outcomes in patients 
range from asymptomatic carriage, moderate to severe diarrhoea, invasiveness in 
immunocompromised individuals [235], ulcerative skin lesions [236], through to rare 
cases of fatality [237]. Antibacterial resistance is not currently commonly reported 
for S. Weltevreden isolates and current therapy includes the use of fluoroquinolones. 
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Some of the earliest attempts to genetically characterise S. Weltevreden involved the 
generation of draft genomes and preliminary comparative genome analysis. Draft 
genomes have been generated for the scallop-associated isolate SL484, the 
Scandinavian outbreak associated isolate S. Weltevreden 2007-60-3289-1 from 
alfalfa sprouts [238] and a multidrug resistant isolate S. Weltevreden “9” isolated 
from seafood [239]. Preliminary comparative genomic studies performed against 
representative isolates of S. Dublin, S. Newport, Salmonella Cholereasius, S. 
Enteritidis, Salmonella Gallinarium, Salmonella Heidelberg, Salmonella Agona, S. 
Paratyphi (A, B and C), Salmonella Schwarzegrund, and S. Typhi [238] were used to 
generate a phylogenetic tree showing their comparative relationships to S. 
Weltevreden (Figure 3.1).  
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                            Figure 3.1: Phylogenetic tree generated using the core genes (~2650 coding sequences) of various Salmonella. Taken from [238] 
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S. Agona was found to be genetically the closest serovar to S. Weltevreden. The 
analysis of S. Weltevreden 2007-60-3289-1 revealed the presence of additional 
cluster of genes likely associated with carbohydrate metabolism, suggesting the 
possibility of survival in alternative habitats [238]. Indeed, the average S. 
Weltevreden genome is slightly bigger than the average Salmonella genome. The 
presence of many of the major Salmonella SPIs was confirmed in the Scandinavian 
isolate. Interestingly comparative analysis between SL484 and 2007-60-3289-1 
showed high genetic similarity despite the different source and geographic location 
of the isolates [238]. 
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Figure 3.2: Mauve progressive alignment of the draft genomes of S. Weltevreden  2007-60-3289-1, S. Dublin CT_02021853 and S. Weltevreden SL484   
S. Dublin was used as a comparator as this serovar has a similar genome size and shares many features with S. Weltevreden 2007-60-3289-1. Black numbered arrows indicate 
selected features; 1: 1- T6SS1  (Spi 6); 2- T6SS2 (Spi 19); 3- Genomic island 1 (Spi 13); 4- Genomic island II (Spi 13); 5- Genomic island III; 6- Genomic island IV; 7- Genomic 
island V; 8- Genomic island VI; 9- Myo-inositol utilisation loci; 10- Carbohydrate utilisation cluster; 11- Restriction/modification cluster; 12- Phosphonate metabolism. Regions 
containing phage-related genes are indicated with a black arrow without a number. Taken from [238] 
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In this chapter, Illumina and PacBio sequencing technology were used to sequence 
the genomes of a globally distributed collection of 115 S. Weltevreden isolates. 
Subsequently, phylogenetic approaches were exploited to generate a detailed 
population structure and highlight interesting genetic features of these S. 
Weltevreden. 
3.2 Results 
3.2.1 The S. Weltevreden collection 
A collection of 115 S. Weltevreden isolates from 18 countries was compiled through 
collaborative efforts involving Dr. Stephen Baker (Ho Chi Minh City, Vietnam) and 
Dr. Francois-Xavier Weill (Pasteur Institute, France). The isolates were 
predominantly collected from S. Weltevreden endemic area of the South–East Asian 
region and some West Pacific countries, as well as the Pasteur Institute isolates that 
represented Francophile countries and travellers. These isolates were from different 
sources including the environment, food, animal waste, animals, human faeces and 
blood and they covered a period from 1940 to 2013. The map depicted below shows 
the geographical distribution of the isolates included in this study. 
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       Figure 3.3: Geographical distribution of S. Weltevreden isolates included in the study  
       Colours (red and yellows) represent the phylogenetic clusters and the number of the isolates from each location and will be discussed later in the chapter. 
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3.2.2 Generation of a S. Weltevreden reference genome 
In order to gain a better understanding of the genetic architecture of S. Weltevreden, 
DNA from the isolate 10259 obtained from a stool of a diseased Vietnamese child, 
was sequenced using both the Illumina and PacBio RSII long read sequence 
platforms. For a full description of the approaches see the Methods section. After 
manual fixes, a new high quality reference genome for S. Weltevrden 10259 was 
generated which revealed a single contig for the main bacterial chromosome and an 
additional contig for a large plasmid that is present in many isolates. The 
chromosome of S. Weltevreden 10259 is a single circular molecule of 5,062,936 
bases that harbours a 4723 predicted coding DNA sequences (CDSs). The single 
plasmid is 98,756 bases in length with 98 predicted CDSs. The genome has a G+C 
content of 52.1%. Putative functions of coding genes were assigned using the Sanger 
automatic annotation pipeline (Accession number to be provided post submission). 
Figure 3.4 below represents a map of the genome generated using DNA plotter. 
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Figure 3.4: DNA plotter diagram of S. Weltevreden 10259 genome   
The outer black circle designates the genome base positions around the chromosome. The next 2 outer 
blue circles depict predicted CDSs on both strands. The predominantly orange circle represents the main 
chromosome with likely horizontally acquired DNA elements. On this circle, grey areas represent non-
coding RNA (ncRNA) and the green areas represent tRNA. The inner circle represents the % of GC plot. 
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3.2.3 Phylogenetic analysis 
3.2.3.1 Confirmation of sequence type 
DNA from all 115 S. Weltevreden isolates were sequenced on the Illumina 
sequencing platform with an average coverage of ~70 times the genome size. A 
statistical and logistical analysis of the runs can be found in Appendix 4. To correlate 
their serovar identity, all 115 sequences together with the other published sequences 
isolates were run on the reference database 
http://mlst.warwick.ac.uk/mlst/dbs/Senterica to determine their MLST. The data 
confirmed all of the isolates were Weltevreden Sequence Type 365 and Table 3.1 
below summarises the MLST of 10259 as well as the alleles numbers for each 
housekeeping gene used to compile the MLST profile.   
Isolate ST Contamination aroC dnaN hemD hisD purE sucA thrA 
10259 365 none 130 97 25 125 84 9 101 
Table 3.1: MLST data for S. Weltevreden 10259 reporting alleles numbers. 
 
 
3.2.3.2 S. Weltevreden in the context of other S. enterica 
S. Weltevrden is a relatively under studied serovar. Indeed, the exact placement of 
the S. Weltevrden serovar in a comprehensive phylogenetic tree based on whole 
genome sequences inclusive of other Salmonella serovars has not been available. 
Previous limited phylogenetic analysis placed S. Weltevrden close to S. Agona [240] 
and S. Enteritidis [241] in a separate eburst group [59]. The earlier analysis was 
compromised by the poor quality of the published reference genome (accession 
JPIO01) used for those analysis, which included only 1,744 predicted CDSs, a third 
of the expected number.    
To clear up this confusion, the new reference generated in this study was used to 
compare S. Weltevreden with 57 other isolates representative of different S. enterica 
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serovars. A single high quality assembly was chosen for each serovar. Twenty two 
were high quality finished assemblies and thirty six were fragmented assemblies (see 
Table 3.2). A pan genome was constructed with S. Weltevrden and the 57 other 
serovars using Roary and a core genome of 2,572 genes was identified, representing 
2,382,319 bps, with SNPs at 150,074 positions. The size of the core genome is in line 
with previously published work. This data was used to create a phylogenetic tree 
using RAxML with 100 bootstraps. The nearest serovar phylogenetically is S. 
Elizabethville with a difference of 11,989 bases in the core genes of the 
representative isolates with 0.5% variation. This observation is also supported by the 
similarities in their serology (S. Weltevreden is O:3, O:10 or 15 and r, z6 positive and 
S. Elizabethville is O:3, O:10 and r, 1,7 positive). S. Agona, which has already been 
reported to be genetically close to S. Weltevreden, also mapped closely to S. 
Weltevreden in this independent analysis with 20,916 bp differences in the core 
genes representing a variation of 0.877%. 
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Figure 3.5: Maximum likelihood tree comparing S. Weltevreden with selected S. enterica serovars  
2,572 core genes representing 2,382,319 bps were used to build the tree with SNPs at 150,074 
positions. 
 
Below is a table listing the different serovars used to build the global tree. 
 
 
84 
 
Serovar Accession Type 
Aberdeen ERS179732 Illumina 
Abortusequi ERS179705 Illumina 
Abortusovis ERS179728 Illumina 
Agama ERS037945 Illumina 
Agona CP006876 Complete Reference 
Anatum ERS179686 Illumina 
Arechavaleta ERS016018 Illumina 
Bareilly ERS218079 Illumina 
Brandenburg ERS179748 Illumina 
Chester ERS015989 Illumina 
Choleraesuis CM001062 Complete Reference 
Coeln ERS218091 Illumina 
Cubana CP006055 Complete Reference 
Derby ERS179704 Illumina 
Dublin CM001151 Complete Reference 
Eastbourne ERS179718 Illumina 
Elizabethville ERS394435 Illumina 
Enteritidis Unpublished PacBio 
Gallinarum CM001153 Complete Reference 
Goldcoast ERS530430 PacBio 
Hadar ERS004922 Illumina 
Heidelberg CP003416 Complete Reference 
Hvittingfoss ERS179726 Illumina 
Infantis CM001274 Complete Reference 
Java ERS207735 Illumina 
Javiana CP004026 Complete Reference 
Johannesburg ERS015996 Illumina 
London ERS179679 Illumina 
Madelia ERS743095 PacBio 
Minnesota ERS015985 Illumina 
Montevideo ERS016005 Illumina 
Moscow ERS179753 Illumina 
Muenchen ERS218081 Illumina 
Muenster ERS016008 Illumina 
Naestved ERS400249 Illumina 
Newport CP001113 Complete Reference 
Oranienburg ERS743094 PacBio 
Oslo ERS179729 Illumina 
Panama ERS016015 Illumina 
Paratyphi_A FM200053 Complete Reference 
Paratyphi_B CP000886 Complete Reference 
Paratyphi_C CP000857 Complete Reference 
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Poona ERS668408 Illumina 
Potsdam ERS179673 Illumina 
Pullorum Unpublished Complete 
Reading ERS179721 Illumina 
Rubislaw ERS218070 Illumina 
Schwarzengrund CP001125 Complete Reference 
Sendai ERS179752 Illumina 
Senftenberg ERS451416 PacBio 
Stanley ERS179745 Illumina 
Tennessee ERS218098 Illumina 
Thompson ERS179680 Illumina 
Typhi AL513382 Complete Reference 
Typhimurium FQ312003 Complete Reference 
Urbana ERS015987 Illumina 
Virchow ERS668352 Illumina 
Weltevreden Unpublished PacBio 
 
Table 3.2: List of S. enterica serovars and Isolates used for comparison and their accession numbers 
where available  
Assemblies fall into 3 general categories, fragmented short read assemblies using Illumina, high quality 
long read assemblies using PacBio and high quality complete assemblies using a variety of technologies 
and manual finishing. 
 
A simpler tree was subsequently generated that included S. Weltevreden isolates 
SW10259 and SWC2346, S. Elizabethville and several other reference Salmonella 
genomes deposited on the NTCT database (Figure 3.6). Here, S. Goldcoast is one of 
the closest related serovars to S. Weltevreden. S Goldcoast is mostly associated with 
zoonosis and rarely infects human with exception of a few reported outbreaks. 
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Figure 3.6: Simplified phylogeny of selected S. enterica serovars deposited on the NCTC database 
compared to S. Weltevreden. 
 
3.2.4 Genetic diversity of S. Weltevreden  
To investigate the population structure of S. Weltevreden in more detail the genomes 
of the sequenced S. Weltevreden isolates were mapped against the S. Weltevreden 
10259 reference genome. 
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3.2.4.1 Chromosome analysis 
A multi-FASTA alignment was generated from the aligned samples for the 
chromosome. SNPs were present at 22,569 positions, but these were subsequently 
filtered before the generation of the final tree. As the samples were sequenced using 
Illumina short read technology, repeats longer than the target fragment size (~400 
bases) were detected by blasting the reference chromosome against itself and the 
plasmid sequence against the chromosome. For this analysis, 63 regions greater than 
400 bases with a percentage identity of more than 99% were excluded in the multi-
FASTA alignment, which resulted in 42 SNPs being excluded. After removal of 
these long repeats units, Gubbins (a software designed to identify regions of potential 
recombination that exploits SNP density) was used to limit the effects of 
recombination on the phylogeny. A total of 218 recombination blocks were identified 
in the sample set, which reduced the number of core SNPs to 2601. The outcome of 
this Gubbins-based analysis is shown in Figure 3.7, where the red blocks represent 
recombination events identified in comparison to the ancestral node and the blue 
blocks recombination events only present in one isolate.  
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Figure 3.7: Gubbins-based analysis representing the recombination events across the tree  
The red blocks represent recombination events identified in comparison to the ancestral node and the blue 
block recombination events only present in one isolate. Recombination regions across the genome are 
highlighted in green on the reference genome on top.  
 
From this refined set of SNPs, a phylogenetic tree was generated with RAxML using 
100 bootstraps. The isolates were clustered using BAPS (see methods) identifying 2 
primary clusters, which we refer to as the ‘Islands Cluster’ and the ‘Continental 
Cluster’ correlating closely in most cases with where the samples were collected. S. 
Weltevreden was definable as a monophyletic serovar sub-dividable into 5 sub-
clusters, again correlating closely to where the samples were collected, or their 
suspected origin (figure 3.8). The Islands Cluster contains 2 distinct sub-clusters, one 
is drawn primarily from islands in the Indian Ocean (Indian Ocean subcluster) and 
the other from islands in Oceania or from nearby South East Asian countries 
(Oceania subcluster). The Islands Cluster had a different profile to the Continental 
Cluster. The phylogeny suggests there were independent introductions into different 
islands and that these subsequently evolved independently. Thus, the phylogeny 
provides evidence of significant levels of geographical clustering from regional to 
national. Overall, these data suggest that S. Weltevreden slowly evolves within a 
specific geographical region rather than spreading from one location to another on a 
frequent basis. 
The Continental Cluster is dominated by isolates from Vietnam, which reflects the 
sample bias but this cluster also includes a few isolates from the ‘French’ islands of 
the West Indies. There are 3 distinct sub-clusters which capture the circulating 
lineages, Vietnam 1, Vietnam 2 and Vietnam resistance. The Vietnam resistance sub-
cluster is interesting because out of 14 isolates, 4 have genes linked to antimicrobial 
resistance and this may be a worrying emerging trend that has not thus far affected S. 
Weltevreden as a whole. 
S. Weltevreden isolates obtained from France were scattered throughout the tree 
without showing any particular clustering. These are likely to be associated, at least 
in some instances, with international travel. Interestingly, no particular clustering 
was observed based on the environmental/human source of the isolates. Indeed, 
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isolates from animal, food, environment and humans were distributed throughout the 
tree. No evidence of significant temporal clustering was observed.  
There are 112 SNPs that can be used to discriminate between the 2 main clusters. 
These SNPs are the same bases in all isolates of one clusters and different from all 
isolates outside the cluster (Appendix 3). For instance, in the aminopeptidase gene 
pepN, encoding an aminopeptidase, the SNP in position 1,202,670 within the gene is 
a T in all isolates from the Continental cluster and an A in all isolates from the 
Island cluster. These 112 defining SNPs are dispersed evenly throughout the genome 
with no high density clusters. None of these changes introduce stop codons, so 
pseudogene formation is not evident. 
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Figure 3.8: Population Structure of S. Weltevreden isolates with key metadata information  
Maximum likelihood tree build on 2601 SNPs showing A: geographic origin (region), cluster and  sub 
cluster. B: antimicrobial profile (laboratory confirmed and predicted); in blue resistant and in red 
susceptible. 
3.2.4.2 Plasmids 
A single major plasmid with 98,756 bases in the reference S. Weltevreden 10259 is 
present in 90% of the isolates. It is possible that more of the isolates originally 
contained this plasmid but it may have been lost from some isolates on storage and 
culturing as it is missing in a relatively random manner across the tree, particularly 
from older isolates. There is relatively little variation in the plasmids with only 970 
SNPs discriminating plasmids on the tree. If a single potential recombinatorial region 
is excluded from 7 isolates originating in La Reunion the number of SNPs drops to 
just 48, which is a variation of 0.048%, indicating a very stable plasmid structure. 
The plasmid tree structure matches that of the main chromosome, with nearly all the 
clusters matching identically, indicating that it has evolved with the chromosome.  
Two of the sub-clusters are interleaved, due to insufficient variation (Figure 3.9). 
This plasmid shares 99% of similarity with the plasmid pSW82 found in S. 
Weltevreden 2007-60-3289-1 published earlier and contains many classical plasmid 
genes including toxin and anti-toxin genes, integrase and plasmid maintenance genes 
(see also Chapter 6). Many isolates contain more than one plasmid, but these are 
usually medium to small plasmids, which are scattered across the tree. 
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Figure 3.9: Maximum likelihood plasmid tree build on 48 SNPs. 
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3.2.4.3 Resistome 
Antimicrobial resistance has not been frequently reported for S. Weltevreden. 
Indeed, there is very little evident of resistance in the sample set, either 
phenotypically or through predicted resistance from the genomic data. Known 
resistance genes were detected in 7 isolates using ARIBA [211], where antimicrobial 
resistance was conservatively inferred using strict conditions; genes had to be 
matched throughout the full open reading frame, with 98% identity to the genes 
known to confer resistance. Isolate 2013_2776, originating from contaminated food 
in France (potentially imported from South East Asia) was found to have 6 AMR 
genes, located on a plasmid very similar to the S. Heidelberg plasmid pSH111_227 
(accession JN983042). 
Gene Accession 10347 
38_NTM
D 
94_VNQ
N 
iNT_63
5 
2011_0227
9 
2013_277
6 
03_198
6 
qnrD FJ228229 R    R         
tetA AJ517790   R   R     R 
qnrS1 AB187515   R   R       
blaTEM3
0 AJ437107 
        R     
dfrA1 JQ690541             R 
sul3 AJ459418             R 
aph3 V00359           R   
oqxA EU370913           R   
oqxB EU370913           R   
strA NC_003384 
          R   
strB M96392           R   
tetB AF326777           R   
 
Table 3.3: Genes known to confer antimicrobial resistance found in S. Weltevreden and the isolates 
in which they were detected.  
 
3.2.4.3.1 Additional plasmids present in the samples flagged as antimicrobial 
resistant 
A Kraken database was created using all plasmids from RefSeq as well as the S. 
Weltevreden 10259. All of the de novo assemblies for the samples which were 
flagged as having, or potentially having antimicrobial resistance were compared to 
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the  Kraken database, which categorised each contig as a novel plasmid or as related 
to the S. Weltevreden reference chromosome plus plasmid. The novel potential 
plasmid contigs were extracted for further analysis. This pre-filtering step reduced 
the size of the input data set by 98%. As the de novo assemblies originate from short 
reads, plasmids are fragmented into multiple pieces. To overcome this issue a 
nucleotide blast approach was exploited to accurately assign contigs to plasmids and 
a database was created of all the plasmid sequences in RefSeq. All of the candidate 
sequences from the de novo assemblies were then blasted against these reference 
plasmid sequences and the novel plasmids were conservatively called (more >95% 
identity, hits over 10,000 bases in length). Where there were matches to multiple 
plasmids, a combination of the high values and percentage coverage of the reference 
plasmid were used.  
Table 3.4 lists the 7 isolates with predicted additional plasmids. The equivalents of 
these plasmids are found in a diverse range of other species and genus. Of the 8 
samples with predicted or laboratory confirmed antimicrobial resistance, 7 harboured 
additional predicted plasmids, equivalents of which have been linked to 
antimicrobial resistance previously [242-245]. The one phenotypically resistant 
isolate absent from the list, iNT_635, had too much fragmentation to confidently call 
a plasmid. However a plasmid related to pEBG1 is likely present in this isolate 
(accession NC_025182.1). 
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Sample AMR Predicted 
AMR 
Additional Plasmids Accession 
03_1986 Resistant Resistant S. Heidelberg plasmid 
pSH1148_107 
NC_019123.1 
2013_2776 Resistant Resistant Serratia marcescens 
plasmid R478 
NC_005211.1 
2011_02279 Resistant Resistant E. coli HUSEC2011 
plasmid pHUSEC2011-1 
NC_022742.1 
38_NTMD Susceptible Resistant E. coli strain 09/22a 
plasmid pEBG1 
NC_025182.1 
10347 Susceptible Resistant Klebsiella oxytoca 
CAV1099 
pKPC_CAV1099 
NZ_CP011615.1 
94_VNQN Susceptible Resistant K. oxytoca CAV1099 
pKPC_CAV1099 
NZ_CP011615.1 
2013_2912 Resistant Susceptible Citrobacter freundii 
CAV1321 plasmid 
pCAV1321-135 
NZ_CP011610.1 
 
Table 3.4: Isolates likely to harbour antimicrobial resistance-associated plasmids. 
3.2.4.4 Accessory genome analysis 
The predicted pan genome of the S. Weltevreden isolates was created using Roary 
from annotated de novo assemblies. This reference free approach captures much of 
the sequence diversity, unlike alignment-based approaches, which miss sequences 
absent in the reference genome. S. Weltevreden genomes have ~4500-5000 predicted 
CDSs, depending on the mobile elements present. A core of 4046 CDSs present in 
each isolate was identified using this approach against 2572 core CDSs identified 
early using an alignment based approach on a wider set of serovars. The total 
accessory genome consisted of 7923 CDSs as show in Figure 3.10.  
 “Get homologues software” was used to estimate core and pan genome sizes and 
generate a parse-pan-genome matrix in order to compute and graph the core, cloud, 
and shell genome compartments [246]. GET_HOMOLOGUES defines these 
compartments empirically, as follows: core, genes contained in all genomes analysed 
considered; soft core, genes contained in 95% of the genomes analysed, as described 
in the study described in [246]; cloud, genes present only in a few of genomes 
analysed and shell, the remaining genes, present in several genomes.  
An average of 15 new predicted CDSs was added to the pan genome with every new 
isolate (Figure 3.11) and there are an underlying number of unique genes that are 
only found in one isolate. Some of these gene calls are theoretically due to DNA 
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contamination and/or mis-assemblies; however the majority appear to be attributable 
to mobile elements or gene islands. Given the rate of new gene acquisition and the 
increasing size of the pan genome as seen in Figure 3.12, S. Weltevreden appears to 
have a relatively open pan genome.  
Consequently, the size of the potential gene pool from Salmonella and in particular 
S. enterica, along with the commonality of a variety of mobile elements, indicates 
that more sequencing will be required to fully capture the total pan genome of this 
serovar. 
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Figure 3.10: Breakdown of the frequency of gene in isolates and in the overall collection of S. 
Weltevreden  
Here, the core genome is defined by genes present in 99-100% of isolates, the soft-core by 95-99%, the 
shell by 15-95% and the cloud by 1-15% as defined in (Contreras-Moreira and Vinuesa, 2013) [246]. 
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Figure 3.11: Plot showing variance in the number of unique genes found in one isolate only and the 
number of new genes as genomes are added to the pan genome. 
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Figure 3.12: Variance in the total number of predicted CDSs (genes) in the pan genome and the of 
conserved CDSs (99% of isolates) in the core genome as samples are added. 
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3.2.4.5 Phylogeny of the distribution of phage-like elements 
In order to address the phylogeny of genetic elements with phage-like signatures on 
the tree, the genome sequences of the isolates 10259, C2346, 98_11262 and 
99_3134, representing some of the diversity within the tree, were investigated using 
the website “PHAST”. Several relatively complete phages were identified on each 
isolates, with an average of 12 phage elements per isolates. Figure 3.13 illustrates the 
distribution of such phages within the genome of S. Weltevreden 10259.  
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Figure 3.13: Predicted phage distribution across the genome of the S. Weltevreden 10259  
The outer circle defines the position in the genome; the red blocks represent the larger phage elements 
found across the genome while the green blocks represent partial phage sequences. Picture generated 
using Phast 
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Most phages identified on PHAST were shared by all isolates; these include classical 
Salmonella phages such as Gifsy 1 and 2, Fels 1, as well as entero PsP3 [247]. Figure 
3.14 below shows ACT snapshots comparing the 4 genomes at the DNA level. The 
spaces apparent in each genome likely represent recently acquired DNA. Indeed, 
more detailed analysis revealed many had signatures of phage or mobile elements 
and corresponded to regions identified in the PHAST search (Appendix 4). 
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       Figure 3.14: Comparative analysis of the genome sequence of S. Weltevreden (1) 10259 (2) 98_11262 (3) 99_3134 and (4) C2346  
            Red, blue and yellow areas represent core genetic elements and the white areas represent potential mobile genetics elements. Analysis performed in ACT 
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3.3 Discussion  
In this study we analysed the genomes of 115 S. Weltevreden isolates collected from 
18 countries representing the most comprehensive genomic study on S. Weltevreden 
to date involving whole genome sequencing technologies. These analyses revealed 
that the average S. Weltevreden genome is relatively large compare to most S. 
enterica serovars. Indeed, the genomes of all the S. Weltevreden isolates were above 
5,000000 bps. S. Elizabethville was phylogenetically the closest S. enterica serovar 
to S. Weltevreden, nicely linking the genotype to the serological phenotype. Indeed, 
serological test confirmed the high similarities between the 2 serovars with S. 
Weltevreden being O:3, O:10 or 15 and r, z6 positive and S. Elizabethville being O:3, 
O:10 and r, 1,7 positive. This population structure analysis revealed that S. 
Weltevreden is a monophyletic serovar organised into 2 major clusters of largely 
continental and island isolates, displaying high level of geographical clustering. 
There was some evidence of geographical clustering within the sub-phylogeny, 
suggesting that the S. Weltervreden serovar continues to evolve within a specific 
geographical region rather than frequently spreading from one location to another. 
There was no obvious temporal clustering within the phylogeny, although this could 
be because most of our isolates were of relatively recent origin. Importantly, the 
phylogeny did not correlate with disease type or source of the isolate. For example, it 
was not possible to distinguish phylogenetically between isolates from diseased 
patients or controls or even for a specific disease types. Thus, it was not possible to 
link specific genotype to any disease syndrome. 
The two main clusters can be discriminated between using the 112 SNPs (Appendix 
3). These SNPs will enable the design of specific probes that could be used in SNP 
or PCR analysis to discriminate between isolates and allocate novel S. Weltevreden 
to the appropriate cluster. For example, primers flanking selected regions containing 
the defining SNPs could be used in diagnostic and epidemiology analysis to assign 
isolates to particular phylogenetic clusters or even to likely country/region of origin. 
This could be especially useful for travellers returning from multiple destinations to 
trace down the region of contamination and to further understand the burden of S. 
Weltevreden infection across the globe. 
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Interestingly, despite the diversity of geographical origin 104 isolates out of 115 
possessed a highly related plasmid to that in the reference S. Weltevreden 10259, as 
illustrated by a plasmid tree built with 48 SNPs. Indeed, removal of a single 
recombination region found in 7 isolates from the same area brought the number of 
plasmid-associated SNPs down from 970 to 48. This plasmid is more than 99% 
identical to the plasmid pSW82 found in S. Weltevreden 2007-60-3289-1.  
Antibiotic resistance was not a very common phenotype within our S. Weltevreden 
collection and genome analysis for the presence of antibiotic resistance signatures 
within the genomes of our collection confirmed the laboratory findings, with just 7 
isolates out of the whole set displaying antimicrobial resistance genes. Further 
analysis suggested that these resistant isolates harboured novel plasmids of types 
previously described in other bacteria. Thus, S. Weltevreden, although largely still 
susceptible to antibiotics, has the potential to acquire multiple antibiotic resistance 
and any trends in this direction should be carefully monitored in the future. 
A total of 4046 core predicted genes present in each isolate were identified using 
reference free accessory genome analysis. S. Weltevreden appears to have a 
relatively open pan genome based on the rate of new gene acquisition and the size of 
the pan genome. However, further analysis will be required for a comprehensive 
description of the S. Weltevreden accessory genome. Initial work showed that phages 
and mobile elements varied depending on the isolate. Well characterised Salmonella 
phages were present as well as more novel phage types. Thus, in common with other 
S. enterica, phage and other mobile elements are a key driver of diversity, suggesting 
that the serovar is undergoing rapid and continuous evolution.  
The ability to generate DNA sequence and to construct accurate phylogeny will 
facilitate further epidemiological analyses and functional genomic work designed to 
link phenotype to genotype. The initial steps in this direction described in this 
Chapter benefited greatly from the generation of an accurate reference genome S. 
Weltevreden 10259 that will be made available to the community. This genome can 
provide a basis for further functional genomic work, including mutagenesis, RNA-
seq and proteomics. 
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4 Phenotypic characterisation of S. 
Weltevreden 
 
4.1 Introduction 
The Kauffman-White scheme has been used for decades to classify Salmonella into 
serovars based upon serological analysis. This phenotypic approach has proved to be 
invaluable in public health terms for epidemiological and clinical work, although the 
level of resolution limits its utility. Work described in the previous chapter defined 
the levels of genetic diversity within a collection of S. Weltevreden isolates at a 
whole genome level using phylogenomic approaches. These studies defined S. 
Weltevreden as a monophylectic group that could be divided into sub-clades with 
distinct genetic structures. Our interest in this serovar was stimulated in part by 
increasing reports of an association of S. Weltevreden with clinical disease in 
different geographical regions. For example, our collaborators working at the Oxford 
University Clinical Centre in Ho Chi Minh City, Vietnam were isolating S. 
Weltevreden from both diseased and control individuals (see Appendix 1). Most of 
the clinical disease was associated with gastroenteritis and there was an indirect link 
with marine food sources (Dr. S. Baker, personal communication). Additionally, S. 
Weltevreden is emerging as one of the most frequently isolated serovars in clinical 
salmonellosis cases from other regions. 
Despite an increasing effort to genetically characterise S. Weltevreden, little to no 
phenotypic data is currently available in the published literature Thus, there is a lack 
of knowledge and a clear understanding of the mechanisms of microbial 
pathogenesis associated with this serovar. Such information would be of value for 
designing approaches to prevent and tackle disease. Thus with an aim to gain more 
insights into the pathogenesis and host response to infection stimulated by S. 
Weltevreden, we embarked on a series of experiments designed to phenotype 
selected isolates representing the diversity of the phylogenetic tree. These isolates 
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were tested in various experimental settings to define characteristics using isolates 
representative of specific genetic clusters (where isolates were available) with the 
overarching goal of linking the genotype to the phenotype. A comparative analysis of 
isolates of the S. Weltevreden and S. Typhimurium serovars was performed in each 
experiment in order to capture the key differing features between these 2 groupings. 
For the experiments described in this chapter, S. Typhimurium SL1344 was used as a 
control as this isolate has been used extensively in laboratories around the world and 
in various in-vitro and in-vivo models of infection [248, 249]. For example, as a 
mouse pathogen, S. Typhimurium SL1344 has been used in both the typhoid [250] 
and streptomycin treated gastroenteritis (colitis) mouse model [160]. Thus, here we 
exploit the extensive genetic and phenotypic data already available on S. 
Typhimurium SL1344 to characterise and compare S. Weltevreden isolates to this 
more common nontyphoidal Salmonella. 
4.2 Results 
4.2.1 Microbial characterisation and confirmation of 
serotype 
S. Weltervreden isolates SW C2346, SW 10259, SW98_11262 and SW99_3134 
were selected for use in phenotypic assays. Their positions within the S. 
Weldervreden phylogeny are shown in Figure 3.8.  As a step towards validating that 
the isolates were phenotypically S. Typhimurium or S. Weltervreden they were 
propagated on L-agar and characterised for microbial growth and serotyped using 
reference serotyping sera. Initially, an agglutination test was performed on S. 
Typhimurium SL1344 using O4 and 05 sera, according to the Kauffman-White 
classification for S. Typhimurium. O10 typing sera were used as a negative control. 
The agglutination data for S. Typhimurium SL1344 were consistent with the 
Kauffman-White serological classification. In order to further validate that this 
isolate was SL1344 and not the aroA mutant derivative SL3261, which is also 
frequently used in the laboratory, the presence of the aroA gene was confirmed by 
colony PCR by amplifying the aroA region using primers specific for S. 
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Typhimurium. The isolate was also able to grow on media lacking aromatic 
supplements. These assays confirmed that the isolate did not harbour an aroA 
mutation. 
Similarly, to validate the serotype of the S. Weltevreden isolates, agglutination tests 
were performed on all isolates. Based on the Kauffman-White classification, S. 
Weltevreden is O3 positive, O10 or O15 positive for O antigen and, R and Z6 
Positive for phase 1 and 2 H antigens respectively. Here, O4 typing sera was used as 
a negative control and the tests were performed as described in the methods section. 
Additionally, all isolates were Vi-negative. Table 4.1 below summarise the results.  
Strain Somatic antigen Flagella antigen Virulence 
antigen 
03 04 010 015 
R Z6 Vi 
SW C2346  +++ - +++ - + +++ - 
SW 10259 ++ - - +++ ++ - - 
SW 98_11262  ++++ - ++++ - + + - 
SW 99_3134   +++ - ++++ - + + - 
Table 4.1: Sera agglutination results summary  
 -: no agglutination observed, +: low agglutination, ++: mild agglutination, +++: strong agglutination, 
++++: very strong agglutination. 
 
All isolates were strongly positive for the core-typing antigen O3 whereas isolates 
SW C2346, SW98_11262 and SW99_3134 were additionally positive for O10. 
Isolate SW 10259 was positive for O15 but not O10. All isolates were negative for 
the control O4 typing sera. All 4 isolates were positive for HR and isolates SW 
C2346, SW98_11262 and SW99_3134 were positive for the Phase 2 antigen Z6. 
Again, SW 10259 was distinct in that it did not react with Z6 sera. This may be 
expected as Phase 2 antigens are not always expressed. The data retrieved from the 
112 
 
tests were generally consistent with the Kauffman-White scheme and taken together 
with the phylogenetic data the isolate fall into the S. Weltervreden serovar grouping.  
4.2.2  Bacterial growth in-vitro 
To ensure that any further phenotypic difference observed between the isolates was 
not due to any general differences in their growth rate this was assessed in LB 
medium over the course of 24 hours at 37° C. The results are shown in Figure 4.1. 
All isolates grew with a similar doubling time in this medium.  
 
Figure 4.1: Standarisation curve reporting the number of colony forming units (CFUs) per OD600 
in LB medium for each bacterial isolate  
Biological triplicates were used while performing this experiment.  
 
4.2.3 Metabolic profiling using the Biolog Phenotype 
Microarray system 
To gain more insight into the phenotypic diversity of S. Weltevreden compared to S. 
Typhimurium, 2 of the S. Weltevreden isolates, SW C2346 and SW 10259 were 
tested alongside S. Typhimurium SL1344 for metabolic activities using Biolog 
Phenotype Microarray™ plates and any metabolic differences were scored and 
analysed using the Biolog OPM data analysis platform [251]. Plates PM1 and PM2 
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(covering different carbon sources), plate PM3 (Nitrogen sources), plate PM4 
(phosphorus and sulfur sources), plate PM9 (osmolytes) and plate PM10 (pH) were 
used in the assays, which were repeated several times. Overall the different isolates 
had a consistent metabolic profile with most individual assays reporting similar 
results. Both S. Weltervreden gave indistinguishable metabolic profiles. The key 
metabolic differences between S. Weltervreden and S. Typhimurium are shown in 
Figure 4.2.  
 
Figure 4.2:Carbon source utilisation microarray  
The carbon sources differentially utilised by S. Weltevreden (SW) and S. Typhimurium SL1344 (ST). 
The green circles represent the dominantly utilised energy sources and red circles represent the less 
favoured sources for each serovars. This data is representative of multiple biological replicates. 
 
The results confirmed that both S. Weltevreden isolates have the capacity to exploit 
similar carbon sources (Appendix 5). In contrast, notable difference in carbon 
choices was observed between S. Typhimurium SL1344 and the S. Weltevreden 
isolates. D–xylose has been associated with amino sugar and nucleotide sugar 
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metabolism, pentose and glucoronate inter-conversion as well as starch and sucrose 
metabolism [252, 253]. Glyoxylic acid is associated with purine and amino acid 
metabolism, carbon fixation pathways, biosynthesis of secondary metabolites and 
microbial metabolism in diverse environments. 
4.2.4 Invasion into Hep 2 cells 
Eukaryotic host cells growing in culture have been used extensively to monitor 
cellular interactions between host and microbe. A classical method involves the 
exposure of cell lines growing in-vitro to different numbers of either wild type or 
mutant pathogens followed by microscopic or microbiological observations. 
Salmonella have the ability to both adhere to and invade cultured cells, including 
macrophage and epithelial cell lines. Exposure to the antibiotic gentamicin, which is 
a poor killer of intracellular bacteria, has been routinely used as a method for 
estimating invasion levels. Consequently, cultured Hep 2 cells were exposed 
independently to either S. Typhimurium SL1344(pSsaG) or one of S. Weltevreden 
SW C2346(pSsaG), SW 10259(pSsaG), SW98_11262(pSsaG) or SW 
99_3134(pSsaG) at a multiplicity of infection (MOI) of ~50 bacteria per cell. 
Plasmid pSsaG directs the expression of GFP from the SPI-2-associated ssaG 
promoter. Thus, host bacteria only become green when they have established a SCV 
(Figure 4.3).  
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Figure 4.3: Confocal microscopy of S. Typhimurium SL1344 and S. Weltevreden in Hep 2 cells, 2 
and 6 hours post exposure  
Cell nuclei were stained with DAPI (blue), common surface antigens (CSA) on the Salmonella bacteria 
are stained in red and the Salmonella (pSsaG) where GFP expressing and are visible in green (GFP). This 
data is representative of biological replicates of different S. Weltevreden isolates. 
 
All S. Typhimurium and S. Weltevreden were able to invade Hep 2 epithelial cells to 
some extent as monitored using fluorescent microscopy. Green intracellular 
Salmonella bacteria were observed in all cases by monitoring for the expression of 
GFP. S. Typhimurium SL1344 (pSsaG) exhibited a consistently stronger fluorescent 
signal at both the 2 and 6 h observation windows, compared to all S. Weltevreden. 
However, no significant difference in bacterial burden was obvious using this 
approach between the all S. Weltevreden isolates. Importantly, there were 
consistently lower levels of GFP-positive S. Weltevreden in the microscope imaging 
field than S. Typhimurium, indicating that they may be generally less invasive in this 
assay. 
To assess the bacterial burden using an alternative and more quantitative approach, a 
gentamicin-killing assay, in which predominantly internalised bacteria should 
survive, was performed. For S. Typhimurium SL1344, there was a consistent 
increase in the number of viable internalised bacteria between 2 and 6 h post 
infection. At 6 h post infection, there was a statistically significant difference 
(SL1344: P= 0.0001) in the number of viable bacteria recovered compared to the 2 h 
time point (Figure 4.4). However no significant differences in recovered numbers 
were observed between 2 h and 6 h for the S. Weltevreden isolates. Additionally, 
there was a consistently lower level of invasion by all S. Weltevreden isolates 
compared to S. Typhimurium SL1344. Thus, these data support the observations 
made using microscopy. 
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Figure 4.4: Number of viable Salmonella recovered in gentamicin killing assay  
The solid bars indicate the numbers of intracellular CFU recovered 2 h (black) and 6 h (Grey) post 
infection from Hep 2 cells infected with S. Typhimurium SL1344, S. Weltevreden SW C2346, SW 10259 
SW98_11262 or SW99_3134 (MOI, 50); the error bars indicate standard deviations. The 2-way ANOVA 
multiple comparisons statistics shows that S. Weltevreden isolates did not differ significantly between 2 h 
and 6 h. In contrast S. Typhimurium SL1344 numbers recovered increased significantly between 2 h and 
6 h. S. Typhimurium SL1344 was also generally more invasive than the S. Weltevreden. Biological 
triplicates were used while performing this experiment.. (Symbols: ns: p > 0.05, *: p ≤ 0.05, **: P ≤ 0.01, 
***: P ≤ 0.001, ****: P ≤ 0.0001). 
4.2.4.1 Electron microscopy 
Electron microscopy was utilised to further investigate the interactions between Hep 
2 cells and S. Weltevreden. Upon contacting host cells S. enterica can induce host 
cell membrane extensions called ruffles, which are particularly obvious upon entry 
into non-phagocytic cells. The appearance of such ruffles has been linked to the 
expression of the SPI-1 TTSS [254]. Initially Salmonella-Hep 2 cell interactions 
were investigated using Scanning Electron Microscopy (SEM). One hour post 
exposure of Hep 2 cells to S. Typhimurium SL1344 or the different S. Weltervreden, 
thin, long filopodia were observed in contact with the bacteria. These were readily 
visible on the Hep 2 cell surface associated with all bacteria and in the surrounding 
areas (Figure 4.5). These cell membrane ruffles were more obvious on the surface of 
S. Typhimurium SL1344 infected cells (Figure 4.5, middle panels). In contrast, Hep 
2 cells infected with all S. Weltevreden isolates showed less obvious ruffling on the 
cell surface, particularly in contact with adherent or invading bacteria (Figure 4.5, 
right panels). However, no obvious differences in this phenotype were observed 
between the different S. Weltevreden isolates.  
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Figure 4.5: SEM of Hep 2 cells infected with S. Typhimurium SL1344 or S. Weltevreden C2346 
Red arrows show Salmonella and blue arrows show structures observed in S. Weltevreden infected cells 
suggestive of reduced levels of ruffling. This data is typical of replicate assays performed over 3 times 
with different S. Weltevreden isolates. 
 
 
This data suggests that S. Weltevreden is generally less efficient at invading Hep 2 
cells. 
To further investigate the intracellular aspects of the infection, Hep 2 cells 
challenged with S. Typhimurum SL1344 or S. Weltevreden 10259 (only one 
representative of S. Weltevreden was used as no major differences between the 
isolates were observed in the previous experiments) were investigated using 
Transmission Electron Miscoscopy (TEM). Two hours post exposure to S. 
Typhimurum SL1344 and S. Weltevreden 10259, bacteria were routinely observed, 
many of which were residing within membrane-bound vacuoles (Figure 4.6). For S. 
Typhimurum SL1344 the SCV was well defined, and an enclosing membrane was 
clearly present. The S. Typhimurium had a generally healthy rod shape (Figure 4.6, 
panel A). Several cells with more than one bacterium within the vacuole were also 
observed, indicating that intracellular replication could be occurring (Figure 4.6, 
panel C). In contrast, cells infected with S. Weltevreden 10259 displayed a generally 
less distinct SCV, with a host membrane apparently very close to the bacterium 
resident within the vacuole. The bacterial cell also often exhibited an elongated form, 
potentially reflecting a more stressed state (Fig. 4.6, panel B). Fewer S. Weltervreden 
10259 were observed within vacuoles or indeed within challenged Hep 2 cells. 
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                   Figure 4.6: Typical TEM ultrastructures visualised within Hep 2 cells infected with S. Typhimurium (panel A) or S. Weltevreden  (panel B)  
                  A; black arrow indicating potential SCV membrane. Replication of S. Typhimurium Sl1344 within the SCV is represented in sub-panel C. This data is typical of        
replicate assays. 
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The observations are consistent with the concept that S. Weltevreden is less adapted 
to invasion and growth within Hep 2 cells compared to the typical S. Typhimurium 
SL1344.  
4.2.5 S. Weltevreden in the murine model  
As discussed previously there are a number of different murine models of Salmonella 
infection including the classical systemic typhoid model and the streptomycin pre-
treatment model more related to gastroenteritis. Consequently, S. Weltervreden was 
evaluated in both of these murine infection models. 
4.2.5.1 Systemic challenge 
To determine the systemic virulence of S. Weltevreden, C57bl/6 (Salmonella 
susceptible, Nramp-1 negative) mice were infected intravenously with either S. 
Typhimurium SL1344, S. Weltevreden SW C2346 or S. Weltervreden SW 10259 
using a dose of 2000 CFU/mice.  Mice were subsequently followed over a course of 
4 days to monitor clinical symptoms using an approved humane scoring method. 
Mice infected with the S. Weltevreden isolates were able to survive 4 days post 
infection and remained well thereafter until sacrificed. In contrast some of the 
C57bl/6 mice infected with S. Typhimurium SL1344 mice were deemed to be at the 
clinical endpoint in terms of severity by day 2 post infection and the others reached 
this state by day 4 and were sacrificed (Figure 4.7). 
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Figure 4.7: Percentage of survival of C57bl/6 mice challenged with S. Typhimurium SL1344,  
S. Weltevreden C2346 and S. Weltevreden 10259 following intravenous infection  
This data is typical of replicate assays performed in triplicate. 
 
4.2.5.2 Evaluation of S. Weltevreden in the streptomycin pre-treated 
colitis model 
S. Weltevreden is an emerging cause of colitis in humans. In order to model aspects 
of this disease and to unravel details of the potential mechanism of infection, 
streptomycin pre-treated C57bl/6 mice were orally challenged to investigate the 
ability of S. Weltevreden isolates to induce an inflammatory response and cause 
infection in the caecum. Four days post infection, a histopathological analysis of 
caecum revealed pronounced inflammation characterised by oedema in the 
submucosa, with distinct cellular inflammatory infiltrates in the submucosa, the 
lamina propria, and the epithelial layer, as well as the presence of immune cells in 
the intestinal lumen. Crypts elongation and erosive changes in the surface epithelium 
were also observed. These features were present in the caecum of mice infected with 
either S. Weltevreden and S. Typhimurium were as the caecum of PBS challenged 
mice displayed no noticeable oedema or neutrophil infiltration (Figure 4.8). 
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Figure 4.8: Histopathological analysis of caecum sections of mice infected with S. Typhimurium 
SL1344, S. Weltevreden C2346 or mock-injected with PBS 4 days post infection  
The top panels (a, b and c) show a representative section for each infection at magnification 10X. The 
mid panels (d. e and f) show details of the submucosa with infiltrates at magnification 40X. The bottom 
panels (g. h and i) show the structure of the crypts for each infection at magnification 40X. 
Abbreviations: sm: submucosa, oe: oedema, ns: normal structure, er: erosion of the membrane and pmd: 
polymorphonuclear leukocytes infiltrates. This data is representative of biological replicates  
 
Thus, in contrast to the attenuated phenotype displayed by S. Weltevrden in the 
systemic murine model, similar pattern in intestinal pathology were observed 
between the 2 serovars in the caecum after challenge of streptomycin-treated mice. 
Additionally, the levels of colonisation by the different S. enterica isolates was 
monitored by plating outweighed sections of the caecum and counting the number of 
surviving Salmonella per milligram of tissue (Figure 4.9). Plating weighed lobes of 
the liver also provided insights into the ability of these serovars to cause systemic 
infection post oral gavage in streptomycin pre-treated murine model (Figure 4.10). 
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Figure 4.9: Analysis of the impact of colonisation of the ceacum by S. Typhimurium SL1344,  
S. Weltevreden C2346 or S. Weltevreden 10259 in C57bl/6 mice 4 days post infection  
The Mann Whitney U T-Test shows a significant higher burden in ceaca infected with S. Typhimurium 
SL1344 compared to caecum infected with S. Weltevreden (p = 0.0317 and p = 0.0075). No significant 
difference between the different S. Weltevreden isolates was noted. This data is representative of 
biological replicates 
 
Interestingly, S. Typhimurium SL1344 exhibited a consistently higher level of 
caecum colonisation compare to the S. Weltevreden isolates and these differences 
reached statistical significance. In contrast, there was no significant difference in 
caecal colonisation between the two S. Weltevreden isolates studied.  
Ceacum comparison
SL1344 C2346 10259
100
101
102
103
104
105
106
107
CF
Us
 
/ m
g 
o
f t
is
s
u
e
SL1344
C2346
10259
ns
p = 0.0317
p = 0.0075
127 
 
 
Figure 4.10: Analysis of the levels of liver colonisation of S. Typhimurium SL1344, S. Weltevreden 
C2346  or  S. Weltevreden 10259 in C57bl/6 mice 4 days post infection  
A significantly higher bacterial burden was detected in the livers infected with S. Typhimurium SL1344 
compared to S. Weltevreden isolates as determined by the Mann Whitney U T-Test (p = 0.0001 and p < 
0.0001). No significant difference was observed between the colonisation levels of the livers by the S. 
Weltevreden isolates. This data is representative of biological replicates 
 
Thus, similarly to the data determined for colonisation in the caecum, S. 
Typhimurium SL1344 displayed a significantly higher colonisation level in murine 
liver compare to the S. Weltevreden isolates. Similarly, there was no significant 
difference in liver colonisation between the S. Weltevreden isolates. 
4.3 Discussion 
Phylogenetic analysis confirmed that the sequenced S. Weltevreden isolates fell into 
a monophyletic clade formed of several sub-clades. As S. Welterveden is an 
emerging cause of gastroenteritis in certain parts of the world, particularly South 
East Asia, it is important to link the genotype of isolates to classical phenotypic 
properties associated with pathogenesis. However, relatively little is known about the 
phenotypic properties of this serovar. Here, by comparing several S. Weltervreden 
isolates with the well-characterised S. Typhimurium SL1344, which was originally 
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isolated from a case of cattle enteritis, we were able to initiate a phenotypic 
characterisation of this serovar. 
The initial serology confirmed the serotype of all isolates according to the Kauffman-
White scheme. S. Weltevreden has an unusual (O10, O15) LPS antigen and r flagella 
type, falling into Salmonella Group E1. Other serovars with a similar antigenic 
composition include S. Ughelli, S. Elizabethville and S. Simi, all relatively rare in 
terms of their frequency of isolation. Indeed, there are virtually no reports on 
infections by these 3 serovars in the recent literature apart from the isolation of S. 
Simi in the Congo. 
Although the S. Weltervreden grew well on laboratory medium and were 
metabolically similar to S. Typhimurium SL1344, they exhibited defects in their 
ability to interact with eukaryotic cells and in their relative virulence for mice. 
Indeed, the S. Weltevreden isolates were significantly less invasive in terms of their 
ability to enter Hep 2 cells compare to S. Typhimurium SL1344. Furthermore, 
membranes ruffles on the cell surface were less likely to be observed in cells infected 
with S. Weltevreden. In contrast, less robust structures were observed in the surface 
of the Hep 2 cells exposed to S. Weltervreden, usually directly associated with 
attached bacteria. Interestingly, S. Weltervreden appears to have a normal SPI-1 
invasion system as far as can be deduced from simple comparative DNA analysis so 
it is not clear how the different invasive phenotypes are moderated genetically. S. 
Weltervreden may encode unknown effector proteins that have not yet been 
identified. Additionally different regulatory pathways may be in operation that 
impact on the expression of the SPI-1 system, although this was not investigated. 
Whatever, it is interesting that S. Weltervren does interact differently with Hep 2 
cells and this could impact directly on the virulence potential of this serovar. 
Similar to what was observed in-vitro in the Hep 2 invasion assays, the S. 
Weltevreden isolates were moderately attenuated in the mouse in both intravenous 
and oral streptomycin treated infection models, compare to S. Typhimurium SL1344. 
In fact, mice intravenously infected with S. Weltevreden were able to survive 4 days 
post infection while by day 2 post infection, some S. Typhimurium SL1344 infected 
mice were clinically moribund and had to be sacrificed according to the humane 
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protocols. Although similar levels of inflammation was observed in streptomycin 
treated mice infected with both serovars, there were higher systemic colony counts in 
the S. Typhimurium SL1344 infected animals. Indeed, the S. Weltevreden isolates 
displayed reduced growth and replication within the caecum and the liver of infected 
mice. Again, it is not clear why the S. Weltervreden were so attenuated in mice 
compared to S. Typhimuirum SL1344. Clearly, the reduced ability to exploit the SPI-
1 invasion system could be a factor, although this system is known not to be 
absolutely required for mouse virulence. There was no obvious mutation, for 
example in a known virulence factors that could explain the attenuation, as 
determined from the initial interrogations of genome sequence. Clearly, this is an 
area worthy of further investigation in alternative systems (see next Chapter). 
Some of the S. Weltervreden isolates under study were from cases of clinical disease 
and this serovar is now recognised as an emerging cause of gastroenteritis in a 
number of distinct geographical settings. It is interesting that even though S. 
Weltervreden shows some characteristics of attenuation on these models the isolates 
of this serovar are able to still cause disease in humans. Clearly, it is well established 
that host adaptation or even restriction is a relatively common property of Salmonella 
isolates and this may be to some degree what is being revealed by these studies. 
Derivatives of other Salmonella serovars that lack a fully functional SPI-1 or SPI-2 
system can cause disease in humans. For example, S. bongori lacks SPI-2 but is able 
to cause sporadic human gastroenteritis. Thus, clearly alternative host specific 
mechanisms of pathogenesis occur and not all have been defined to date. 
This first insight into the phenotypic characteristics of S. Weltevreden revealed an 
overall attenuated pathology compare to S. Typhimurium SL1344. Further studies 
addressing the metabolic choice of carbon sources as well as the mechanistic of 
epithelial cells invasion would provide a better understanding of S. Weltevreden 
interactions with the host. 
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5 S. Weltevreden in the zebrafish infection 
model 
 
5.1 Introduction 
In the previous chapters a phylogeny and phenotypic analysis of S. Weltevreden 
isolates was performed in an attempt to build up a database of information on this 
understudied serovar. S. Weltevreden has now been reported as a commonly isolated 
serovar both from the environment and from clinical cases in different parts of the 
world. Although the potential source of these S. Weltevreden isolates is varied, 
seafood products have been frequently implicated, implying a potential aquatic 
source, both fresh and salt water. These reports indicate that aquatic food sources 
may be an important transmission route of S. Weltevreden into the human population 
[229, 255] suggesting possibilities for marine and freshwater ecosystems as natural 
niches.  
This link with aquatic sources indicated that S. Weltevreden could potentially be a 
coloniser of fish. Thus, it was postulated that S. Weltevreden could potentially infect 
the zebrafish, which is frequently used as an infection model [256]. Additionally, 
many reports of S. Weltevreden are specifically linked to South East Asia, a native 
environment of the zebrafish. The zebrafish embryo has been extensively validated 
as a tool for investigations into many aspects of biology ranging from development 
to infection and immunity. A number of different bacteria can infect zebrafish 
embryos and indeed adult fish [257-265], for example. M. marinum has been used 
extensively as a model both for tuberculosis and for granuloma formation studies 
[163, 266]. Moreover, the zebrafish has been used to explore the pathogenesis of 
Salmonella infections, in particular to analyse the early host response to infection. 
The availability of zebrafish lines harbouring mutations in individual genes has 
extended the value of such studies. A particular focus has been on the role of 
macrophage in the dissemination and control of Salmonella infection. 
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                 Figure 5.1: Transgenic zebrafish embryos infected with S. Typhimurium SL1027 48 hpi. Taken from [164] 
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Here, the zebrafish infection model has been utilised to investigate the ability of S. 
Weltevreden to colonise or cause significant infection in a fish species. To this end, 
embryos were microinjected with either S. Typhimurium or S. Weltevreden using 
wild type or mutant zebrafish lines and the course of infection was followed over 
several days. 
5.2 Results 
5.2.1 Bacterial growth in-vitro at 28°C 
Since the optimal growth temperature for zebrafish is 28°C, S. Typhimurium 
SL1344, S. Weltevreden C2346 and 10259 were grown independently in LB broth at 
28°C and their respective growth was assessed over a time course of 24 hours. The 
results, shown in Figure 5.2, indicated that all isolates grew at a similar growth rate 
in this medium. The number of bacteria per OD is similar to what observed at 37°C 
in the same media (see Chapter 4) but the time of replication was longer (Figure 5.2).  
 
Figure 5.2: Growth curve showing the duplication time of S. Typhimurium SL1344 , S. 
Weltevreden C2346 and S. Weltevreden 10259 in LB medium at 28°C. 
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5.2.2 Infection challenge 
To determine the ability of S. Weltevreden isolates to infect zebrafish, 48 hour old 
embryos were systemically challenged using microinjection with ~250 CFU of either 
S. Typhimurium SL1344 or S. Weltevreden SW C2346 or they were mock infected 
using microinjection alone.  The embryos were subsequently monitored for up to 70 
hours post infection, scoring for survival (Figure 5.3). No deaths were recorded in S. 
Weltevreden infected embryos or those mock infected.  In contrast, ~50% of the 
embryos infected with S. Typhimurium were dead by 40 hours post infection (Figure 
5.3). 
 
 
Figure 5.3: Percentage of survival of zebrafish embryos microinjected with S. Typhimurium 
SL1344 (ST), S. Weltevreden C2346 (SW) or mock injected  
 (P < 0.0001 between S. Typhimurium SL1344 and S. Weltevreden C2346). 
 
As S. Weltevreden C2346 was clearly attenuated in this model compared to S. 
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survived despite the use of a higher challenge dose. These data confirms a significant 
level of attenuation of S. Weltevreden C2346 in the zebrafish embryo challenge 
model. 
5.2.3 Salmonella viability in the zebrafish embryo model 
The numbers of S. Weltevreden C2346 and S. Typhimurium SL1344 surviving at 
different time points after microinjection into embryos was assessed using viable 
counts. This involved plating out whole embryos and counting the number of 
surviving Salmonella at different time points after challenge (Figure 5.4). The 
number of viable Salmonella recovered from the embryos was similar to the number 
microinjected at 6 hours post infection (data not shown in the Figure) suggesting 
limited growth had occurred at this time point.  
 
Figure 5.4: Analysis of Salmonella survival within zebrafish embryos microinjected with 250 - 
300CFUs of S. Typhimurium SL1344 or S. Weltevreden C2346  
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Time points were 20 hpi, 39 hpi, 48 hpi. All S. Typhimurium challenged embryos were dead by 48 hours 
post challenge whereas S. Weltevreden C2346 was cleared at this point. The purple samples represent 
severely moribund fish in each group. 
 
Because the mortality between the 2 groups was not substantially different at 20 
hours post infection, statistical analysis were conducted at that time point to assess 
the replication of each bacterial strain within the embryos (figure 5.5). As observed 
earlier in the murine model, S. Typhimurium SL1344 displayed a significantly higher 
replication level in larvae compare to S. Weltevreden C2346. 
 
Figure 5.5: Analysis of the replication level within zebrafish embryos microinjected with 250 - 300 
CFUs of S. Typhimurium SL 1344 (ST SL1344) and S. Weltevreden C2346 (SW C2346) 20 hours 
post infection - P value < 0.0001. 
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were subsequently cleared around 2 days post infection as shown in Figure 5.6 
below. 
 
 
 
 
Figure 5.6: Kinetics of S. Weltevreden C2346 survival within zebrafish embryos over the course of 
the infection following challenge with 250 - 300 CFUs. 
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codons [225]. irf8 -/- zebrafish mutants are characterized by a complete lost of 
macrophages but an over production of neutrophils. Heterozygous mutant (irf8 +/-) 
fish harbour normal levels of macrophages and neutrophils [225]. 
irf8 +/- heterozygous parents were crossed and the resulting offspring was infected 
with a low dose (~100 CFU) of S. Typhimurium SL1344, S. Weltevreden C2346 or 
mock injected. The infection was followed over a course of 70 hours and the 
surviving fish were genotyped. The expected distribution of genotypes in each clutch 
is 50% irf8 +/-, 25% irf8 -/- and 25% of wild-type. Figure 5.7 summarises a 
compilation of the genotyping and viability data obtained in a typical experiment. 
 
Figure 5.7:Percentage of survival of wild-type irf8+/+, heterozygous mutants irf8st95/+ and 
homozygous mutants irf8 st95/st95 challenged with S. Typhimurium SL 1344 (ST), S. Weltevreden 
C2346 (SW) or mock-injected 70 hours post infection  
 
 
mock ST SW
0
20
40
60
80
100
Su
rv
iv
in
g 
la
rv
a
e
IRF8_st95 inx survival 70hpi (percentage)
irf8st95/st95
WT (irf8+/+ & irf8st95/+)
n = 43 n = 40 n = 31
Genotypes of surviving larvae
+/+ st95/+ st95/st95
mock 14 20 9
ST 11 19 1
SW 13 20 7
138 
 
It is evident that irf8 st95/st95 embryos infected with S. Weltevreden C2346 or mock 
injected have a higher survival rate than similar embryos challenged with S. 
Typhimurium SL1344. Thus, the attenuated phenotype of S. Weltevreden C2346 is 
significantly independent of the presence of macrophages. This indicates that the 
mechanism of attenuation is not macrophage dependent or associated. 
5.3 Discussion 
The initial phenotypic characterisation of S. Weltevreden described in the previous 
chapter revealed an overall attenuated phenotype in different models of disease 
compare to S. Typhimurium SL1344. S. Weltevreden was significantly attenuated in 
mouse models and in the ability to infect Hep 2 cells in an invasion assay. At this 
point, the mechanism of attenuation remains unknown. Interestingly, in the face of 
this ‘attenuated’ phenotype many reports are linking this serovar to serious cases of 
illness in humans. Thus, the correlation between these model systems and human 
infectivity is not absolute. Indeed, others have reported significant levels of 
attenuation in mouse-virulence and invasiveness with other Salmonella, for example 
the ST313 S. Typhimurium associated with invasive disease in sub-Saharan Africa 
[16, 267]. Again, in these cases the mechanisms of attenuation remain unknown, 
although genome degradation similar to S. Typhi has been reported [16]. However, 
we found no evidence for significant levels out of the norm for S. Weltevreden (see 
Chapter 3). 
Seafood and water based products have been implicated a potential source and/or 
transmission route for infection with S. Weltevreden. This association prompted in 
part this investigation into the ability of S. Weltevreden to infect zebrafish embryos.  
A comparative analysis of infectivity was undertaken by setting up simultaneous 
infections with either S. Typhimurium SL1344 to S. Weltevreden C2346. S. 
Typhimurium SL1344 is known to be significantly virulent for zebrafish embryos 
and this strain and similar S. Typhimurium have been extensively characterised by 
others in this model [257]. 
S. Weltevreden C2346 exhibited a significant level of attenuation following 
microinjection into young embryos even if different doses were used. Whereas 
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embryos infected with S. Typhimurium SL1344 routinely succumbed to infection 
embryos similarly challenged with S. Weltevreden C2346 normally survived and 
were even able to clear the infection challenge within 48-72 hours post challenge. 
Importantly, this lack of virulence of S. Weltevreden C2346 was even present when 
embryos defective in macrophage production (irf8 +/- mutant) were challenged. This 
indicates that the mechanism of attenuation is significantly independent of 
macrophages, which are known to be key cells involved in the pathogenesis and 
control of Salmonella infections in fish and other animals [268]. The ability of 
macrophage-deficient (irf8 -/- mutants) to clear the infection suggests a potential 
involvement of neutrophils in controlling S. Weltevreden infection. Whatever, S. 
Weltevreden C2346 displays significant levels of attenuation in multiple classical 
virulence models yet the serovar can still cause significant disease in humans.  
In a natural setting, infection may occur in adult fishes with fully developed immune 
systems, likely via the oral route. Thus, it would be interesting to explore the 
virulence of S. Weltevreden in adult zebrafish but this would require an animal 
licence not available during this study. Further studies in adult fish populations could 
help unravel the true relationship between S. Weltevreden and fish confirming 
whether the serovar is a natural commensal or pathogenic or simply attenuated in this 
particular host.   
The attenuated phenotype of S. Weltevreden in zebrafish embryos remains of interest 
and further experiments are planned beyond the immediate scope and time-frame of 
this thesis. RNA-seq analysis will be used to explore the nature of the host response 
to S. Weltevreden compared to S. Typhimurium infection and other isolates of S. 
Weltevreden should be used in this model to assess how broadly the attenuated 
phenotype is present in the serovar. Additionally, other mutant zebrafish lines could 
be used to explore further the mechanisms of attenuation, for example to identify 
mutant lines that succumb to S. Weltevreden challenge. 
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6 Summary and future directions 
 
In this study, a combination of whole genome sequencing, phylogenomics and in-
vitro/in-vivo phenotyping were used to characterise the serovar S. Weltevreden.  
Additionally, a complete reference genome was generated that will prove of value 
for further genetic work on this serovar. This analysis revealed that the average S. 
Weltevreden genome is larger than those of many other S. enterica serovars, with an 
average size above 5,000,000 base pairs. Much of this additional DNA can be 
accounted for in the accessory genome, where whole prophage and additional phage-
related elements are common. S. Elizabethville and S. Goldcrest were 
phylogenetically the closest S. enterica serovars to S. Weltevreden amongst the 
serovars for which other whole genome sequences are available. Interestingly, S. 
Elizabethville shares common core serological properties with S. Weltevreden but 
this serovar is not a common pathogen in humans. However, it will be interesting to 
see if these related serovars increase in their association with human diseases in the 
future. 
S. Weltevreden appears to be a monophyletic serovar assignable to 2 major 
phylogenetic clusters of largely ‘Continental cluster’ and ‘Island cluster’ isolates. 
Thus, there is evidence of a significant level of geographical clustering within S. 
Weltevreden. Some geographical clustering is also detectable within the sub-
phylogeny, suggesting that the S. Weltervreden serovar continues to evolve within a 
specific geographical region rather than frequently spreading from one location to 
another. Geographical subclustering has been detected in other serovars, including 
the S. Typhimurium ST313 clades within sub-Saharan Africa [269]. This suggests 
that Salmonella clades can become established in an environment or a population 
where they persist and evolve.  
One hundred and twelve SNPs were found to be cluster-specific and these could be 
of value in epidemiological tracking. For example, it will be interesting to determine 
if this type of data can be used to map potential transmission routes within 
populations. Can solid phylogenetic links be identified between seafood and S. 
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Weltevreden in human diseases? Is there evidence of human-to-human transmission? 
Here, some of the cluster-associated or even private SNPs will be exploitable in 
simple SNP-based assays for the rapid identification of S. Weltevreden isolates in the 
field. Such approaches have been developed for other Salmonella serovars, including 
S. Typhi [270, 271].  
It is significant that the phylogeny of S Weltevreden does not correlate with date of 
isolation, disease type or source (environment, animal, human) of the isolate, making 
it impossible to link particular genotypes to any disease syndrome. The inability to 
link genotype to human disease is intriguing and suggests that factors such as 
infectious dose, host susceptibility or environment could be influencing the patterns 
of disease. Here, more thorough epidemiological studies will be required to try to 
link isolates either in environment to human, animal to human or human to human 
transmission routes. Such studies could be performed in countries with significant 
levels of endemic S. Weltevreden disease or by analysing transmission within 
outbreaks, should they be identified. We are planning to perform such studies in 
Vietnam, where the incidence of S. Weltevreden is currently comparatively high. 
Here SNP-based assays will be applied. 
The analysis of S. Weltevreden plasmids revealed the presence of a large and highly 
conserved plasmid among the isolates, despite the diversity of geographical origin. 
More detailed recent analysis identified a number of candidate genes that could 
influence the phenotype of S. Weltevreden and possibly persistence in the 
environment and host (Figure 6.1). For example, 2 large tandem non-ribosomal 
peptide synthetases (NRPSs) of respectively 8381 and 13304 bp were found on the 
plasmid adjacent to a transporter, a rare scenario in the Salmonella genus. Tandem 
NRPSs, in combination with polyketide synthases (PKs) are commonly involved in 
small antimicrobial peptide synthesis [272]. The latter are usually implicated in a 
wide range of bioactivities including antibiotic production [273, 274], toxins, 
immuno-suppressants [275], anti-cancer molecules [276] and anti-fungals [277, 278]. 
The use of small antimicrobial peptide by the bacteria remains unclear; previous 
studies have speculated their potential use in fighting rival microorganism [279].  
Nevertheless, the fact that this plasmid is retained in the population suggests that it 
may offer a selective advantage to S. Weltevreden in some environments. The 
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generation if plasmid-less derivatives or even site-directed mutations in specific 
genes would facilitate studies on metabolism and virulence and it would be 
interesting to see if any plasmid-associated mutations were picked up in any future 
virulence screens.  
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Figure 6.1: Circular map of S. Weltevreden 10259 plasmid  
The restriction sites are marked on the plasmid. The purple and blue arrows represent the non-ribosomal peptide synthetase found on the plasmid adjacent to a putative transporter 
(orange arrow). 
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Antibiotic resistance is currently not commonly associated with S. Weltevreden. In 
fact, only a few antibiotic resistance genes were found in a few isolates. These very 
rare antibiotic resistant isolates harboured novel plasmids of types previously 
described in other bacteria. Thus, S. Weltevreden clearly has the capacity to acquire 
resistance and to evolve multiple antibiotic resistance. It will, thus, be important to 
maintain surveillance on the serovar in order to detect early any trend to increasing 
resistance.  
Phenotypic characterisation of S. Weltevreden in comparative analysis showed an 
overall attenuated pathology in in different models of disease compare to S. 
Typhimurium SL1344. S. Weltevreden isolates were significantly less invasive in 
terms of their ability to enter and replicates in Hep 2 cells. Indeed, membranes 
ruffles, key hallmark of Salmonella infection on the cell surface were less likely to 
be observed in cells infected with S. Weltevreden. In contrast, less robust structures 
were observed in the surface of the Hep 2 cells exposed to S. Weltervreden. Similarly 
to what observed in vitro in the Hep 2 cells, S. Weltevreden isolates were moderately 
attenuated in the mouse in both intravenous and oral streptomycin treated infection 
models, compare to S. Typhimurium SL1344. In fact, mice intravenously infected 
with S. Weltevreden were able to survive 4 days post infection while by day 2 post 
infection, some S. Typhimurium SL1344 infected mice were clinically moribund. 
Infection challenges of S. Weltevreden in zebrafish embryos also revealed an 
extremely attenuated phenotype and lack of virulence even in macrophage deficient 
zebrafish larvae. Considering that in a natural setting, infection is more likely to 
occur in adult fishes with fully developed immune systems via oral gavage, this 
exceptionally attenuated phenotype in laboratory setting suggests that the serovar is 
likely to be non-pathogenic for adult zebrafish. Unfortunately, we were unable to 
assess the virulence of S. Weltevreden in adult fish due to constraints on our animal 
licence but this work will be progressed in the future. Further studies in fish will be 
required to explain the prevalence of S. Weltevreden in marine products. In addition 
to the lack of virulence observed with this serovar in the fish, the ability of 
macrophage-deficient mutants to clear the infection suggest a critical involvement of 
neutrophils in controlling S. Weltevreden infection. 
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Despite the lack of antimicrobial resistance reported and the high level of attenuation 
reported in all diseased models explored in this study, more reports are linking S. 
Weltevreden to serious cases of foodborne illness and its predominance as a 
foodborne pathogen, particularly in the South-East Asian region. These data support 
the case for additional studies must be undertaken on the pathogenicity of S. 
Weltevreden. However, the options for studies on human disease are limited. One 
option might be to exploit human models based on differentiated human stem cell. 
New advances have facilitated the generation of different cell types and organoids 
from human induced pluripotent stem cells [280-284]. These include human 
macrophages and intestinal organoids that have both been used previously to explore 
Salmonella pathogenicity [285-287]. It would be interesting to evaluate the 
interaction of S. Weltevreden in such systems and studies of this type are planned. 
Alternatively human challenge studies similar to those undertaken with S. Typhi 
could be performed with S. Weltevreden [288]. 
A number of other questions remain to be answered including: 
Does the accessory genome impact on S. Weltevreden infection and regional 
spread? Despite the low level of antibiotic resistance reported in S. Weltevreden, the 
serovar is successful in colonising, causing disease and spreading, as observed 
throughout South-East Asia. It is not clear yet how this has been driven but this is 
unlikely to be only associated with the core genome, which is broadly shared across 
S. enterica. Phage and other mobile elements are known to be key drivers of 
diversity and evolution within S. enterica [128] and such elements might be worth 
interrogating experimentally in order to get a better answer on the geographical 
predominance of this serovar. However, additional sequencing coupled with a larger 
sample collection will be required to better characterise the accessory genome. The 
work presented here might be the foundation for further functional genomic work, 
including mutagenesis, RNA-seq and proteomics aiming to link the genotype to 
different phenotypes. 
Does S. Weltevreden exploit alternative regulatory pathway to invade and cause 
disease? S Weltevreden appears to have normal SPI-1 locus as determined by DNA 
sequencing and comparative DNA analysis. However, defects in invasion and/or 
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intracellular colonisation were observed in both in-vitro and in-vivo systems. In 
addition, the utilisation of alternative carbon sources commonly associated with soil 
and plant organism might suggest that S. Weltervreden inhabits different host 
environments compared to other Salmonella. For example, the accessory genome 
may encode novel effector proteins that could either exploit alternative survival 
pathways. Alternatively S. Weltevreden might have evolved novel regulatory 
systems that impact on the expression of the SPI-1 and other virulence-associated 
system. Experiments manipulating different pathways alongside RNA-seq analysis 
might begin to unravel the mechanisms of S. Weltevreden interaction with the host. 
Are neutrophils key in controlling S. Weltevreden infection? In our zebrafish 
infection studies, S. Weltevreden control appeared to coincide with the peak of the 
emergency granulopoiesis, previously reported after Salmonella infection in larvae 
by others [289].  We found that macrophage-deficient zebrafish larvae survived S. 
Weltevreden infection, suggesting that neutrophils might be essential in controlling 
such infections.  Future experiments addressing the role of neutrophils in S. 
Weltevreden infection might include using mutations that block neutrophil 
development in zebrafish embryos, such as Csf3r [290] or Runx1 [291]. Here, 
morpholinos could also be used to inhibit neutrophil effector mechanisms like 
reactive oxidase production [291]. Other approaches could involve depleting 
neutrophils in mice with antibody.  
Is S. Weltevreden a commensal in zebrafish and potentially other marine 
animals? Initial experiments presented here on S. Weltevreden infections in 
zebrafish embryos suggest an extremely attenuated phenotype. Monitored 
experiment in adult population replication the natural scenario in the wild could 
provide insight in the relationship between S. Weltevreden and marine animals. 
Indeed, it is possible that S. Weltevreden is a commensal in such populations, able to 
colonise without causing disease. This would potentiate any threat to humans who 
consumed contaminated food. Thus, it might be worth performing extensive 
environmental studies, particularly in potentially contaminated environments, to try 
to capture the true habitat of S. Weltevreden. Finally, it is clear that S. Weltevreden is 
emerging as a potential threat to human health in many parts of the world and that we 
know very little about the epidemiology of disease and the pathogenicity of the 
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serovar. Clearly there is a need for continuing studies in this serovar, some as 
outlined here. 
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Appendix 1: Samples’ information (metadata) 
 
The table below summarises key information of all samples used in the phylogenetic 
analysis. This includes the origin (country and region) of the isolates, year and 
source of isolation and antibiotic resistance profile. 
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Lane Name Country Region Year Source AMR Predicted 
AMR 
Cluster Sub-
Cluster 
12227_3#4 2011_00503 Guadeloupe Latin America 2011 Human Susceptible Susceptible 1 3 
12227_3#10 2011_11351 Guadeloupe Latin America 2011 Human Susceptible Susceptible 1 3 
12216_4#54 09_5462 Guadeloupe Latin America 2009 Human Susceptible Susceptible 1 2 
12227_3#57 2013_1467 France Europe 2013 Food (meat and vegetables) Susceptible Susceptible 2 4 
12227_3#56 2013_1418 France Europe 2013 Seafood and fish Susceptible Susceptible 1 1 
12227_3#55 2013_1051 France Europe 2013 Food (meat and vegetables) Susceptible Susceptible 2 4 
12227_3#54 2013_1032 France Europe 2013 Food (meat and vegetables) Susceptible Susceptible 1 3 
12227_3#53 2013_1005 France Europe 2013 Food (meat and vegetables) Susceptible Susceptible 1 3 
12227_3#51 2013_101 France Europe 2013 Seafood and fish Susceptible Susceptible 1 3 
12227_3#50 2013_71 France Europe 2013 Food (meat and vegetables) Susceptible Susceptible 1 3 
12227_3#44 2013_2776 France Europe 2013 Food (meat and vegetables) MDR Resistant 1 2 
12227_3#35 2013_4066 France Europe 2013 Seafood and fish Susceptible Susceptible 2 4 
12227_3#28 2006_3866 France Europe 2006 Seafood and fish Susceptible Susceptible 1 3 
12227_3#27 2006_3740 France Europe 2006 Seafood and fish Susceptible Susceptible 1 3 
12227_3#6 2011_02279 Mayotte Island Indian Ocean 2011 Human Ampicillin Resistant 2 5 
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12227_3#46 2013_2847 La Reunion Island Indian Ocean 2013 Animal Susceptible Susceptible 2 5 
12227_3#41 2012_4716 La Reunion Island Indian Ocean 2012 Environment Susceptible Susceptible 2 5 
12227_3#40 2012_4538 La Reunion Island Indian Ocean 2012 Food (meat and vegetables) Susceptible Susceptible 2 5 
12227_3#37 2012_2981 La Reunion Island Indian Ocean 2012 Environment Susceptible Susceptible 2 5 
12227_3#36 2012_2474 La Reunion Island Indian Ocean 2012 Animal Susceptible Susceptible 2 5 
12227_3#34 2013_3667 La Reunion Island Indian Ocean 2013 Animal Susceptible Susceptible 2 5 
12227_3#32 2013_3456 La Reunion Island Indian Ocean 2013 Food (meat and vegetables) Susceptible Susceptible 2 5 
12227_3#30 2013_3736 La Reunion Island Indian Ocean 2013 Animal Susceptible Susceptible 2 5 
12227_3#29 2013_3452 La Reunion Island Indian Ocean 2013 Food (meat and vegetables) Susceptible Susceptible 2 5 
12227_3#25 2013_05036 La Reunion Island Indian Ocean 2013 Human Susceptible Susceptible 2 5 
12227_3#2 2011_00200 La Reunion Island Indian Ocean 2011 Human Susceptible Susceptible 2 5 
12227_3#18 2013_00011 La Reunion Island Indian Ocean 2013 Human Susceptible Susceptible 2 5 
12227_3#17 2012_01076 La Reunion Island Indian Ocean 2012 Human Susceptible Susceptible 2 5 
12227_3#16 2012_02882 La Reunion Island Indian Ocean 2012 Human Susceptible Susceptible 2 5 
12227_3#14 2012_02227 La Reunion Island Indian Ocean 2012 Human Susceptible Susceptible 2 5 
12227_3#1 2010_06598 La Reunion Island Indian Ocean 2010 Human Susceptible Susceptible 2 5 
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12216_4#61 2010_09035 Mayotte Island Indian Ocean 2010 Human Susceptible Susceptible 2 5 
12216_4#55 09_8500 Mauritius Indian Ocean 2009 Human Susceptible Susceptible 2 5 
12216_4#51 08_2437 Maldives Indian Ocean 2008 Human Susceptible Susceptible 2 4 
12216_4#45 00_9879 Madagascar Indian Ocean 2000 Human Susceptible Susceptible 2 5 
12216_4#43 99_3134 La Reunion Island Indian Ocean 1999 Human Susceptible Susceptible 2 5 
12227_3#21 2013_02479 Algeria North Africa 2013 Human Susceptible Susceptible 1 1 
12227_3#7 2011_03604 Tahiti Island Oceania 2011 Human Susceptible Susceptible 2 4 
12227_3#49 2013_69 New Caledonia Oceania 2013 Animal Susceptible Susceptible 2 4 
12227_3#48 2013_2912 New Caledonia Oceania 2013 Industrial (porcine feed) MDR Susceptible 2 4 
12227_3#47 2013_2908 New Caledonia Oceania 2013 Industrial (porcine feed) Susceptible Susceptible 2 4 
12227_3#45 2013_2778 New Caledonia Oceania 2013 Seafood and fish Susceptible Susceptible 2 4 
12227_3#33 2013_3102 New Caledonia Oceania 2013 Food (meat and vegetables) Susceptible Susceptible 2 4 
12227_3#31 2013_3101 New Caledonia Oceania 2013 Food (meat and vegetables) Susceptible Susceptible 2 4 
12227_3#3 2011_00324 Tahiti Island Oceania 2011 Human Susceptible Susceptible 2 4 
12227_3#23 2013_104810 New Caledonia Oceania 2013 Human Susceptible Susceptible 2 4 
12227_3#20 2013_02134 Tahiti Island Oceania 2013 Human Susceptible Susceptible 2 4 
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12227_3#19 2013_00482 Tahiti Island Oceania 2013 Human Susceptible Susceptible 2 4 
12227_3#13 2012_08537 New Caledonia Oceania 2012 Human Susceptible Susceptible 2 4 
12227_3#12 2012_01335 Tahiti Island Oceania 2012 Human Susceptible Susceptible 2 4 
12227_3#11 2012_05005 Tahiti Island Oceania 2012 Human Susceptible Susceptible 2 4 
12216_4#62 2010_08341 Tahiti Island Oceania 2010 Human Susceptible Susceptible 2 4 
12216_4#47 03_1986 New Caledonia Oceania 2003 Human MDR Resistant 2 4 
12216_4#42 98_11262 New Caledonia Oceania 1998 Human Susceptible Susceptible 2 4 
12227_3#8 2011_07037 French Guyana Latin America 2011 Human Susceptible Susceptible 1 2 
12227_3#24 2013_04851 French Guyana Latin America 2013 Human Susceptible Susceptible 1 3 
12216_4#49 03_5461 French Guyana Latin America 2003 Human Susceptible Susceptible 1 2 
12216_4#48 03_4395 French Guyana Latin America 2003 Human Susceptible Susceptible 1 2 
12227_3#9 2011_09395 India South and South-
East Asia 
2011 Human Susceptible Susceptible 1 1 
12227_3#43 2013_2518 India South and South-
East Asia 
2013 Environment Susceptible Susceptible 1 2 
12227_3#42 2013_2515 India South and South-
East Asia 
2013 Food (meat and vegetables) Susceptible Susceptible 2 4 
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12227_3#39 2012_3614 India South and South-
East Asia 
2012 Seafood and fish Susceptible Susceptible 1 1 
12227_3#38 2012_3395 India South and South-
East Asia 
2012 Seafood and fish Susceptible Susceptible 2 4 
12227_3#15 2012_01497 Thailand South and South-
East Asia 
2012 Human Susceptible Susceptible 1 3 
12216_4#60 2010_08132 India South and South-
East Asia 
2010 Human Susceptible Susceptible 1 2 
12216_4#59 2010_07622 Sri Lanka South and South-
East Asia 
2010 Human Susceptible Susceptible 2 4 
12216_4#41 840K Sri Lanka South and South-
East Asia 
1956 Human Susceptible Susceptible 2 4 
Pacbio_10259_v
0.2 
10259 Vietnam South and South-
East Asia 
2009 Human Susceptible Susceptible 1 3 
9472_3#9 30291 Vietnam South and South-
East Asia 
2009 Human Susceptible Susceptible 1 3 
9472_3#8 20510 Vietnam South and South-
East Asia 
2009 Human Susceptible Susceptible 1 3 
9472_3#7 20372 Vietnam South and South-
East Asia 
2009 Human Susceptible Susceptible 1 2 
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9472_3#6 20069 Vietnam South and South-
East Asia 
2009 Human Susceptible Susceptible 1 3 
9472_3#5 10347 Vietnam South and South-
East Asia 
2009 Human Susceptible Resistant 1 2 
9472_3#4 10290 Vietnam South and South-
East Asia 
2009 Human Susceptible Susceptible 1 3 
9472_3#34 003_D14 Vietnam South and South-
East Asia 
2005 Human Susceptible Susceptible 1 1 
9472_3#33 C2512 Vietnam South and South-
East Asia 
2010 Human Susceptible Susceptible 1 2 
9472_3#32 C2511 Vietnam South and South-
East Asia 
2010 Human Susceptible Susceptible 1 1 
9472_3#31 C2471 Vietnam South and South-
East Asia 
2010 Human Susceptible Susceptible 1 3 
9472_3#30 C2377 Vietnam South and South-
East Asia 
2010 Human Susceptible Susceptible 1 3 
9472_3#28 C2346 Vietnam South and South-
East Asia 
2010 Human Susceptible Susceptible 1 1 
9472_3#27 C2248 Vietnam South and South-
East Asia 
2010 Human Susceptible Susceptible 1 3 
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9472_3#25 C2036 Vietnam South and South-
East Asia 
2010 Human Susceptible Susceptible 1 3 
9472_3#24 C2142 Vietnam South and South-
East Asia 
2010 Human Susceptible Susceptible 1 1 
9472_3#23 170_NVTN Vietnam South and South-
East Asia 
2007 Human Susceptible Susceptible 1 3 
9472_3#22 008_PNTL Vietnam South and South-
East Asia 
2007 Human Susceptible Susceptible 1 3 
9472_3#21 179_LTKT Vietnam South and South-
East Asia 
2007 Human Susceptible Susceptible 1 1 
9472_3#20 194_SL Vietnam South and South-
East Asia 
2007 Human Susceptible Susceptible 1 1 
9472_3#2 10162 Vietnam South and South-
East Asia 
2009 Human Susceptible Susceptible 1 2 
9472_3#19 184_VTHT Vietnam South and South-
East Asia 
2007 Human Susceptible Susceptible 2 4 
9472_3#18 46_DNBH Vietnam South and South-
East Asia 
2007 Human Susceptible Susceptible 1 3 
9472_3#17 38_NTMD Vietnam South and South-
East Asia 
2007 Human Susceptible Resistant 1 2 
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9472_3#16 8_LTPO Vietnam South and South-
East Asia 
2007 Human Susceptible Susceptible 1 3 
9472_3#15 132_NTNK Vietnam South and South-
East Asia 
2007 Human Susceptible Susceptible 1 3 
9472_3#14 94_VNQN Vietnam South and South-
East Asia 
2007 Human Susceptible Resistant 1 3 
9472_3#13 106_MR Vietnam South and South-
East Asia 
2007 Human Susceptible Susceptible 1 1 
9472_3#12 63_AYSA Vietnam South and South-
East Asia 
2007 Human Susceptible Susceptible 1 1 
9472_3#11 72_LNPT Vietnam South and South-
East Asia 
2007 Human Susceptible Susceptible 1 3 
9472_3#10 30438 Vietnam South and South-
East Asia 
2010 Human Susceptible Susceptible 1 1 
9472_3#1 iNT_635 Vietnam South and South-
East Asia 
2009 Human Susceptible Resistant 1 2 
12227_3#5 2011_00823 Indonesia South and South-
East Asia 
2011 Human Susceptible Susceptible 1 1 
12227_3#26 2013_05421 Thailand South and South-
East Asia 
2013 Human Susceptible Susceptible 1 3 
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12227_3#22 2013_03357 Thailand South and South-
East Asia 
2013 Human Susceptible Susceptible 2 4 
12216_4#58 2010_08825 Malaysia South and South-
East Asia 
2010 Human Susceptible Susceptible 1 2 
12216_4#57 2010_09500 Laos South and South-
East Asia 
2010 Human Susceptible Susceptible 1 3 
12216_4#56 2010_05280 Indonesia South and South-
East Asia 
2010 Human Susceptible Susceptible 1 1 
12216_4#53 09_4703 Indonesia South and South-
East Asia 
2009 Human Susceptible Susceptible 1 1 
12216_4#46 02_1171 Thailand South and South-
East Asia 
2002 Human Susceptible Susceptible 2 4 
12216_4#44 00_9824 Thailand South and South-
East Asia 
2000 Human Susceptible Susceptible 1 3 
12216_4#40 139K Indonesia South and South-
East Asia 
1940 Human Susceptible Susceptible 1 1 
10900_1#32 SR046 Vietnam South and South-
East Asia 
NA Animal Susceptible Susceptible 1 3 
10900_1#31 SR134 Vietnam South and South-
East Asia 
NA Animal Susceptible Susceptible 1 1 
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10868_1#91 74_V_379 Vietnam South and South-
East Asia 
NA Animal Susceptible Susceptible 1 3 
10868_1#90 7_H_437 Vietnam South and South-
East Asia 
NA Animal Susceptible Susceptible 1 3 
10868_1#89 71_V_366 Vietnam South and South-
East Asia 
NA Animal Susceptible Susceptible 1 3 
12227_3#52 2013_690 Unknown Unknown 2013 Seafood and fish Susceptible Susceptible 2 4 
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Appendix 2: Illumina HiSeq output 
 
The table below summarises the outcome of the Illumina HiSeq runs of all samples 
included in the study.  
  Mapping De novo assembly 
Name Reads Mapped 
% 
Coverage Length Contigs N50 Genes 
10868_1#89 3889532 98.1 73.94 5044941 97 112822 4949 
10868_1#90 4688928 98.7 89.64 5006424 78 144704 4905 
10868_1#91 4260526 93.1 76.88 5044922 177 147001 4919 
10900_1#31 2801512 95.5 51.83 5151860 80 143020 5053 
10900_1#32 3599042 99.4 69.34 5045168 76 149123 4951 
12216_4#40 5144766 99 98.65 4868524 71 134434 4748 
12216_4#41 4699890 98.4 89.61 4859440 65 144627 4757 
12216_4#42 4363564 98.5 83.26 4906994 64 133432 4769 
12216_4#43 4341900 94.4 79.43 5007548 57 214657 4946 
12216_4#44 4519078 99.5 87.12 5004210 78 149409 4894 
12216_4#45 4708460 97.7 89.15 5011241 63 164965 4917 
12216_4#46 4592746 98.2 87.41 4944440 74 139950 4871 
12216_4#47 4703734 84.5 76.97 5005467 62 172717 4948 
12216_4#48 4753954 99.2 91.38 4952303 72 161583 4828 
12216_4#49 4917208 99.2 94.49 4842349 69 175797 4722 
12216_4#51 4428042 97.9 84 4966191 60 195013 4857 
12216_4#53 4566100 98.4 87.07 4895076 72 162400 4784 
12216_4#54 5162754 97.9 97.93 5020258 67 195411 4933 
12216_4#55 4871450 95.8 90.43 5072792 52 284108 4980 
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12216_4#56 5284370 97.4 99.69 5052883 88 146745 4960 
12216_4#57 4568892 94.5 83.68 5090761 83 149007 4987 
12216_4#58 3952184 98.4 75.33 4976493 67 161403 4871 
12216_4#59 4459446 98.5 85.1 4921713 50 195414 4790 
12216_4#60 4151724 98.9 79.58 4960208 57 195403 4831 
12216_4#61 4393012 97.5 83 5007607 55 195318 4916 
12216_4#62 4618592 94.3 84.36 4945027 49 251959 4840 
12227_3#1 5194158 98.5 99.12 4962601 50 215020 4842 
12227_3#10 4570594 98.1 86.89 5042864 79 146957 4934 
12227_3#11 4926752 99.1 94.61 4751595 47 238100 4605 
12227_3#12 4813016 98.3 91.62 4924337 50 251914 4795 
12227_3#13 5236316 98.9 100.31 4915900 55 159187 4771 
12227_3#14 5412332 95.8 100.44 5101676 58 214999 4997 
12227_3#15 5730108 99.2 110.09 5042706 76 189557 4943 
12227_3#16 6052146 97.8 114.67 4996706 56 261708 4900 
12227_3#17 5260846 97.4 99.3 5008621 58 143289 4908 
12227_3#18 5372556 97.4 101.37 4988534 71 195207 4869 
12227_3#19 5187148 98 98.48 4883424 50 212167 4755 
12227_3#2 5011300 98.3 95.47 4965443 54 214985 4852 
12227_3#20 4480874 98.5 85.54 4923384 48 195388 4780 
12227_3#21 4586082 98.1 87.16 4978574 83 146469 4857 
12227_3#22 5036370 95.5 93.18 5035718 69 195212 4909 
12227_3#23 5827672 98.6 111.31 4944434 57 159186 4818 
12227_3#24 5502848 99.6 106.16 5023404 81 149196 4907 
12227_3#25 5068292 95.7 94.01 5101214 59 296488 5009 
12227_3#26 4538930 99.1 87.17 5038836 67 167656 4945 
12227_3#27 5409458 99.5 104.31 5047209 73 149174 4959 
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12227_3#28 5104036 99.5 98.35 5048510 76 146959 4953 
12227_3#29 5053162 97.7 95.65 4976937 55 195293 4860 
12227_3#3 5867244 98 111.44 4851166 52 251953 4690 
12227_3#30 4883262 98.5 93.17 4965221 48 214747 4847 
12227_3#31 5537958 98.3 105.48 4946827 58 159194 4816 
12227_3#32 5310382 97.8 100.65 4865035 47 195395 4764 
12227_3#33 4583850 98.3 87.29 4947501 64 159222 4819 
12227_3#34 4717704 96 87.75 5068657 56 255910 4958 
12227_3#35 5417350 99.1 104 4891302 56 162271 4755 
12227_3#36 5565292 97.7 105.32 5019360 58 214869 4915 
12227_3#37 5349784 97.8 101.4 4995518 59 255919 4890 
12227_3#38 4578170 98.4 87.26 4917439 44 282900 4786 
12227_3#39 5412292 97.9 102.62 4955321 69 162412 4847 
12227_3#4 5644922 98 107.2 5045161 69 175809 4929 
12227_3#40 5413274 97.6 102.32 5010535 58 195289 4924 
12227_3#41 4807198 90.9 84.64 5226277 59 195402 5169 
12227_3#42 5387826 97.8 102.04 4905900 47 236046 4774 
12227_3#43 5302882 98.4 101.13 4920067 60 175603 4792 
12227_3#44 5684572 97.2 107.07 5089435 79 176985 4997 
12227_3#45 5291962 98.2 100.69 4946756 58 227814 4822 
12227_3#46 5332544 97.6 100.78 5007769 56 205697 4919 
12227_3#47 5327502 98.7 101.85 4926290 52 206554 4775 
12227_3#48 4881750 98.6 93.29 4926529 53 236317 4780 
12227_3#49 4881894 98.1 92.82 4986584 56 160361 4868 
12227_3#5 6169240 98.7 117.95 4954924 75 162452 4808 
12227_3#50 4635114 99.5 89.37 5007888 72 149266 4887 
12227_3#51 4746446 99.5 91.5 5048359 76 149111 4955 
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12227_3#52 5429082 98.2 103.28 4965012 51 201132 4850 
12227_3#53 4376474 97.3 82.47 5133374 83 192470 5036 
12227_3#54 4530426 97.2 85.3 5130868 87 146957 5022 
12227_3#55 5260556 97.3 99.17 4927651 50 256825 4811 
12227_3#56 5363480 96.6 100.36 5132332 79 181687 5031 
12227_3#57 4621298 96.2 86.09 4977137 55 251917 4858 
12227_3#6 5679188 94.4 103.83 5098879 66 195247 5018 
12227_3#7 6293382 98.3 119.83 4841149 57 176642 4704 
12227_3#8 6262826 97.2 117.96 5001905 60 195413 4902 
12227_3#9 5228332 98.4 99.63 4991840 87 146861 4875 
9472_3#1 12568808 96.3 234.35 4935559 66 195369 4858 
9472_3#10 9411182 96.6 176.06 5135834 80 146736 5055 
9472_3#11 10538574 99.5 203.19 5052882 76 175982 4976 
9472_3#12 9721890 96.9 182.41 5165454 81 146725 5088 
9472_3#13 10502146 97.4 198.08 5161880 86 198510 5095 
9472_3#14 9740586 99 186.89 5066549 74 175906 4997 
9472_3#15 9668256 99.7 186.76 5012030 78 147037 4921 
9472_3#16 9882038 98.8 189.1 5058896 74 150539 4991 
9472_3#17 9964280 96.3 185.89 5029157 74 175836 4934 
9472_3#18 8627588 99.5 166.34 5045229 92 175630 4957 
9472_3#19 9728464 97.6 183.97 4934937 54 215006 4818 
9472_3#2 9987104 97.9 189.32 4988511 70 162584 4888 
9472_3#20 10661266 98.7 203.89 5015618 85 143410 4919 
9472_3#21 10592012 96.9 198.87 5169321 86 145882 5086 
9472_3#22 9617680 99.3 185.04 5014284 75 162533 4920 
9472_3#23 9213008 99.4 177.34 5064218 87 146103 4996 
9472_3#24 10013626 97 188.12 5166931 92 134459 5079 
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9472_3#25 11974942 99.4 230.49 5020379 70 147031 4938 
9472_3#27 9596238 99.8 185.5 5005406 72 146959 4899 
9472_3#28 8842562 96.9 166.04 5148340 87 146762 5056 
9472_3#30 8930070 89.8 154.96 5010158 73 175874 4916 
9472_3#31 8948484 98.3 170.44 5085083 65 195350 4995 
9472_3#32 10228588 94.4 187.04 5197912 101 134125 5125 
9472_3#33 11191750 90.5 195.31 5039988 69 243732 4975 
9472_3#34 7232246 87.2 121.62 5160889 79 146730 5074 
9472_3#4 8464880 98.6 161.76 5003613 73 146959 4963 
9472_3#5 10708366 97.8 202.92 5042617 75 195368 4974 
9472_3#6 8478962 98.2 161.31 5087212 67 175850 5003 
9472_3#7 9953400 97.4 187.83 4939069 70 162515 4850 
9472_3#8 9396910 99.3 180.81 5044982 77 147011 4959 
9472_3#9 11845904 99.5 228.27 4998331 75 162227 4890 
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Appendix 3: SNPs defining the major 
phylogenetic clusters 
 
A hundred and twelve SNPs were found to enable to discriminate between the 2 
major clusters. The table below provides a comprehensive description of each SNP, 
their position in the genome and putative functions of the genes they were found in. 
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Coordinates Continental Islands Type Change Name Function 
38110 T G Nonsynonymous M1I yhcR secreted 5'-nucleotidase 
53518 C G Nonsynonymous V1M ribF riboflavin biosynthesis protein RibF 
150218 T C Synonymous 287R murD UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase 
159866 G A Intergenic 
   
165171 A G Synonymous 48V lysR_1 LysR family transcriptional regulator 
171185 G C Nonsynonymous Y110H hofB protein transport protein HofB 
186542 A G Intergenic 
   
455296 A G Intergenic 
   
482321 T C Nonsynonymous T116A yajI lipoprotein 
493751 G A Intergenic 
   
551959 T A Nonsynonymous D132N ybaN Inner membrane protein YbaN 
553182 G T Intergenic 
   
555948 G A Nonsynonymous R136C SBOV4431 chaperone protein HtpG 
623261 A G Intergenic 
   
666014 A G Intergenic 
   
667137 A G Intergenic 
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694039 C A Nonsynonymous A14V entF enterobactin synthetase component F 
731339 G A Nonsynonymous N142K citF_2 citrate lyase subunit alpha 
877723 A G Nonsynonymous L16P sdcS_1 cation transporter 
882274 C T Nonsynonymous N160T 10259_00846 membrane protein 
885476 T C Synonymous 245N gpmA phosphoglyceromutase 
928510 C T Synonymous 217L ybhL_1 membrane protein 
969008 A G Intergenic 
   
1087552 T C Synonymous 94D cydD cysteine/glutathione ABC transporter membrane/ATP-binding component 
1102354 C T Nonsynonymous L171F dmsB_2 anaerobic dimethyl sulfoxide reductase subunit B 
1151458 C T Synonymous 268T 10259_01111 amino acid:proton symporter 
1202670 T A Nonsynonymous S177P pepN aminopeptidase N 
1283933 T C Synonymous 70P 10259_01257 hypothetical protein 
1461980 A T Intergenic 
   
1539870 A G Intergenic 
   
1560429 T C Intergenic 
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1625658 G A Intergenic 
   
1669118 G A Intergenic 
   
1694992 A C Intergenic 
   
1697445 G A Nonsynonymous P186L SBOV16411 putative inner membrane protein 
1703784 G C Nonsynonymous L19R 10259_01695 protein ydcJ 
1720617 T C Synonymous 76N gatC_1 phosphotransferase enzyme 
1735902 C A Nonsynonymous V190I ydcR_1 GntR family transcriptional regulator 
1743929 A G Synonymous 37R 10259_01734 ssrAB activated gene 
1782320 G A Intergenic 
   
1792507 C T Synonymous 243Y galS_1 transcriptional regulator 
1827483 T G Intergenic 
   
1842679 C T Nonsynonymous P191L 10259_01827 lipoprotein 
1904277 G A Synonymous 33P ydhJ multidrug resistance efflux pump 
1938526 G T Nonsynonymous Y191H sseC pathogenicity island 2 effector protein SseC 
1945318 G C Nonsynonymous A206T ssrA sensor kinase 
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1948148 C T Nonsynonymous P212A ycgE_1 MerR family transcriptional regulator 
1952986 T C Nonsynonymous N234H ttrB tetrathionate reductase subunit B 
1955378 C T Synonymous 391L ttrA tetrathionate reductase subunit A 
2072991 C T Synonymous 395H dosC diguanylate cylase 
2104434 A T Intergenic 
   
2155215 T C Synonymous 29G mnmA tRNA-specific 2-thiouridylase MnmA 
2179555 A C Nonsynonymous I24T ycfS LD-transpeptidase YcfS 
2306947 T G Nonsynonymous I253V ackA_1 propionate kinase 
2312418 C T Nonsynonymous V262L dacD penicillin-binding protein 
2327448 G A Synonymous 20L hisC histidinol-phosphate aminotransferase 
2349279 C T Nonsynonymous G266D rfbD_2 dTDP-4-dehydrorhamnose reductase 
2368620 T C Nonsynonymous P271H wcaC glycosyltransferase 
2388569 G A Nonsynonymous G3R yegN RND family transporter protein 
2397768 A G Intergenic 
   
2487266 C T Nonsynonymous N31H yeiO sugar efflux transporter 
2571886 C A Synonymous 233G arnB UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate 
aminotransferase 
2644752 C T Nonsynonymous A315V folC folylpolyglutamate synthase 
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2655437 C A Intergenic 
   
2745065 A G Synonymous 152R xapA purine nucleoside phosphorylase 
2751842 T C Intergenic 
   
2806294 A C Nonsynonymous T319I dapE succinyl-diaminopimelate desuccinylase 
2830342 A G Nonsynonymous I331S ppx exopolyphosphatase 
2918022 A C Nonsynonymous H332D dmsA_4 putative anaerobic dimethylsulfoxide reductase 
2939599 T C Nonsynonymous L349Q 10259_02939 reductase 
3029090 G A Nonsynonymous L36P nadB L-aspartate oxidase 
3044150 G A Synonymous 372K kgtP alpha-ketoglutarate transporter 
3165103 G T Nonsynonymous G366S gabR DeoR family transcriptional regulator 
3192557 G A Synonymous 87L srlA Glucitol/sorbitol permease IIC component 
3247227 A G Synonymous 216Q spaR virulence associated secretory protein 
3250702 G A Synonymous 12Q spaI secretory apparatus ATP synthase (associated with 
virulence) 
3258960 A C Intergenic 
   
3323082 G A Nonsynonymous W394C SBOV30001 conserved hypothetical protein 
3469564 A G Synonymous 84Q yqgD inner membrane protein 
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3502405 T C Nonsynonymous R422L 10259_03509 FIC domain-containing protein 
3559237 G T Nonsynonymous E431Q STY3343 putative exported protein 
3638294 T C Nonsynonymous R451L tdcD propionate/acetate kinase 
3710463 G A Synonymous 122L mtgA monofunctional biosynthetic peptidoglycan 
transglycosylase 
3715222 T G Intergenic 
   
3734518 G A Intergenic 
   
3784257 T C Synonymous 260V acrF acriflavin resistance protein F 
3798695 G A Synonymous 51P fmt methionyl-tRNA formyltransferase 
3844549 C T Intergenic 
   
3861654 A G Synonymous 68* aroB 3-dehydroquinate synthase 
3933453 A G Intergenic 
   
3935103 G A Synonymous 226S php phosphotriesterase 
4022010 T A Nonsynonymous A49V 10259_04023 putative inner membrane protein 
4054900 G A Nonsynonymous D498G xylR xylose operon regulatory protein 
4087478 C A Intergenic 
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4151451 A G Intergenic 
   
4179949 T C Synonymous 81N 10259_04171 putative secreted protein 
4183764 C A Intergenic 
   
4202714 G A Nonsynonymous A51T dsdX permease 
4231325 T G Nonsynonymous M5118T 10259_04223 2-oxo-3-deoxygalactonate kinase 
4343874 A G Nonsynonymous S55R hemC porphobilinogen deaminase 
4464873 G A Nonsynonymous L550Q siaT_2 integral membrane transport protein 
4469553 A C Nonsynonymous A561E cpxA two-component sensor kinase protein 
4478528 G A Synonymous 175K yicJ_2 sodium:galactoside symporter 
4525097 G A Intergenic 
   
4528083 T C Intergenic 
   
4537997 A G Intergenic 
   
4613302 A G Nonsynonymous T68A 10259_04597 histidine biosynthesis protein 
4651837 A T Intergenic 
   
4659202 C T Synonymous 224N bepC type-I secretion protein 
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4676493 T C Nonsynonymous N697H 10259_04641 Ig domain-containing protein 
4740492 T C Intergenic 
   
4783210 C T Nonsynonymous P7S sugE SugE protein 
4785518 A C Nonsynonymous H71Y frdB fumarate reductase, iron-sulfur protein 
4794271 C T Nonsynonymous S75T psd phosphatidylserine decarboxylase proenzyme 
4863047 C T Intergenic 
   
4865401 G A Nonsynonymous F78I iolB 5-deoxyglucuronate isomerase 
4867756 G T Intergenic 
   
4867800 G A Intergenic 
   
4872126 T C Synonymous 359D 10259_04826 lysosomal glucosyl ceramidase 
4883973 G A Synonymous 37E pmbA peptidase PmbA 
4901727 G A Nonsynonymous G84D mgtA magnesium-transporting ATPase MgtA 
4982215 C G Nonsynonymous R88Q mdtM sugar transport protein 
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Appendix 4: MLST data 
 
The table below summarises the sequence type (ST) and the alleles numbers for the 
house keeping genes used to compile the MLST profile of all samples used in the 
study and the ones that were discarded.  
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Isolate-LANE ID ST aroC dnaN hemD hisD purE sucA thrA 
10868_1#89.contigs_velvet 1500 130 97 25 125 422 9 101 
10868_1#90.contigs_velvet 1500 130 97 25 125 422 9 101 
10868_1#91.contigs_velvet 1500 130 97 25 125 422 9 101 
10900_1#31.contigs_velvet 1500 130 97 25 125 422 9 101 
10900_1#32.contigs_velvet 1500 130 97 25 125 422 9 101 
12216_4#40.contigs_velvet 559 130 97 25 125 U 9 101 
12216_4#41.contigs_velvet 1500 130 97 25 125 422 9 101 
12216_4#42.contigs_velvet 1500 130 97 25 125 422 9 101 
12216_4#43.contigs_velvet 559 U 97 25 125 U 9 101 
12216_4#44.contigs_velvet 1500 130 97 25 125 422 9 101 
12216_4#45.contigs_velvet 1500 130 97 25 125 422 9 101 
12216_4#46.contigs_velvet 1500 130 97 25 125 422 9 101 
12216_4#47.contigs_velvet 1500 130 97 25 125 422 9 101 
12216_4#48.contigs_velvet 1500 130 97 25 125 422 9 101 
199 
 
12216_4#50.contigs_velvet 1500 130 97 25 125 422 9 101 
12216_4#49.contigs_velvet 1500 130 97 25 125 422 9 101 
12216_4#51.contigs_velvet 1500 130 97 25 125 422 9 101 
12216_4#52.contigs_velvet 518 101 41 40 184 76 90 3 
12216_4#53.contigs_velvet 1500 130 97 25 125 422 9 101 
12216_4#54.contigs_velvet 1500 130 97 25 125 422 9 101 
12216_4#55.contigs_velvet 1500 130 97 25 125 422 9 101 
12216_4#56.contigs_velvet 1500 130 97 25 125 422 9 101 
12216_4#57.contigs_velvet 1500 130 97 25 125 422 9 101 
12216_4#58.contigs_velvet 1500 130 97 25 125 422 9 101 
12216_4#59.contigs_velvet 1500 130 97 25 125 422 9 101 
12216_4#60.contigs_velvet 1500 130 97 25 125 422 9 101 
12216_4#61.contigs_velvet 1500 130 97 25 125 422 9 101 
12216_4#62.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#10.contigs_velvet 1500 130 97 25 125 422 9 101 
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12227_3#11.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#12.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#13.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#14.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#15.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#16.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#17.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#18.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#19.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#1.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#20.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#22.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#21.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#24.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#23.contigs_velvet 1500 130 97 25 125 422 9 101 
201 
 
12227_3#26.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#25.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#28.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#27.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#29.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#2.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#30.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#31.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#32.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#33.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#34.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#35.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#36.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#37.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#38.contigs_velvet 559 130 97 25 125 422 9 U 
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12227_3#39.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#3.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#40.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#41.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#42.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#43.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#44.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#45.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#46.contigs_velvet 559 U 97 25 125 422 9 101 
12227_3#47.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#48.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#49.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#4.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#50.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#51.contigs_velvet 1500 130 97 25 125 422 9 101 
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12227_3#52.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#53.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#54.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#55.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#56.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#57.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#5.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#6.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#7.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#8.contigs_velvet 1500 130 97 25 125 422 9 101 
12227_3#9.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#10.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#11.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#12.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#13.contigs_velvet 1500 130 97 25 125 422 9 101 
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9472_3#14.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#15.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#16.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#17.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#18.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#19.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#1.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#20.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#21.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#22.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#23.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#24.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#25.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#26.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#28.contigs_velvet 1500 130 97 25 125 422 9 101 
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9472_3#27.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#2.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#29.contigs_velvet 1684 U U U U 281 U 
 
9472_3#30.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#31.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#32.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#33.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#3.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#34.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#4.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#5.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#6.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#7.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#8.contigs_velvet 1500 130 97 25 125 422 9 101 
9472_3#9.contigs_velvet 1500 130 97 25 125 422 9 101 
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Appendix 5: Phage search in Phast   
 
The table below shows an the outcome of the phage search performed on Phast for 4 
S. Weltevreden isolates.  
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S. Weltevreden 10259 contig 1 undefined product 1:5062936 forward .5062936, GC%: 52.16%, length = 5062936 bps 
 
Total : 13 prophage regions have been identified, of which 9 regions are intact, 3 regions are incomplete, 1 regions are questionable.  
REGION REGION_LENGTH COMPLETENESS SCORE #CDS REGION_POSITION POSSIBLE PHAGE GC % DETAIL 
1  41Kb  intact  150  53  624585-665599  PHAGE_Salmon_Fels_1_NC_010391, ......  
51.97%
  
Detail 
2  43.8Kb  intact  150  52  1014619-1058492  PHAGE_Salmon_ST64B_NC_004313, ......  
49.45%
  
Detail 
3  32.9Kb  questionable  70  9  1057625-1090615  
PHAGE_Cronob_vB_Csa
M_GAP32_NC_019401, 
......  
53.59%
  
Detail 
4  47.3Kb  intact  150  57  1153517-1200901  PHAGE_Gifsy_2_NC_010393, ......  
51.04%
  
Detail 
5  11.8Kb  incomplete  40  12  1431061-1442946  PHAGE_Entero_HK106_NC_019768, ......  
51.78%
  
Detail 
6  47.8Kb  intact  150  63  2107247-2155075  PHAGE_Gifsy_1_NC_010392, ......  
51.83%
  
Detail 
7  40.7Kb  intact  105  58  2674176-2714885  PHAGE_Salmon_c341_NC_013059, ......  
47.29%
  
Detail 
8  58.5Kb  intact  105  57  2822899-2881489  PHAGE_Escher_TL_2011b_NC_019445, ......  
51.06%
  
Detail 
9  18.4Kb  incomplete  50  21  2980916-2999341  PHAGE_Aggreg_S1249_NC_013597, ......  
50.88%
  
Detail 
10  37.6Kb  intact  100  30  2987821-3025476  PHAGE_Salmon_SPN3UB_NC_019545, ......  
51.98%
  
Detail 
11  34.8Kb  intact  128  45  3060402-3095234  PHAGE_Entero_PsP3_NC
_005340, ......  
51.90%
  
Detail 
12  24.8Kb  incomplete  30  14  4930004-4954832  PHAGE_Entero_P4_NC_001609, ......  
49.57%
  
Detail 
13  7.5Kb  intact  110  15  4943648-4951226  PHAGE_Shigel_SfIV_NC
_022749, ......  
49.24%
  
Detail 
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S. Weltevreden C2346 Contig 1 5129845 forward .5129845, GC%: 52.18%, length = 5129845 bps 
 
Total: 11 prophage regions have been identified, of which 8 regions are intact, 3 regions are incomplete, 0 regions are questionable.  
REGION REGION_LENGTH COMPLETENESS SCORE #CDS REGION_POSITION POSSIBLE PHAGE GC % DETAIL 
1  41Kb  intact  150  54  634260-675274  
PHAGE_Salmon_
Fels_1_NC_0103
91, ......  
51.97%  Detail 
2  26.8Kb  incomplete  60  9  1022187-1049025  
PHAGE_Cronob_
vB_CsaM_GAP3
2_NC_019401, 
......  
53.51%  Detail 
3  48.7Kb  intact  150  60  1121849-1170548  
PHAGE_Gifsy_2
_NC_010393, 
......  
51.04%  Detail 
4  48.1Kb  intact  150  61  1459559-1507668  
PHAGE_Gifsy_1
_NC_010392, 
......  
51.80%  Detail 
5  19.3Kb  incomplete  40  12  2157246-2176555  
PHAGE_Entero_
HK106_NC_0197
68, ......  
45.84%  Detail 
6  54.4Kb  intact  110  56  2762040-2816527  
PHAGE_Entero_
phiV10_NC_0078
04, ......  
51.36%  Detail 
7  44.5Kb  intact  150  54  2910719-2955279  
PHAGE_Salmon_
SPN3UB_NC_01
9545, ......  
51.18%  Detail 
8  34.8Kb  intact  128  43  2990205-3025037  
PHAGE_Entero_
PsP3_NC_005340
, ......  
51.90%  Detail 
9  64.6Kb  intact  150  58  4650120-4714751  
PHAGE_Salmon_
ST64B_NC_0043
13, ......  
51.83%  Detail 
10  24.8Kb  incomplete  30  14  4996913-5021741  PHAGE_Entero_ 49.57%  Detail 
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P4_NC_001609, 
......  
11  7.5Kb  intact  110  15  5010557-5018135  
PHAGE_Shigel_S
fIV_NC_022749, 
......  
49.24%  Detail 
 
S. Weltevreden 98_11262 Contig 1 4897142, GC%: 52.18%, length = 4897142 bps 
 
Total : 8 prophage regions have been identified, of which 4 regions are intact, 3 regions are incomplete, 1 regions are questionable.  
REGION REGION_LENGTH COMPLETENESS SCORE #CDS REGION_POSITION POSSIBLE PHAGE GC % DETAIL 
1  51.6Kb  intact  120  79  940-52580  
PHAGE_Entero_
ST64T_NC_0043
48, ......  
47.13%  Detail 
2  6.3Kb  questionable  90  13  792695-799011  
PHAGE_Ralsto_p
hiRSA1_NC_009
382, ......  
48.41%  Detail 
3  12.1Kb  incomplete  40  17  801306-813443  
PHAGE_Entero_
P4_NC_001609, 
......  
50.81%  Detail 
4  34.1Kb  intact  110  41  2133831-2168020  
PHAGE_Vibrio_
8_NC_022747, 
......  
50.01%  Detail 
5  48.1Kb  intact  150  62  3446723-3494831  
PHAGE_Gifsy_1
_NC_010392, 
......  
51.80%  Detail 
6  19.3Kb  incomplete  40  12  4142117-4161426  
PHAGE_Entero_
HK106_NC_0197
68, ......  
45.84%  Detail 
7  48.3Kb  intact  150  58  4391859-4440190  
PHAGE_Gifsy_2
_NC_010393, 
......  
51.09%  Detail 
8  18.9Kb  incomplete  60  9  4513062-4532052  PHAGE_Cronob_ 53.58%  Detail 
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vB_CsaM_GAP3
2_NC_019401, 
......  
 
S. Weltevreden 99_3134 Contig 1 4977779, GC%: 52.15%, length = 4977779 bps 
 
Total : 11 prophage regions have been identified, of which 7 regions are intact, 3 regions are incomplete, 1 regions are questionable.  
REGION REGION_LENGTH COMPLETENESS SCORE #CDS REGION_POSITION POSSIBLE PHAGE GC % DETAIL 
1  34.9Kb  intact  150  48  309-35286  
PHAGE_Salmon_
Fels_1_NC_0103
91, ......  
47.34%  Detail 
2  51.5Kb  intact  100  54  370802-422363  
PHAGE_Entero_
P22_NC_002371, 
......  
48.13%  Detail 
3  6.3Kb  questionable  80  12  1162475-1168791  
PHAGE_Ralsto_p
hiRSA1_NC_009
382, ......  
48.41%  Detail 
4  23.5Kb  incomplete  30  14  1158855-1182435  
PHAGE_Entero_
P4_NC_001609, 
......  
49.37%  Detail 
5  34.3Kb  intact  100  39  2503660-2537985  
PHAGE_Vibrio_
8_NC_022747, 
......  
50.01%  Detail 
6  34.7Kb  intact  125  48  3050986-3085752  
PHAGE_Entero_
PsP3_NC_005340
, ......  
52.60%  Detail 
7  61.9Kb  intact  150  56  3861593-3923505  
PHAGE_Gifsy_1
_NC_010392, 
......  
51.81%  Detail 
8  24.8Kb  incomplete  50  8  3911226-3936104  
PHAGE_Cronob_
vB_CsaM_GAP3
2_NC_019401, 
......  
51.64%  Detail 
211 
 
9  46.1Kb  intact  150  57  4009349-4055531  
PHAGE_Gifsy_2
_NC_010393, 
......  
50.73%  Detail 
10  11.8Kb  incomplete  40  12  4279868-4291753  
PHAGE_Entero_
HK106_NC_0197
68, ......  
51.79%  Detail 
11  26.8Kb  intact  150  41  4950836-4977691  
PHAGE_Gifsy_1
_NC_010392, 
......  
49.80%  Detail 
Legend: 
REGION: the number assigned to the region 
REGION_LENGTH: the length of the sequence of that region (in bp) 
COMPLETENESS: a prediction of whether the region contains a intact or incomplete prophage based on the above criteria 
SCORE: the score of the region based on the above criteria 
#CDS: the number of coding sequnce 
REGION_POSITION: the start and end positions of the region on the bacterial chromosome 
PHAGE: the phage with the highest number of proteins most similar to those in the region  
GC_PERCENTAGE: the percentage of gc nucleotides of the region 
DETAIL: detail info of the region
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Appendix 5: Microarray (Biolog) data  
 
The graphs below show the results of the metabolic assay for each Phenotype 
Microarray (PM) plates used. Each data set contains the template of the PM with the 
respective graph of the results. 
 
Each well displays the kinetics of the utilisation of a specific metabolite (see 
template). The blue lines represent the metabolite utilisation by S. Typhimurium 
SL1344, the green lines represent the metabolite’s utilisation by S. Weltevreden 
C2346 and the red lines represent the metabolite’s utilisation by S. Weltevreden 
10259. Each experiment was conducted in duplicates therefore each well display 2 
line per isolates. 
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PM 1 dataset 
214 
 
 
 
 
 
PM 2 dataset 
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PM 3 dataset 
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PM 4 dataset 
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PM 9 dataset 
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PM 10 dataset 
 
 
 
